CURRICULUM VITAE - UCOMcGuffin P and Murray R M (Eds). Butterworth-Heinmann: Oxford 1991. 5a. Schizophrenia (First Edition) Frangou S and Murray R M. Martin Dunitz: London 1996. (Revised

CURRICULUM VITAECURRICULUM VITAE

Name: ROBIN MacGREGOR MURRAY

CURRENT POST

Professor of Psychiatric Research, Institute of Psychiatry at the Maudsley, Kings College, University of London

EDUCATION

Royal High School, EdinburghGlasgow University: Graduated MB ChB in 1968, having been awarded the year prizes in Psychiatry and Social Medicine

PRE-REGISTRATION POSTS

1968-1969 Surgery at the Royal Hospital for Sick Children, Glasgow1969 Medicine at the Western Infirmary, Glasgow

POST-REGISTRATION

1969-1971 Senior House Officer on the Medical Training Rotationat the Western Infirmary, Glasgow

1971-1972 Medical Registrar to Professor G.M. Wilson, Regius Professor of Medicine, Glasgow University

1972-1975 Senior House Officer and Registrar at the Maudsley Hospital, London1975-1976 Research Worker and Honorary Senior Registrar

at the Institute of Psychiatry and Maudsley Hospital, London1976-1977 Visiting Fellow in Psychiatry (nominated by the UK Medical

Research Council) at the Clinical Neuropharmacology Branch,National Institute of Mental Health, Bethesda, Maryland

1977-1978 Senior Registrar at the Bethlem Royal Hospital, London1978-1984 Senior Lecturer at the Institute of Psychiatry1978-present Honorary Consultant Psychiatrist, Bethlem & Maudsley

Hospitals1984-1989 Reader in Biological Psychiatry at the Institute of Psychiatry1982-1989 Dean, Institute of Psychiatry1989-1999 Professor of Psychological Medicine, Institute of Psychiatry and

King's College Hospital Medical School

1

1998-2009 Professor of Psychiatry and Chairman, Division of Psychological Medicine and Psychiatry, Institute of PsychiatryPOSTGRADUATE QUALIFICATIONS

MRCP (UK) 1971MRCPsych 1974MD (Glasgow) 1974M Phil (London) l976FRCP (Glasgow) 1984FRCPsych 1986DSc (London) 1988FMedSci 1998

FRS 2010

AWARDS

Gaskell Gold Medal for Clinical Psychiatry of the Royal College of Psychiatrists, 1975

Research Prize of the Royal College of Psychiatrists, 1976

MRC Travelling Fellowship, 1976-77

Mapother Travelling Fellowship, 1979

Leverhulme Fellowship, 1988

Royal Society Senior Research Fellowship, 1993-94

Kurt Schneider Award from "Deutschen Gesellschaft furPsychiatrie", 1994

Adolf Meyer Award of the American Psychiatric Association, 1997

Paul Hoch Award of the American Psychopathological Association, 1998

Dean Award of the American College of Psychiatrists, 1999

Hilton Distinguished Investigator Award of the National Alliance for Research into Schizophrenia and Depression (NARSAD), 1999

Robert Sommer Award, 2000

Fifth Castilla del Pino Award for Achievement in Psychiatry, 2002

Elected Lifetime Honorary Member of the Association of European Psychiatry, 2002

Psykiatriyhdistys Suomen Medal of the Finnish Psychiatric Society, 2003

Lieber Award for Schizophrenia Research of NARSAD 2003

2

Elected Foreign Member of the US Institute of Medicine. 2003

Fellow of Kings College, London 2004

Medal of University of Helsinki 2004

William K. Warren Award of the International Congress on Schizophrenia Research 2005

Elected Member of Academia Europaea 2005

British Medical Association: Psychiatric Book of the Year (Madness and Marijuana) jointly with David Castle 2005

Great Britons Awards sponsored by Morgan Stanley/Daily Telegraph. Runner up for the scientist who has made the greatest contribution to public understanding in 2005

British Medical Association: Chosen as one of 20 “Role Models” in Medicine, 2005.

Medal of the University of Palermo 2006

Eric Stromgren Medal, University of Arrhus, 2007

Honorary Membership to the Italian Society of Psychiatric Epidemiology 2007

Marsh Award for Mental Health Work, Rethink, 2007

"Pieter Baan Award" of the Dutch Association of Psychiatrists 2008

Research Unit named after me in University of Sao Paulo 2008

King's College Lifetime Achievement Award 2008

Honorary Fellowship Royal College of Psychiatrists 2010

Fellow of the Royal Society 2010

SOME PROFESSIONAL ADMINISTRATIVE AND COMMITTEE RESPONSIBILITIES

Present:President of Schizophrenia International Research SocietyJoint Editor of Psychological Medicine

2000-2009Member of Council of Royal College of Psychiatrists

3

Chairman Academic Faculty of the Royal College of PsychiatristsMedical Research Council Advisory College of Experts

2000-2004Chairman Medical Research Council Co-op in Neurodevelopmental Basis of Psychosis

2003-PresentVisiting Professor in Psychiatry at the University of the West Indies.

1998/ 9/2000:UK Committee on Safety of MedicinesCouncil of Imperial CollegeWellcome Trust Tropical Interest Group PanelAdvisory Board, Centre for Mental Health Services Development

1995-1996:President of the Association of European Psychiatrists

1989- 2004Member of the Management Board of Kings College School of Medidicne and then Guys, Kings and St Thomas’ School of Medicine

1985-Present:Visiting Professor in Psychiatry at the University of Sao Paulo, Brazil. During this time, 24 Brazilian colleagues have received PhDs from the Institute of Psychiatry.

1986- Present: At different times, advisor to various Governments/Universities/Research Councils re Psychiatric Services and Research – UK, Holland, Norway, Sweden, Kenya, Jamaica, South Africa, Singapore, Hong Kong

1989-Present:Member of numerous committees within Institute of Psychiatry (IOP), Guys, Kings, and St Thomas’ School of Medicine, and South London & Maudsley NHS Trust.

1982-89:As Dean of Institute of Psychiatry, the IOP representative on numerous Committees, e.g. Bethlem & Maudsley SHACamberwell Health AuthorityBoard of British Postgraduate Medical FederationVarious committees within University of London and SE Thames RHA

1982-85:Research Committee of the Mental Health Foundation

1980-83:4

Secretary, Programmes and Meetings Committee, Royal College of Psychiatrists

1977-80:Secretary, Addiction Section, Royal College of Psychiatrists

1977-78:Trainee representative on the Council of the Royal College of Psychiatrists

1975-78:Member of the Trainees Working Party of the Royal College of Psychiatrists

1975:Chairman, Association of Psychiatrists in Training (APIT)

1974:Secretary, Junior Common Room, Maudsley Hospital

JOURNAL BOARDS and REVIEWING

Member of Editorial Boards of Schizophrenia Research, Schizophrenia Bulletin, Psychiatry Research, Psychological Medicine, Psychiatric Genetics, Neuropsychiatric Genetics, European Psychiatry, International Review of Psychiatry, plus a variety of national and regional journals, Guarantor of Brain.

Regular Reviewer for Archives of General Psychiatry, American Journal of Psychiatry, Acta Psychiatrica Scandinavica, British Journal of Psychiatry, Lancet, British Medical Journal, etc.

THESES* SUPERVISED1981 E Shur MPhil1982 C A Clifford PhD1984 P McGuffin PhD1984 A Topham PhD1985 P McKeon MD1986 S W Lewis MPhil1986 A J Holland MPhil1988 M A Reveley PhD1988 H M D Gurling MD1991 I Harvey MD1991 P Sham MSc1992 R Persaud MPhil1992 J Rutherford MPhil1993 S W Lewis MD1995 L Lim PhD1995 E Dawson PhD1995 D Castle MD1995 H Vallada PhD1995 J van Os PhD1995 C Duggan MD1995 P Wright MD

5

1996 A Macdonald PhD1996 T Rushe PhD1996 N Takei PhD1997 B Coid PhD1997 P Jones PhD1997 M-W Lin PhD1997 T Griffiths MD1998 P W R Woodruff PhD1998 P K McGuire PhD1998 A Cleare PhD1999 A Grech MSc2000 T Dixon PhD2000 T Toulopoulou PhD2001 E Kravariti PhD2001 C-K Chen PhD2002 M Cannon PhD2002 S Frangou PhD2002 F Mapua-Filbey PhD2002 Y Linney PhD2002 A Lebessi PhD2002 E M Walsh MD2003 E-W Loh PhD2003 K Morgan PhD2003 L McIntosh PhD2003 S Frearson PhD2003 C Gilvarry PhD2004 M Cuddy PhD2004 T Li PhD2005 E Giouroukou PhD2005 P Fearon PhD2005 E Bramon PhD2005 P Birkett MD2006 P Dazzan PhD 2006 K Schulze PhD2006 M-H Hall PhD2006 M Allin MD2006 A Ruiz PhD2007 J Maccabe PhD2007 I Mata PhD2008 M Walshe PhD2008 A Pentaraki PhD2008 B Magnusdottir PhD 2008 J Lappin PhD2008 R Gafoor PhD2009 V Mondelli PhD2009 I Williams PhD2010 R Dutt PhD2010 S Smith MD

2010 F Kane PhD 2010 S Tosato PhD

6

*100% successful

PUBLICATIONS

BOOKS

1a. Essentials of Postgraduate Psychiatry (First Edition)Hill P, Murray R M and Thorley A (Eds). Academic Press: London 1979.

1b. Essentials of Postgraduate Psychiatry (Second Edition)Hill P, Murray R M and Thorley A (Eds). Grune and Stratton: London 1986.

1c. Essentials of Postgraduate Psychiatry (Third Edition)Murray R M, Hill P, McGuffin P (Eds). Cambridge University Press: Cambridge 1997.

1d. Essential Psychiatry (Fourth Edition)Murray R M, Kendler KS, McGuffin P, Wessely S, and Castle DJ (Eds). Cambridge University Press: Cambridge 2008.

2. The Misuse of Psychotropic DrugsMurray R, Ghodse H, Harris C, Williams D and Williams P (Eds).Gaskell: London 1981.

3. Lectures on the History of PsychiatryMurray R M and Turner T H (Eds). Gaskell: London 1990.

4. The New Genetics of Mental IllnessMcGuffin P and Murray R M (Eds). Butterworth-Heinmann: Oxford 1991.

5a. Schizophrenia (First Edition)Frangou S and Murray R M. Martin Dunitz: London 1996.(Revised Edition: 1997; Swedish Edition: 1997).

5b. Schizophrenia (Second Edition)Frangou S and Murray R M. Martin Dunitz: London 2000.

(Italian Edition: 2001; Japanese Edition: 2002)

6. Neurodevelopment and Adult PsychopathologyKeshaven M S and Murray R M (Eds). Cambridge University Press: Cambridge 1997.

7. Psychosis in the Inner City: The Camberwell First Episode StudyMaudsley Monograph. Castle D, Wessely S, van Os J and Murray R M.Psychology Press: Hove 1998.

8. First Episode of PsychosisAitchison K J, Meehan K, and Murray R M. Martin Dunitz: London 1999.

9. Comprehensive Care of SchizophreniaLieberman J A and Murray R M (Eds). Martin Dunitz: London 2001.

10. An Atlas of SchizophreniaStefan M D, Travis M and Murray R M (Eds). Parthenon Publishing: London 2002.

11. The Maudsley Handbook of Practical Psychiatry (Fourth Edition)Goldberg D, Murray R (Eds). OUP: Oxford 2002.

7

12. The Epidemiology of SchizophreniaMurray R M, Jones P B, Susser E, van Os J and Cannon M (Eds). CUP: Cambridge 2003.

13. A Guide to Neuroimaging in Psychiatry Fu CHY, Russell T, Senior C, Weinberger DR, Murray RM (Eds) Martin Dunitz, London 2003

14. Schizophrenia: Challenging the Orthodox. McDonald C, Schulze K, Murray R and Wright P (Eds). Martin Dunitz, London 2004.

15 Marijuana and Madness Castle D and Murray R (Eds) Cambridge University Press, 2004

16 Neurodevelopment and schizophrenia Keshavan M, Kennedy J and Murray R (Eds) Cambridge University Press, 2004

17 Bipolar disorder: the upswing in research and treatment McDonald C, Schulze K, Murray R and Mauricio Tohen (Eds). Martin Dunitz, London 2005.

18 The Maudsley Handbook of Practical Psychiatry (Fifth Edition)Goldberg D, Murray R (Eds). OUP: Oxford 2006.

19 Beyond Nature and Nurture in Psychiatry. Edited by J.Maccabe, O.O'Daly, RM Murray, PMcGuffin, P.Wright Informa Healthcare, Abingdon, 2006

20 Cognition and schizophrenia: improving real life function. Edited by K Morgan, A David, R Murray, J Eberhard Cambridge Medical Communication Ltd, UK, 2006

21 The Maudsley Handbook of Practical Psychiatry (Fifth Edition). Goldberg D, Murray R (Eds). OUP: Oxford 2006.

ARTICLES AND BOOK CHAPTERS

1970

1. Lawson DH, Murray RM, Parker JLW, Hay G (1970). Hypokalaemia in Megaloblastic Anaemias. Lancet, 2, 588-590.

2. Murray RM, Timbury GC, Linton AL (1970). Analgesic abuse in psychiatric patients. Lancet, 1, 1303-1305.

1971

3. Murray RM, Lawson DH, Linton AL (1971). Analgesic nephropathy: clinical syndrome and prognosis. British Medical Journal, 1, 479-482.

4. Murray RM, Greene JG, Adams JH (1971). Analgesic abuse and dementia. Lancet, 2, 242-245.

5. Murray RM (1971). Analgesic abuse. Lancet, 2, 1960. (Letter).

1972

6. Lawson DH, Murray RM, Parker JLW (1972). Early mortality in the megaloblastic anaemias. Quarterly Journal of Medicine, 41, 1-14.

7. Murray RM, Smith R (1972). Co-existent analgesic nephropathy and bromism. Lancet, 1, 73-74.

8

8. Murray RM (1972). Persistent analgesic abuse in analgesic nephropathy. Journal of Psychosomatic Research, 16, 57-72.

9. Murray RM (1972). Removal of phenacetin from proprietary analgesics. British Medical Journal, 4, 131-172.

10. Murray RM (1972). The use and abuse of analgesics. Scottish Medical Journal, 17, 393-397.

1973

11. Murray RM (1973). Survey of analgesic consumption. Lancet, 1, 554. (Letter).

12. Murray RM (1973). The geographical distribution of analgesic nephropathy. Health Bulletin, 31, 1-3.

13. Murray RM (1973). The origins of analgesic nephropathy. British Journal of Psychiatry, 123, 99-106.

14. Murray RM (1973). Patterns of analgesic use and abuse in medical patients. Practitioner, 211, 639-644.

15. Murray, RM (1973). The wages of analgesics. Lancet, 2, 1484-5. (Editorial).

16. Murray RM (1973). Dependence on analgesics in analgesic nephropathy. British Journal of Addiction, 68, 265-272.

17. Murray RM (1973). The origins of analgesic nephropathy: the psychosocial background of patients with analgesic nephropathy. In “Proceedings of the International Symposium on Phenacetin Abuse”. Facta Publications: Vienna.

1974

18. Murray RM (1974). Personality factors in analgesic nephropathy. Psychological Medicine, 4, 69-73.

19. Murray RM (1974). Analgesic abuse. British Journal of Hospital Medicine, 11, 772-780.

20. Murray RM (1974). Psychiatric illness in doctors. Lancet, 1, 1211-1213.

21. Murray RM (1974). Dimethyltryptamine and psychosis. Lancet, 2, 140. (Editorial)

1975

22. Adams GF, Murray RM (1975). The radiological diagnosis of analgesic nephropathy. Clinical Radiology, 26, 417-427.

23. Oon MCH, Murray RM, Brockington IF, Birley JLT, Rodnight R (1975). Urinary dimethyltryptamine in psychiatric patients. Lancet, 2, 1146-7. (Letter).

24. Murray RM (1975). New approaches to alcoholism. Update, June, 379-381.

25. Murray RM (1975). Alcoholism and employment. Journal of Alcoholism, 10, 23-26.

1976

26. Jefferys P, Murray RM (1976). Trainees' assessment of "Vocational" training in psychiatry; A Pilot Study at the Maudsley Hospital. Medical Education, 10, 52-55.

27. Murray, RM (1976). A Wellcome Boost. Lancet, 2, 29. (Editorial).

28. Murray RM, Oon MCH (1976). The excretion of Dimethyltryptamine in psychiatric patients. Proceedings of the Royal Society of Medicine, 69, 831-832.

29. Murray RM (1976). Alcoholism amongst male doctors in Scotland. Lancet, 2, 729-731.

30. Murray RM (1976). Characteristics and prognosis of alcoholic doctors. British Medical Journal, 2, 1537-1539.

9

31. Rodnight R, Murray RM, Oon MCH, Brockington IF, Nicholls P, Birley JLT (1976). Urinary dimethyltryptamine and psychiatric symptomatology and classification. Psychological Medicine, 6, 649-657.

1977

32. Murray RM (1977). Screening and early detection instruments for disabilities related to alcohol consumption. In “Alcohol Related Disabilities”. Edited by Edwards G, Gross MM, Keller M, Moser J, Room R. WHO: Geneva.

33. Murray RM (1977). Psychiatric illness in male doctors and controls: an analysis of Scottish hospitals inpatient data. British Journal of Psychiatry, 131, 1-10.

34. Murray RM (1977). The alcoholic doctor. British Journal of Hospital Medicine, 18, 144-149. Reprinted in Contemporary Psychiatry. Edited by S. Crown, pp.182-188. Butterworths: London, 1984.

35. Oon MCH, Murray RM, Rodnight R, Murphy M, Birley, JLT (1977). Factors affecting the urinary excretion of endogenously formed dimethyltryptamine in normal human subjects. Psychopharmacology, 54, 171-175.

1978

36. Murray RM (1978). Genesis of analgesic nephropathy in the United Kingdom. Kidney International, 13, 50-57.

37. Murphy DL, Shiling D, Murray RM (1978). Psychoactive drug responder subgroups: possible contributions to psychiatric classification. In “Psychopharmacology; A Generation of Progress”. Pp. 807-820. Edited by Lipton MA, DiMascio A, Killam KF. Raven Press: New York.

38. Murray RM, Murphy DL (1978). Drug response and psychiatric nosology. Psychological Medicine, 8, 667-681.

39. Murray RM (1978). The health of doctors: a review. Journal of the Royal College of Physicians, 12, 403-415.

1979

40. Murray RM (1979). A reappraisal of American psychiatry. Lancet, i, 255-258.

41. Murray, RM (1979). Born to drink? Lancet, 1, 24-25. (Editorial).

42. Toone B, Clare A, Creed F, Murray RM (1979). Psychiatrists' Models of Mental Illness and their personal backgrounds. Psychological Medicine, 9, 165-178.

43. Murray RM (1979). Psychiatric morbidity among medical practitioners. Update, February, 143-148.

44. Murray RM, Cooper JE, Smith A (1979). The Leyton Obsessional Inventory: an analysis of the responses of 73 obsessional patients. Psychological Medicine, 9, 305-311.

45. Murray RM, Oon MCH, Rodnight R, Birley JLT, Smith A (1979). Increased excretion of dimethyltryptamine and certain features of psychosis: a possible association. Archives of General Psychiatry, 36, 644-649.

46. Hill P, Murray RM, Thorley A (Editors) (1979). The Essentials of Postgraduate Psychiatry. Academic Press. Also the chapters therein on Measurement in Psychiatry (jointly), Schizophrenia, Alcoholism, and Psychiatry of Old Age (jointly).

47. Murray RM (1979). Contribution to the "Report on Alcohol and Alcoholism" of the Royal College of Psychiatrists. Tavistock Press, 1979. Reprinted in Modern Medicine, Dec 1979, 8 & 11.

48. Murray RM (1979). The Kessel Report. British Journal of Addiction, 74, 436. (Letter).

49. Murray RM (1979). America salutes Lithium. Lancet, ii, 1168. (Editorial).

10

1980

50. Murray RM (1980). Minor analgesic abuse: the slow recognition of a public health problem. British Journal of Psychiatry, 75, 9-17.

51. Murray RM (1980). The medical profession. In "Alcohol Problems in Employment". Pp 61-76. Edited by Hore BD and Plant MA. Croom Helm: London.

52. Murray RM (1980). An epidemiological and clinical study of alcoholism in the medical profession. In “Aspects of Alcohol and Drug Dependence”. Pp 213-219. Edited by Madden JS, Walker R, Kenyon WH. Pitman Press: Bath.

53. Murray RM, Gurling HMD (1980). Genetic contributions to normal and abnormal drinking. In “The Psychopharmacology of Alcohol”. Pp 89-106. Edited by Sandler M. Raven Press: New York.

54. Checkley SA, Murray RM, Oon MCH, Rodnight R, Birley JLT (1980). A longitudinal study of urinary excretion of N N Dimethyltryptamine in psychotic patients. British Journal of Psychiatry, 137, 236-239.

55. Murray RM (1980). Why are the drug companies so disinterested in alcoholism? British Journal of Addiction, 75, 113-115.

56. Murray, RM (1980). Twins at Jerusalem. Lancet, 2, 244. (Editorial).

57. Reveley AM, Murray RM (1980). The genetic contribution to the functional psychoses. British Journal of Hospital Medicine, 24, 166-171. (Reprinted in Contemporary Psychiatry. Edited by S. Crown, pp. l0-l8. Butterworths: London, 1984).

58. Murray RM, Bernadt M (1980). Early detection of alcoholism. Medicine, 35, 1811-1815. (Reprinted in Readings in Psychiatry. Edited by W. Jackson. Medicine Publishing Foundation: Oxford, 1982).

59. Murray RM, Bernadt M (1980). Mental illness in doctors. Geriatric Medicine, 10, 49-51.

60. Murray RM (1980). Screening Tests for Alcoholism? Lancet, 2, 1117. Editorial.

1981

61. Creed F, Murray RM (1981). The teaching of clinical skills at a postgraduate hospital. Psychological Medicine, 11, 391-399.

62. Murray RM (1981). The detection and management of alcohol abuse in General Practice. In “Psychiatry in General Practice”. Pp 31-43. Edited by Edwards G. University of Southampton Press.

63. Reveley AM, Gurling HMD, Murray RM (1981). Mortality and psychosis in twins. In “Twin Research 3: Intelligence, Personality and Development”. Pp 175-178. Edited by Gedda L, Parisi P, Nance WE. Alan Liss: New York.

64. Clifford CA, Fulker DW, Murray RM (1981). A genetic and environmental analysis of obsessionality in normal twins. In “Twin Research 3: Intelligence, Personality and Development". Pp 163-169. Edited by Gedda L, Parisi P and Nance WE. Alan Liss: New York.

65. Gurling HMD, Clifford CA, Murray RM (1981) . Investigations into the genetics of alcohol dependence, and into its effects on brain function. In “Twin Research 3: Epidemiological and Clinical Studies". Pp 77-87. Edited by Gedda L, Parisi P, Nance WE. Alan Liss: New York.

66. Clifford CA, Fulker DW, Murray RM (1981). Preliminary Findings from a Twin Study of Alcohol Use. In “Twin Research 3: Epidemiological and Clinical Studies". Pp 47-52. Edited by Gedda L, Parisi P, Nance WE. Alan Liss: New York.

67. Reveley AM, Murray RM (1984). The genetic contribution to the neuroses. British Journal of Hospital Medicine, 25, 185-190. (Reprinted in “Contemporary Psychiatry”. Pp 1-9. Edited by Crown S. Butterworths: London, 1984).

11

68. Murray, RM (1981). Minor brain damage and alcoholism. British Medical Journal, 283, 435-456. (Editorial).

69. Reveley AM, Reveley MA, Murray RM (1981). Effects of neuroleptic drugs on MAO activity. British Journal of Psychiatry, 139, 475-476. (Letter).

1982

70. Murray RM, Cutting J (1982). Alcohol problems in the general hospital. In "Medicine and Psychiatry: A Practical Approach". Pp 396-410. Edited by Creed F, Pfeffer JM. Pitman: London.

71. Scott A, Kelleher MJ, Smith A, Murray RM (1982). Regional differences in obsessionality and obsessional neurosis. Psychological Medicine, 12, 131-134.

72. Murray RM, Gurling HMD (1982). Alcoholism: polygenic influence on a multifactorial disorder. British Journal of Hospital Medicine, 27, 328-334.

73. Barrison IG, Viola L, Mumford J, Murray RM, Gordon M, Murray-Lyon I M (1982). Detecting excessive drinking among admissions to a general hospital. Health Trends, 14, 80-83.

74. Bernadt M, Mumford J, Taylor C, Smith B, Murray RM (1982). Comparison of questionnaire and laboratory tests in the detection of excessive drinking and alcoholism. Lancet, 1, 325-328.

75. Reveley AM, Reveley MA, Clifford CA, Murray RM (1982). Cerebral ventricular size in twins discordant for schizophrenia. Lancet, 1, 540-541.

76. Reveley AM, Murray RM (1982). Genetic studies of anxiety neurosis. Journal of Drug Research, 7, 35-41.

77. Murray RM, Stabenau JR (1982). Genetic factors in alcoholism predisposition. In "American Handbook of Alcoholism". Pp 135-144. Edited by Pattison EM, Kaufman E. Gardner Press: New York.

78. Bhattacharya SK, Glover V, Sandler M, Clow A, Topham A, Bernadt M, Murray RM (1982). Raised endogenous Monoamine Oxidase Inhibitor output in postwithdrawal alcoholics: effects of L-Dopa and Ethanol. Biological Psychiatry. 17, 829-836.

1983

79. Higgitt A, Murray RM (1983). A psychotic episode following Erhard Seminars Training. Acta Psychiatrica Scandinavica, 67, 436-439.

80. Murray RM (1983). A genetic contribution to alcoholism? In “Alcohol: The Preventive Debate”. Pp 180-184. Edited by Grant M, Ritson B. Croom Helm: London.

81. Murray RM (1983). The mentally ill doctor: causes and consequences. Practitioner, 227, 65-75.

82. Murray RM, Clifford CA, Gurling HMD (1983). Twin and adoption studies. How good is the evidence for a genetic role? In "Recent Developments in Alcoholism” Volume 1. Pp 25-48. Edited by Galanter M. Plenum Press: New York.

83. McGuffin P, Festenstein H, Murray RM (1983). A family study of HLA antigens and other genetic markers in schizophrenia. Psychological Medicine, 13, 31-43.

84. Reveley MA, Reveley AM, Clifford CA, Murray RM (1983). Genetics of platelet MAO activity in discordant schizophrenic and normal twins. British Journal of Psychiatry, 142, 560-565.

85. Murray RM (1983). The sick doctor. Medicine International, 1582-1584.

86. Murray RM, McGuffin P (1983). Genetic aspects of mental disorders. In "Companion to Psychiatric Studies” 3rd Edition. Pp 150-176. Edited by Kendell RE, Zealley AK. Churchill Livingstone: Edinburgh.

87. Ewusi-Mensah I, Saunders J, Wodak AD, Murray RM, Williams R (1983). Psychiatric morbidity in patients with alcoholic

12

liver disease. British Medical Journal, 287, 1417-1419.

88. Murray RM, Clifford CA, Gurling HMD, Topham A, Clow A, Bernadt M (1983). Current genetic and biological approaches to alcoholism. Psychiatric Developments, 2, 179-192.

89. Clow A, Stolerman IP, Murray RM, Sandler M (1983). Ethanol preference in rats: increased consumption after intra-ventricular administration of tetrahydropapaveroline. Neuropharmacology,1983, 22, 563-565.

90. Mahmood T, Reveley AM, Murray RM (1983). Genetic studies of affective and anxiety disorders. In “The Scientific Basis of Psychiatry”. Pp 266-276. Edited by M Weller. Bailliere Tindall.

91. Murray RM, Reveley AM (1983). Schizophrenia as an infection Lancet, 1, 583 (Letter).

92. Murray RM, Reveley AM (1983). Genetics of schizophrenia. Lancet, 1, 1159. (Letter).

93. Murray RM (1983). David L Davies: A Tribute. Bethlem and Maudsley Gazette, 31, 31-33.

94. Reveley AM, Reveley MA, Murray RM (1983). Enlargement of cerebral ventricles in schizophrenia is confined to those without known genetic predisposition. Lancet, 2, 525. (Letter).

1984

95. Reveley AM, Reveley MA, Murray RM (1984). Cerebral ventricular enlargement in non-genetic schizophrenia: a controlled study. British Journal of Psychiatry, 144, 89-93.

96. Bernadt MW, Mumford J, Murray RM (1984). A discriminant function analysis of screening tests for excessive drinking and alcoholism. Journal of Studies on Alcohol, 45, 81-85.

97. Bernadt MW, Mumford J, Murray RM (1984). Can accurate drinking histories be obtained from psychiatric patients by a nurse conducting screening interviews? British Journal of Addiction, 79, 201-206.

98. Clifford CA, Murray RM, Fulker DW (1984). Genetic and environmental influences on obsessional traits and symptoms. Psychological Medicine, 14, 791-800.

99. McGuffin P, Farmer A, Gottesman II, Murray RM, Reveley AM (1984). Twin concordance for operationally defined schizophrenia: confirmation of familiality and heritability. Archives of General Psychiatry, 41, 541-545.

100. Cobb MJ, Blizard RA, Fulker DW, Murray RM (1984). Preliminary findings from a study of the effects of a challenge dose of alcohol in male twins. Acta Genetica Medica et Gemellol, 33, 451-456.

101. Holland AJ, Hall A, Murray RM, Russell GFM, Crisp AH (1984). Anorexia Nervosa: A study of 34 twin pairs. British Journal of Psychiatry, 145, 414-419.

102. Clifford CA, Hopper JL, Fulker DW, Murray RM (1984). A genetic and environmental analysis of a twin family study of alcohol use, anxiety and depression. Genetic Epidemiology, 1, 63-79.

103. Murray RM, Gurling HMD, Bernadt M, Ewusi-Mensah I, Saunders J, Clifford CA (1984). Do personality and psychiatric

disorders predispose to alcoholism? In “Pharmacological Treatments of Alcoholism”. Pp 445-462. Edited by Edwards G, Littleton J. Croom Helm: London.

104. Gurling HMD, Murray RM (1984). Alcoholism and genetics: old and new evidence. In “Alcohol Related Problems”. Pp 127-136. Edited by Krasner N. John Wiley: New York.

105. Clifford CA, Fulker DW, Murray RM (1984). Genetic and environmental influences on drinking patterns in normal twins. In “Alcohol-related Problems”. Pp 115-126. Edited by Krasner N. John Wiley: New York.

106. Gurling HMD, Reveley MA, Murray RM (1984). Increased cerebral ventricular volume in monozygotic twins discordant for alcoholism. Lancet, i, 986-988.

107. Reveley AM, Reveley MA, Murray RM (1984). Hypothesis for the aetiology of schizophrenia; a genetic perspective.

13

Psychopharmacology Bulletin, 20, 505-508.

108. Gurling HMD, Oppenheim BE, Murray RM (1984). Depression, criminality and psychopathology related to alcoholism: evidence from a twin study. Acta Medica et Gemellol, 33, 333-339.

109. Murray RM, Daniels O (1984). Alcohol related problems. In “Research in Mental Illness”. Pp 35-47. Edited by Richter D. Heinemann Medical Books: London.

110. Murray RM (1984). Admission to Medical School. British Medical Journal, 289, 1535. (Letter).

1985

111. Holland A, Murray RM (1985). Genetics of schizophrenia: the implications for adoption, fostering and childcare. Adoption and Fostering. 9, 39-45. Reprinted in 'From asthma to thalassaemia' Ed. by Sarah Curtis. British Agencies for Adoption and Fostering. Practice Series No. 14. London, 1986.

112. Murray RM, Reveley AM, Reveley MA, Shur E, Lewis S (1985). Genetic and environmental influences in schizophrenia. In “Genetic Aspects of Human Behaviour”. Pp. 63-74. Edited by Sakai T and Tsuboi T. Igaku-Shoin: Tokyo.

113. McGuffin P, Farmer A, Gottesman I, Murray RM, Reveley AM (1985). The appropriate use of criteria for schizophrenia. Archives of General Psychiatry, 42, 423-4. (Letter).

114. Clow A, Topham A, Saunders JB, Murray RM, Sandler M (1985). The role of salsolinol in alcohol intake and withdrawal. In “Aldehyde Products in Alcoholism”. Pp 101-113. Edited by Collins MA. Alan Liss, New York.

115. Murray RM, Lewis S, Reveley AM (1985). Towards an aetiological classification of schizophrenia. Lancet, i, 1023-1026.

116. Reveley AM, Lewis SW, Murray RM (1985). Subgroups in schizophrenia. Lancet, ii, 216. (Letter).

117. Murray RM (1985). Nicky Paine. Facilitator rather than Governor. Bethlem and Maudsley Gazette, 32, 27-28.

118. Hill P, Murray RM, Thorley A (1985). Editors. “The Essentials of Postgraduate Psychiatry” 2nd Edition. Grune and Stratton: New York and London (and chapters on Alcoholism, Schizophrenia, and Measurement in Psychiatry).

1986

119. Bernadt MW, Murray RM (1986). Psychiatric disorder, drinking and alcoholism: What are the links? British Journal of Psychiatry. 148, 393-400.

120. Gurling HMD, Murray RM, Ron MA (1986). Increased brain radio-density in alcoholism. A cotwin control study. Archives of General Psychiatry, 43, 764-767.

121. Murray RM, Reveley AM, McGuffin P (1986). Genetic vulnerability to schizophrenia. In "Schizophrenia". Pp 3-16 Edited by Roy A. Psychiatric Clinics of North America.

122. Mullan MJ, Gurling HMD, Oppenheim BE, Murray RM (1986). The Relationship between Alcoholism and Neurosis. Evidence from a Twin Study. British Journal of Psychiatry, 148, 435-441.

123. David AS, Farmer AE, Murray RM (1986). Schizophrenia and bulimia. International Journal of Eating Disorders, 5, 771-775.

124. Murray RM, Reveley AM (1986). Gene-Environment interaction in schizophrenia. In “Schizophrenia”. Edited by Kerr A, Snaith P. British Journal of Psychiatry Special Publications.

125. McGuffin P, Farmer A, Gottesman I, Murray RM, Reveley AM (1986). Bruised toes in schizophrenia: An exchange. Archives of General Psychiatry, 43, 295 (Letter).

126. Shiwach RH, Murray RM (1986). Does psychiatric research need training? British Journal of Hospital Medicine, 36, 11.

14

127. Murray RM (1986). The Maudsley: Change or Decay? Bethlem and Maudsley Gazette, 32, 13-16.

128. Nimgaonkar V, Murray RM (1986). Schizophrenia with good and poor outcome. British Journal of Psychiatry, 148, 343-344. (Letter).

129. Roberts JE, Edwards JG, Checkley S, Crammer JL, Cutting JC, Lader MH, Murray RM (1986). A case of resistant schizophrenia. British Journal of Psychiatry, 149, 789-793.

1987

130. Gurling HMD, Murray RM (1987). Genetic influence brain morphology and cognitive deficits in alcoholic twins. In “Genetics and Alcoholism”. Pp 71-82. Edited by Goedde HW, Agarwal DP. Alan Liss.

131. McGuffin P, Murray RM, Reveley AM (1987). Genetic influence on the psychoses. British Medical Bulletin, 43, 531-556.

132. Murray RM (1987). Depression and Alcoholism. In “A Practical Handbook for the Treatment of Depression”. Pp 158-161. Edited by Kelly D, France R. Parthenon Publishing Group: New Jersey.

133. Lewis SW, Reveley AM, Reveley MA, Chitkara B, Murray RM (1987). The familial-sporadic distinction as a strategy in schizophrenia research. British Journal of Psychiatry, 151, 306-313.

134. Murray RM (1987). What is Schizophrenia? In “Schizophrenia”. Pp 13-18. Edited by Herbst KG. Mental Health Foundation: London.

135. McKeon P, Murray RM (1987). Familial aspects of Obsessive-Compulsive Neurosis. British Journal of Psychiatry, 151, 528-534.

136. Murray RM, Gurling HMD, Bernadt MW, Clifford CA (1987). Economics, occupation and genes: A British perspective. In “Alcoholism; Origins and Etiology. Perspectives from the Medical Model”. Pp 111-126. Edited by Rose RM, Barrett J. Raven Press: New York.

137. Lewis SW, Murray RM (1987). Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. Journal of Psychiatric Research, 21, 413-421.

138. McGuffin P, Murray RM (1987). Mental Illness. In “The Oxford Companion of the Mind”. Pp 470-475. Edited by Gregory RL. Oxford University Press.

139. Murray RM, Lewis SW (1987). Is schizophrenia a neurodevelopmental disorder? British Medical Journal, 295, 681-682.

140. Lewis SW, Chitkara B, Reveley AM, Murray RM (1987). Family history and birthweight in monozygotic twins concordant and discordant for psychosis. Acta Genetica Medica et Gemellol, 36, 267-272.

141. Owen MJ, Lewis SW, Murray RM (1987). Obstetric complications and cerebral abnormalities in schizophrenia. In “Etiopathogenic Hypotheses of Schizophrenia”. Pp 9-20. Edited Cazullo CL, Invernizzi G, Sacchetti E. MTP Press: Lancaster.

142. Murray RM, Reveley AM, Lewis SW (1987). Family history, obstetric complications and cerebral abnormality in schizophrenia. In “Handbook of Schizophrenia” volume 3. Pp 531-542. Overall Editor Nasrallah H. Volume Editors Tsuang MT, Simpson J. Elsevier: Amsterdam.

143. Van den Akker OBA, Stein GS, Neale MC, Murray RM (1987). Genetic and environmental variation in menstrual cycle histories of two British twin samples. Acta Genetica Medica Gemellol, 36, 541-548.

144. Foerster A, Murray RM (1987). Genetic counselling. In “Handbook of Schizophrenia” volume 3. Pp 563-577. Overall Editor Nasrallah H. Volume Editors Tsuang M, Simpson J. Elsevier: Amsterdam.

145. Murray RM, Foerster A (1987). Schizophrenia: Is the concept disintegrating? Journal of Psychopharmacology, 1, 133-139.

15

1988

146. Murray RM, Lewis SW (1998). Is schizophrenia a neurodevelopmental disorder? British Medical Journal, 296, 63. (Letter).

147. Murray RM, McGuffin P (1998). Genetic aspects of mental disorder. In “Companion to Psychiatric Studies” 4th Edition. Pp 161-190. Edited by Kendell RE, Zealey A. Churchill Livingstone: London.

148. Murray RM, Kerwin RW, Nimgaonkar V (1988). What have we learned about the biology of schizophrenia? In “Recent Advances in Clinical Psychiatry” Volume 6. Edited by Granville-Grossman K. Churchill Livingstone: London.

149. Lewis SW, Reveley AM, Murray RM (1988). Heterogeneity in sporadic schizophrenia. British Journal of Psychiatry, 152, 573-574. (Letter).

150. Owen MJ, Lewis SW, Murray RM (1988). Obstetric complications and schizophrenia: A computed tomographic study. Psychological Medicine, 18, 331-339.

151. Nimgaonkar V, Wessely S, Murray RM (1988). Prevalence of familiality, obstetric complications and structural brain damage in schizophrenic patients. British Journal of Psychiatry, 153, 191-197.

152. Nimgaonkar V, Wessely S, Tune LE, Murray RM (1988). Response to drugs in schizophrenia; the influence of family history, obstetric complications and ventricular enlargement. Psychological Medicine, 18 (3), 583-592.

153. Murray RM, Lewis SW, Owen MJ, Foerster A (1988). The neurodevelopmental origins of Dementia Praecox. In “Schizophrenia: The Major Issues”. Pp 90-107. Edited by Bebbington P, McGuffin P. William Heinmann: London.

154. Owen MJ, Murray RM (1988). Blue genes: three genes exist for manic-depression. British Medical Journal, 297, 871-2.

155. Lee AS, Murray RM (1988). The longterm outcome of Maudsley depressives: British Journal of Psychiatry, 153, 741-751. (Corres. Lancet, 25 March 1989, 650-651)

156. Macdonald A, Murray RM (1988). Twins, lifestyle and health. Report to the Health Promotion Trust on the use of twin research in promoting healthy behaviours.

157. Kerwin RW, Murray RM (1988). Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry, 45, 1052. (Letter).

1989

158. Lewis SW, Owen MJ, Murray RM (1989). Obstetric complications and schizophrenia; methodology and mechanisms. In “Schizophrenia: A Scientific Focus”. Pp 56-68. Edited by Schulz SC, Tamminga CA. Oxford University Press: New York.

159. Whatley SA, Owen MJ, Murray RM (1989). Neuropsychiatric disorders and the new genetics. In “The Bridge between Neurology and Psychiatry”. Pp 253-379. Edited by Trimble M, Reynolds E. Churchill Livingstone: London.

160. Bernadt MW, Daniels OJ, Blizard RA, Murray RM (1989). Can a computer elicit an alcohol history? British Journal of Addiction, 84, 405-411.

161. Marshall JE, Murray RM (1989). The contribution of twin studies to alcoholism research. In “Alcoholism; Biochemical and Genetic Aspects”. Pp 277-289. Edited by Goedde HW and Agarawal DP. Pergamon Press: New York.

162. Murray RM, Harvey I (1989). The congenital origins of schizophrenia. Psychiatric Annals, 19, 525-529.

163. Mullan MJ, Murray RM (1989). The impact of molecular genetics on our understanding of the psychoses. British Journal of Psychiatry, 154, 591-595.

16

164. Owen MJ, Lewis SW, Murray RM (1989). Family history and cerebral ventricular enlargement in schizophrenia: a case control study. British Journal of Psychiatry, 154, 629-634.

165. Gill M, Murray RM (1989). Is schizophrenia caused by a single abnormal gene? Adoption and Fostering, 12, 49-51.

166. Gill M, Taylor C, Murray RM (1989). Schizophrenia research: attempting to integrate genetics, neurodevelopment and nosology. International Review of Psychiatry, 1, 277-286

167. Owen M, Murray RM (1989). The rollercoaster of psychiatric genetics. International Review of Psychiatry, 1, 217-218.

1990

168. Harvey I, Murray RM (1990). Une approche neurodevelopmentale de la schizophrenie. Neuro-Psychiatrie, 5, 323-336.

169. Duggan C, Lee AS, Murray RM (1990). Does personality predict long-term outcome in depression? British Journal of Psychiatry, 157, 19-25.

170. Taylor CJ, Murray RM (1990). New research in schizophrenia; implications for clinicians. Comprehensive Therapy, 16, 31-36.

171. Der G, Gupta S, Murray RM (1990). Is schizophrenia disappearing? Evidence from England and Wales 1952-1986. Lancet, 335, 513-516.

172. Murray RM, Gupta S, Der G (1990). Trends in schizophrenia. Lancet, 335, 1214.

173. Murray RM, Birley J (1990). Parish Priest and President. The Bethlem and Maudsley Gazette, 37, 43-44.

174. Murray RM, Owen MJ, Goodman R, Lewis SW (1990). A neurodevelopmental perspective on some epiphenomena of schizophrenia. In “Plasticity and Morphology of the Central Nervous System”. Pp185-203. Edited by Cazzullo CL, Invernizzi G, Sacchetti E, Vita A. Kluwer Academic Publishers: Lancaster.

175. Lewis SW, Harvey I, Ron M, Murray RM (1990). Reveley A M. Can brain damage protect against schizophrenia? A case report in twins. British Journal of Psychiatry, 157, 600-603.

176. Murray RM, Gill M (1990). The potential and pitfalls of molecular genetics for psychiatry: An Overview. In “Genetic Approaches in the Prevention of Mental Disorders”. Pp 107-115. Edited by Bulyzhenkov V, Christen Y, Prilipko L. Springer-Verlag: Berlin.

177. Harvey I, Murray RM (1990). Why Kraepelin was wrong; the neurodevelopmental view of Dementia Praecox. In “Psychiatry: A World Perspective Volume”. Pp 223-233. Edited by Stefanis C, Rabavilas AD, Soldatos CR. Excerpts Medica: Amsterdam.

178. Harvey I, Ron M, du Boulay, G, Murray RM and Lewis S (1990). White matter abnormalities on MRI scan in bipolars. Archives of General Psychiatry, 47, 1172-1173. (Letter).

179. Andrews HB, Rogers TD, Roselson R, Binnie CD, Murray RM (1990). Event related potentials in schizophrenc patients during a semantic priming test. Neurophysiologie Clinique, 20, 295.

1991

180. Foerster A, Lewis S, Owen M and Murray RM. Premorbid personality in psychosis: effects of sex and diagnosis. British Journal of Psychiatry, 158, 171-176.

181. Foerster A, Lewis S, Owen M, Murray RM (1991). Low birth weight and a family history of schizophrenia predict poor premorbid functioning in psychosis. Schizophrenia Research, 5, 3-20.

182. Duggan CF, Lee AS, Murray RM (1991). Do Different subtypes of hospitalised depressives have different longterm outcomes? Archives of General Psychiatry, 48 (4), 308-312.

17

183. Foerster A, Lewis SW, Murray RM (1991). Genetic and environmental correlates of the positive and negative syndromes. In “Negative Schizophrenic Symptoms: Pathophysiology and Clinical Implications”. Pp 187-202. Edited by Greden JF, Tandon R . American Psychiatric Press: Washington.

184. Murray RM, O'Callaghan E (1991). Neurodevelopmental schizophrenia. Schizophrenia Monitor, 1, 1-3.

185. Jones P, Murray R M (1991). Aberrant neurodevelopment as the expression of the schizophrenic genotype. In “The New Genetics of Mental Illness”. Pp 112-129. Edited by McGuffin P, Murray RM. Heineman Medical Books: London.

186. Hodgkinson S, Mullan M, Murray RM (1991). The genetics of vulnerability to Alcoholism. In “The New Genetics of Mental Illness”. Pp 182-197. Edited by McGuffin P, Murray RM. Heineman Medical Books: London.

187. Jones P, Owen MJ, Goodman R, Lewis SW, Murray RM (1991). The coming of age of schizophrenic epiphenomena. In “Psychiatry at the Crossroads between Social Science and Biology”. Pp 106-121. Edited by Torgersen S, Abrahamsen P, Sorensen T. Norwegian University Press: Oslo.

188. Castle DJ, Murray RM (1991). The neurodevelopmental basis of sex differences in Schizophrenia.Psychological Medicine, 21, 565-575.

189. Macdonald AM, Murray RM, Clifford CA (1991). The contribution of heredity to obsessional disorder and personality. In “Genetic Issues in Psychosocial Epidemiology”. Edited by Kendler KS, Lyons MJ, Tsuang MT. Rutgers University Press.

190. Meadows G, Turner T, Campbell L, Lewis SW, Reveley MA, Murray RM (1991). Assessing schizophrenia in adults with mental retardation; A Comparative Study. British Journal of Psychiatry, 158, 103-105.

191. Murray RM, Jones P, O'Callaghan E (1991). Foetal brain development and later schizophrenia. Proceedings of Ciba Symposium No. 156 "The Childhood Environment and Adult Disease". Pp 155-171. Edited by Bock GR, Whelan J. John Wiley and Sons: Chichester.

192. Murray RM, O'Callaghan E (1991). The congenital and adult onset psychoses: Kraepelin lost - Kraepelin found. In “Concepts of Mental Disorder”. Pp 48-65. Edited by Kerr A, McClelland H. Gaskell Publications: London.

193. Gurling HMD, Curtis D, Murray RM (1991). Psychological deficit from excessive alcohol consumption: evidence from a cotwin control study. British Journal of Addiction, 86, 151-156.

194. Duggan CF, Sham P, Lee AS, Murray RM (1991). Does recurrent depression lead to a change in neuroticism? Psychological Medicine, 21, 985-990.

195. Pilowsky L, Murray RM (1991). Why don't preschizophrenic children have delusions and hallucinations? Behavioural and Brain Sciences, 14, 41-42.

196. Harvey I, Ron MA, Murray RM, Lewis S, Barker G, McManus D (1991). MRI in schizophrenia: basal ganglia and white matter T1 times. Psychological Medicine, 21, 587-598.

197. Jones P, Murray RM (1991). The genetics of schizophrenia is the genetics of neurodevelopment. British Journal of Psychiatry, 158, 615-623.

198. Pilowsky L, Kerwin R, Murray RM (1991). Neurodevelopment and schizophrenia. In “Etiology of Mental Disorder”. Pp 169-182. Edited by Kringlen E, Lavik N, Torgersen S. University of Oslo.

199. Duggan CF, Sham P, Lee AS, Murray RM (1991). Can future suicidal behaviour in depressed patients be predicted? Journal of Affective Disorder, 22, 111-118.

200. O'Callaghan E, Sham P, Takei N, Glover G, Murray RM (1991). Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet, 337, 1248-1250.

201. Gupta S, Murray RM (1991). The changing incidence of psychiatry. Schizophrenia: fact or artefact? Directions in Psychiatry, 11, 1-7.

202. Macdonald AM, Murray RM (1991). The influences of nature and nurture in health. In “Young People: Behaviours and

18

Opportunities”. Pp 4-25. The Health Promotion Trust: Cambridge.

203. Murray RM, Gupta S, Der G (1991). The incidence of schizophrenia, and of causal environmental factors varies in time and place. European Archives of Psychiatry and Clinical Neuroscience, 240, 373-378. (Letter)

204. Castle D, Wessely S, Der G, Murray RM (1991). The incidence of operationally defined schizophrenia in Camberwell, 1965 to 1984. British Journal of Psychiatry, 159, 790-794.

205. Wessely S, Castle D, Der G, Murray RM (1991). Schizophrenia and Afro-Caribbeans: a case control study. British Journal of Psychiatry, 159, 795-801.

206. Murray RM, Marshall EJ (1991). Familial Alcoholism: inheritance and imitation. British Medical Journal, 303, 72-73.

207. Adityanjee, Murray RM (1991). The role of genetic predisposition in alcoholism. In “International Handbook of Addiction Behaviour”. Pp 41-47. Edited by Glass I, p.41-47 Routledge: London.

208. Castle DJ, Refault S, Murray RM (1991). Research during psychiatric training as a predictor of future academic career: the Maudsley experience. European Psychiatry, 6, 115-118.

209. Gill M, Castle D, Hunt N, Clements A, Sham P and Murray RM (1991). Tyrosine hydroxylase polymorphisms and bipolar affective disorder. Journal of Psychiatric Research, 21, 179-184.

1992

210. Sham P, Gill M, Murray RM (1992). The principles of genetics as applied to psychiatry. In “The Scientific Basis of Psychiatry”. Pp 270-302. Edited by Weller EM, Eysenck M. W B Saunders: London.

211. Taylor C, Macdonald AM, Murray RM (1992). The genetics of psychiatric syndromes. In “The Scientific Basis of Psychiatry”. Pp 270-302. Edited by Weller M, Eysenck H. W B Saunders: London.

212. Murray RM, O'Callaghan E, Castle DJ, Lewis SW. A neurodevelopmental approach to the classification of schizophrenia. Schizophrenia Bulletin, 18, 319-332.

213. Sham P C, O'Callaghan E, Takei N, Murray GK, Hare EH, Murray RM (1992). Schizophrenia following prental exposure to influenza epidemics between 1939 and 1960. British Journal of Psychiatry, 160, 461-466.

214. Sham PC, Takei N, Murray RM and O'Callaghan E. Schizophrenia following prenatal exposure to influenza epidemics between 1939 and 1960. British Journal of Psychiatry, 161, 712-714. (Correspondence).

215. Takei N, O'Callaghan E, Sham P, Glover G, Tamura A, Murray RM (1992). Seasonality of admissions in the psychoses: effect of diagnosis, sex and age-at-onset. British Journal of Psychiatry, 161, 506-511.

216. Gupta S, Murray RM (1992). The relationship of environmental temperature to the incidence and outcome of schizophrenia. British Journal of Psychiatry, 160, 788-792.

217. Kerwin R, Murray RM (1992). A developmental perspective on the pathology and neurochemistry of the temporal lobe in schizophrenia. Schizophrenia Research. 7, 1-12.

218. Takei N, Sham PC, O'Callaghan E, Glover G, Murray RM (1992). Cities, winter birth and schizophrenia. Lancet, 340, 558-559. (correspondence)

219. Heyman I, Murray RM (1992). Neurodevelopment and schizophrenia. Journal of the Royal College of Physicians, 26, 143-146.

220. Lee AS, Duggan C, Murray RM (1992). Can one predict the long term outcome of hospitalised depressives? Journal of Psychopharmacology, Suppl 6, 12-15.

221. Pilowsky LS, Costa DC, Ell PJ, Murray RM, Verhoeff NPLG, Kerwin R (1992). Clozapine, single photo emission tomography and the D2 dopamine receptor blockade hypothesis of schizophrenia. Lancet, 340, 199-202.

19

222. Vallada H, Collier DA, Dawson E, Owen M, Nanko S, Murray RM, Gill M (1992). Debrisoquine 4-hydroxylase (CYP2D) locus and possible susceptibility to schizophrenia. Lancet, 340, 181-182. (Correspondence).

223. Murray RM, McGuffin P (1992). Genetic aspects of psychiatric disorders. In “Companion to Psychiatric Studies”. 5th Edition. Pp:227-263. Edited by Kendell RA, Zealley AK. Churchill Livingstone: Edinburgh.

224. Murray RM, Jones PB, O'Callaghan E, Takei N, Sham P (1992). Genes, Viruses and Neurodevelopmental Schizophrenia. Journal of Psychiatric Research, 26, 225-235.

225. Jones PB, Owen MJ, Goodman R, Lewis SW, Murray RM (1992). Neurodevelopment and the chronological curiosities of schizophrenia. In “Developmental Neuropathology of Schizophrenia”. Pp191-210. Edited by Mednick S, Cannon T, Barr T, La Fosse JM. Plenum Press: New York.

226. Walsh C, Hicks AA, Sham P, Castle D, Hunt N, Clements A, Sander T, M Murray RM, Darlison MG, Gill M (1992). GabaA receptor subunit genes as candidate genes for bipolar affective disorder -an association analysis. Psychiatric Genetics, 2, 239-247.

1993

227. Gilder FJ, Hodgkinson S and Murray RM (1993). ADH and ALDH genotype profiles in caucasians with alcohol-related problems and controls. British Journal of Addiction, 88, 383-388.

228. Howard R, Castle D, Wessely S, Murray RM (1993). A comparative study of 470 cases of early and late onset schizophrenia. British Journal of Psychiatry, 163, 352-357.

229. Castle D, Scott K, Wessely S, Murray RM (1993). Does social deprivation during gestation and early life predispose to later schizophrenia? Social Psychiatry and Psychiatric Epidemiology, 28, 1-4.

230. Wright P, Gill M, Murray RM (1993). Schizophrenia: genetics and the maternal immune response to viral infection. Neuropsychiatric Genetics, 48, 40-46.

231. Jones PB, Bebbington P, Foerster A, Lewis SW, Murray RM, Russell A, Sham P, Toone B, Wilkins S (1993). Premorbid social underachievement in schizophrenia. Results from the Camberwell Collaborative Psychosis Study. British Journal of Psychiatry, 162, 65-71.

232. Bebbington P, Wilkins S, Jones P, Foerster A, Murray RM, Toone B, Lewis SW (1993). Life Events and Psychosis. Initial results from the Camberwell Collaborative Psychosis Study. British Journal of Psychiatry, 162, 72-79.

233. Jones P, Owen MJ, Lewis SW, Murray RM (1993). A case control study of family history and cerebral cortical abnormalities in schizophrenia. Acta Psychiatrica Scandinavica, 87, 6-12.

234. Sharma T, Murray RM (1993). Aetiological theories in schizophrenia. Current Opinion in Psychiatry, 6, 80-84.

235. Castle DJ, Wessely S, Murray RM (1993). Sex and schizophrenia: effects of diagnostic stringency, and associations with premorbid variables. British Journal of Psychiatry, 162, 658-664.

236. Rutherford J, McGuffin P, Katz RJ, Murray RM (1993). Genetic influences on eating attitudes in a normal female twin population. Psychological Medicine, 23, 425-436.

237. Galdos PM, van Os JJ, Murray RM. Puberty and the onset of psychosis (1993). Schizophrenia Research, 10, 7-14. Editor's comments on Galdos et al and Author's reply (1993). Schizophrenia Research, 10, 7-14. Authors' response to Comments (1994). Schizophrenia Research 13 (1994), 85-86.

238. Wright P, Donaldson PT, Underhill JA, Ward AJ, Doherty, DG, Gill M, Murray RM (1993). Do maternal HLA antigens predispose to schizophrenia? Lancet, 342, 117-118. (correspondence)

239. Murray RM (1993). Science and Psychiatry. In “Science in Medicine: How far has it advanced?”. Pp 43-52. Edited by Teeling Smith G. Office of Health Economics: London.

240. Bebbington P, Wilkins S, Jones P, Foerster A, Murray RM, Toone B, Lewis S (1993). Is psychosis triggered by stress? In

20

“Psychiatric Epidemiology and Social Sciences”. Edited by Delgard OS. Norwegian Universities Press: Oslo.

241. Bebbington P, Walsh C, Murray RM (1993). The causes of functional psychosis. “Basic Issues in Psychopathology”. Pp 238-270. Edited by Costelloe GG. Guilford Press: New York.

242. Pilowsky L, Kerwin R, Murray RM (1993). Schizophrenia: A neurodevelopmental perspective. Neuropsychopharmacology, 9, 93-91.

243. Gill M, McGuffin P, Parfitt E, Mant R, Daggers A, Asherson P, Vallada H, Collier D, Powell J, Taylor C, Sargeant M, Clements A, Nanko S, Takawa N, Llewellyn D, Pilowsky L,Brush Y, Williams J, Whatley S, Murray RM, Owen M (1993). A linkage study of schizophrenia with DNA markers from the long arm of chromosome 11. Psychological Medicine, 23, 27-44.

244. Howard R, Castle D, Wessely S, Murray RM. A comparative study of 470 cases of early onset and late onset schizophrenia. British Journal of Psychiatry, 163, 352-257.

245. Wright P and Murray RM (1993). Schizophrenia: prenatal influenza and autoimmunity. Annals of Medicine, 25, 497-502.

246. Harvey I, Ron M, du Boulay G, Wicks D, Lewis SW, Murray RM (1993). Reduction of cortical volume in schizophrenia on Magnetic Resonance Imaging. Psychological Medicine, 23, 591-604.

247. Guth C, Jones P, Murray RM (1993). Familial psychiatric illness and obstetric complications in early onset affective disorder. British Journal of Psychiatry 163, 492-498.

248. McGuire PK, Shah GMS, Murray RM (1993). Increased blood flow in Broca's area during auditory hallucinations in schizophrenia. Lancet, 342, 703-706.

249. Castle DJ, Murray RM (1993). The epidemiology of late-onset schizophrenia. Schizophrenia Bulletin, 19, 691-700.

250. Takei N, O'Callaghan E, Sham P, Glover G, Murray RM (1993). Does prenatal influenza divert susceptible females from later depressive psychosis to schizophrenia? Acta Psychiatrica Scandinavica, 88, 328-336.

1994

251. Jones PB, Guth C, Lewis, SM, Murray RM (1994). Low intelligence and poor educational achievement precede early onset schizophrenic psychosis. In “The Neuropsychology of Schizophrenia”. Pp 131-144. Edited by David AS, Cutting J. Lawrence Erlbaum Associates Ltd.: Hove.

252. Pulver AE and Collaborative Group (1994). Follow up of a report of a potential linkage for schizophrenia on chromosome 22q12-q13.1: Part 2. American Journal of Medical Genetics (Neuropsychiatric Genetics), 54, 44-50.

253. Castle DJ, Sham PC, Wessely S, Murray RM (1994). The subtyping of schizophrenia in men and women: A latent class analysis. Psychological Medicine, 24, 41-51.

254. Ball DM, Murray RM (1994). Genetics of Alcohol Misuse. In 'Alcohol and Alcohol Problems'. British Medical Bulletin, 50, 18-35. Churchill Livingston. Edinbugh. Issue edited by G Edwards and T Peters.

255. Corrigall, RJ, Murray RM (1994). Twin concordance for congenital and adult onset psychosis: the validity of a novel classification of schizophrenia. Acta Psychiatrica Scandinavica, 89, 142-145.

256. Castle D, Murray RM (1994). Schizophrenia: Aetiology and Genetics. In “Principles and Practice of Geriatric Psychiatry” 1st Edition. Pp 653-659. Edited by Copeland JRM, Abou-Saleh MT, Blazer DG. John Wiley and Sons: Chichester.

257. Pilowsky LS, Costa DC, Ell PJ, Murray RM, Verhoeff NPLG, Kerwin RW (1994). D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients - a 123I IBZM SPET (single photon emission tomography) study. British Journal of Psychiatry, 164, 16-26.

258. Takei N, Sham P, O'Callaghan E, Glover G, Murray RM (1994). Prenatal exposure to influenza and the development of schizophrenia : Is the effect confined to females? American Journal of Psychiatry, 151, 117-119.

21

259. Murray RM (1994). The Developing Understanding of Schizophrenia. Transactions of the College of Medicine of South Africa, Jan-Jun, 15-19.

260. Woodruff PWR, Murray RM (1994). The aetiology of brain abnormalities in schizophrenia. In “Schizophrenia: Exploring the Spectrum of Psychosis”. Pp 95-114. Edited by Ancill R. John Wiley & Sons, Chichester.

261. Castle DJ, Phelan M, Wessely S, Murray RM (1994). Which patients with non-affective functional psychosis are not admitted at first psychiatric contact? British Journal of Psychiatry, 165, 101-106.

262. O'Callaghan E, Sham PC, Takei N, Murray G, Glover G, Hare E, Murray RM (1994). The relationship of schizophrenic births in England and Wales to 16 infectious diseases. British Journal of Psychiatry, 165, 353-356.

263. Rifkin L, Lewis S, Jones PB, Toone BK, Murray RM (1994). Low birth weight and schizophrenia. British Journal of Psychiatry, 165, 357-362.

264. Harvey I, Persaud R, Ron MA, Barker G, Murray RM (1994). Volumetric MRI measurement in bipolars compared with schizophrenics and healthy controls. Psychological Medicine, 24, 689-699.

265. Sham P, Jones P, Russell A, Gilvarry K, Bebbington P, Lewis S, Toone B, Murray RM (1994). Age at onset, sex and familial psychiatric morbidity in schizophrenia. Report from the Camberwell Collaborative Psychosis Study. British Journal of Psychiatry, 165, 466-473.

266. Shaikh S, Gill M, Owen M, Asherson P, McGuffin P, Nanko S, Murray RM, Collier DA (1994). Failure to find linkage between a functional polymorphism in the dopamine D4 receptor and schizophrenia. American Journal of Medical Genetics (Neuropsychiatric Genetics), 54, 8-11.

267. Jones PB, Rodgers B, Murray RM, Marmot M (1994). Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. The Lancet, 344, 1398-1402.

268. Murray RM (1994). Neurodevelopmental schizophrenia: the rediscovery of dementia praecox. British Journal of Psychiatry, 165, 6-12.

269. McGrath JJ, Pemberton MR, Welham, JL, Murray RM. Schizophrenia and the influenza epidemics of 1954, 1957 and 1959: A southern hemisphere study. Schizophrenia Research, 14, 1-8.

270. Takei N, Murray RM (1994). Prenatal influenza and schizophrenia. British Journal of Psychiatry, 165, 833-834. (correspondence).

271. O'Keane V, Abel K, Murray RM (1994). Growth hormone responses to pyridostigimine in schizophrenia: evidence for cholinergic dysfunction. Society of Biological Psychiatry, 36, 582-588.

272. Jones PB, Harvey I, Lewis SW, Toone BK, van Os J, Williams M, Murray RM (1994). Cerebral ventricle dimensions as risk factors for schizophrenia and affective psychosis. An epidemiological approach to analysis. Psychological Medicine, 24, 995-1011.

273. McGuire P, Jones P, Harvey I, Bebbington P, Toone B, Lewis S, McGuffin P, Murray R. Cannabis and acute psychosis. Schizophrenia Research, 1994, 13, 161-168.

274. Kirov GK, Jones PB, Murray RM (1994). The impact of familial loading on gender differences in age at onset of schizophrenia. Acta Psychiatrica Scandinavica, 90, 236-237. (Correspondence).

275. Vallada H, Collins JE, Dunham I, Dawson E, Murray RM, Gill M, Collier DA (1994). Genetic mapping of 14 short tandem repeat polymorphisms on human chromosome 22. Human Genetics, 93, 688-690.

276. van Os J, Fahy T, Bebbington P, Jones P, Wilkins W, Sham P, Russell A, Gilvarry K, Lewis S, Toone B, Murray RM (1994). The influence of life events on the subsequent course of psychotic illness. Psychological Medicine, 24, 503-513.

277. Lim LCC, Nothen MM, Korner J, Rietschel M, Castle D, Hunt N, Propping P, Murray RM, Gill M (1994). No evidence of association between dopamine D4 receptor variants and bipolar affective disorder. American Journal of Medical Genetics, 54 (3), 259-263.

22

278. Lim LCC, Powell JF, Murray R, Gill M. (1994) Monoamine oxidase A gene and bipolar affective disorder. American Journal of Human Genetics, 54, 1122-1124 (letter).

279. Bullmore E, Brammer M, Harvey I, Persaud R, Murray R, Ron M (1994). Fractal analysis of the boundary between white matter and cerebral cortex in magnetic resonance images: a controlled study of schizophrenic and manic-depressive patients. Psychological Medicine 24, 771-781.

280. Macdonald AM, Murray RM (1994). The genetics of anxiety disorders. In “Anxiety and Related Disorders”. Pp 91-111. Edited by Wolman BB, Stricker G. New York: Wiley & Sons.

1995

281. Castle DJ, Abel M, Takei N, Murray RM (1995). Gender differences in schizophrenia: hormonal effect or subtypes? Schizophrenia Bulletin, 21, 1-12.

282. Takei N, Sham P, O'Callaghan E, Glover G and Murray RM (1995). Increased risk associated with winter and city birth. A case-control study in 12 regions within England and Wales. Journal of Epidemiology & Community Health, 49, 106-109.

283. Howard R, Dennehey J, Lovestone S, Birkett J, Sham P, Powell J, Castle D, Murray RM (1995). Apolipoprotein E genotype and late paraphrenia. International Journal of Geriatric Psychiatry, 10, 147-150.

284. Morris RG, Rushe T, Woodruff PWR, Murray RM (1995). Problem solving in schizophrenia: a specific deficit in planning ability. Schizophrenia Research, 14, 235-246.

285. Power MJ, Duggan CF, Lee AS, Murray RM (1995). Dysfunctional attitudes in depressed and recovered depressed patients and their first-degree relatives. Psychological Medicine, 25, 87-93.

286. Murray, RM. Eliot Slater, 1904-1983. Images in Psychiatry (1995). American Journal of Psychiatry, 152, 2.

287. Murray, RM, Jones P (1995). Schizophrenia: Disease or Syndrome? Discussion. In “Search for the Causes of Schizophrenia” Vol III. Pp 186-192 Edited by Hafner H, Gattaz WF. Springer-Verlag: Berlin-Heidelberg.

288. McGrath J, Castle D, Murray RM (1995). How can we judge whether or not prenatal exposure to influenza causes schizophrenia? In “Neural Development and Schizophrenia”. Pp 203-214. Edited by Mednick SA, Hollister JM, Plenum Press: New York.

289. Bullmore E, Brammer M, Harvey I, Murray R, Ron M (1995). Cerebral hemispheric asymmetry revisited: effects of handedness, gender and schizophrenia measured by radius of gyration in magnetic resonance images. Psychological Medicine, 25, 349-363.

290. McGuire P, Jones P, Harvey I, Williams M, McGuffin P, Murray RM (1995). Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis. Schizophrenia Research, 15, 277-281.

291. Takei N, Sham P C, O'Callaghan E, Glover G, Murray RM (1995). Early risk factors in schizophrenia; place and season of birth. European Psychiatry,10, 165-170.

292. Vallada H, Gill M, Sham P, Lim LCC, Nanko S, Asherson P, Murray R, McGuffin P, Owen M, Collier DA (1995). Linkage studies on chromosome 22 in familial schizophrenia. American Journal of Medical Genetics (Neuropsychiatric Genetics), 60, 139-146.

293. Takei N, Murray G, O'Callaghan E, Sham P, Glover G, Murray RM (1995). Prenatal exposure to influenza epidemics and risk of mental retardation. European Archives of Psychiatry Clinical Neuroscience, 245, 255-259. Comments: Crow T, Bromet E, Jablensky A., and reply: 260-266.

294. Bullmore E, Brammer, Rouleau G, Everitt B, Simmons A, Sharma T, Frangou S, Murray RM, Dunn G (1995). Computerized brain tissue classification of magnetic resonance images: a new approach to the problem of partial volume artifact. Neuroimage, 2, 133-147.

23

295. Cleare AJ, Bearn J, Allain T, McGregor A, Wessely S, Murray RM, O'Keane V (1995). Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. Journal of Affective Disorders, 35, 283-289.

296. Jones P, Murray RM, Rodgers B (1995). Childhood risk factors for adult schizophrenia in a general population birth cohort at age 43 years. In “Neural Development and Schizophrenia”. Edited by Mednick SA, Hollister JM. Plenum Press: New York.

297. McGuire P, Silbersweig D, Wright I, David A, Murray RM, Frackowiak R, Frith C (1995). Abnormalmonitoring of inner speech: a physiological basis for auditory hallucinations. The Lancet, 346, 596-600.

298. Yakeley J, Murray R M (1995). Genetic and environmental risk factors for schizophrenia. International Academy for Biomedical Drug Research, 10, 9-34.

299. Lim LC, Powell J, Sham P, Castle D, Hunt N, Murray R, Gill M (1995). Evidence for a genetic association between alleles of monoamine oxidase A gene and bipolar affective disorder. American Journal of Medical Genetics (Neuropsychiatric Genetics), 60, 325-331.

300. Dassa D, Takei N, Sham P, Murray RM (1995). No association between prenatal exposure to influenza and autism. Acta Psychiatrica Scandinavica, 92, 145-149.

301. McGrath J, Murray RM (1995). Risk factors for schizophrenia; from conception to birth. In “Schizophrenia”. Pp 187-205. Edited by Hirsch S, Weinberger D. Blackwell, Oxford.

302. Murray RM (1995). European Psychiatry: A Force for the Future. Psychiatric Bulletin, 19, 721-722.

303. Chua S, Murray RM. (1995). The neurodevelopmental theory of schizophrenia: evidence concerning structure and neuropsychology. Acta Neuropsychiatrica, 7 (3), 57-59.

304. McKenzie K, van Os J, Fahy T, Jones P, Harvey I, Toone B, Murray R. (1995). Psychosis with good prognosis in Afro-Caribbean people now living in the United Kingdom. British Medical Journal, 311, 1325-1327.

305. Wright P, Takei N, Rifkin L, Murray RM. (1995). Maternal influenza, obstetric complications and schizophrenia. American Journal of Psychiatry, ,152, 1714-1720.

306. Ball DM, Sherman D, Gibb R, Powell JF, Hillman A, Peters T, Murray RM, Smith I (1995). No association between the c2 allele at the cytochrome P450II31 gene and alcohol induced liver disease, alcohol Korsakoff's syndrome or alcohol dependence syndrome. Drug and Alcohol Dependence, 39, 181-184.

307. Van Os J, Thomas A, Fahy T, Jones P, Harvey I, Lewis SW, Williams M, Toone B, Murray RM (1995). Increased intra-cerebral cerebrospinal fluid spaces predict unemployment and negative symptoms in psychotic illness: a prospective study. British Journal of Psychiatry, 166, 750-759.

308. Van Os J, Howard R, Takei N, Murray RM (1995). Increasing age is a risk factor for psychosis in the elderly. Social Psychiatry and Psychiatric Epidemiology, 30, 161-165.

309. McGrath JJ, van Os J, Hoyos C, Jones PB, Harvey I, Murray RM (1995). Minor physical anomalies in the functional psychoses: associations with clinical and putative aetiological variables. Schizophrenia Research, 18, 9-20.

310. Okoro C, Bell R, Sham P, Nanko S, Asherson P, Owen M, Gill M, McGuffin P, Murray RM, Collier DA (1995). No evidence for linkage between the X-chromosome marker DXS7 and schizophrenia. Brief communication. American Journal of Medical Genetics (Neuropsychiatric Genetics), 60, 461-464.

311. Dawson E, Powell JF, Sham P, Shaikh S, Taylor C, Clements A, Asherson P, Sargeant M, Collier DA, Nanko S, Whatley S, Murray RM, McGuffin P, Owen M, Gill M (1995). Systematic search for major genes in schizophrenia: methodological issues and results from chromosome 12. American Journal of Medical Genetics (Neuropsychiatric Genetics), 60 (5), 424-433.

312. Cotter D, Takei N, Farrell M, Sham P, Larkin C, Oxford JS, Murray RM, O'Callaghan E (1995). Does Prenatal Exposure to Influenza Induce Pyramidal cell disarray in mice? Schizophrenia Research, 16, 233-241.

313. van Os J, Takei N, Castle DJ, Wessely S, Der G and Murray R M (1995). Premorbid abnormalities in mania, schizomania,

24

acute schizophrenia and chronic schizophrenia. Social Psychiatry and Psychiatric Epidemiology, 30, 274-278.

314. Lin M-W, Curtis D, Williams, N, Arranz M, Nanko S, Collier D, McGuffin P, Murray R, Owen M, Gill M, Powell JF (1995). Suggestive evidence for linkage of schizophrenia to markers on chromosome 13q14.1-q22. Psychiatric Genetics, 5, 117-126.

315. Dawson E, Powell JF, Sham PC, Nothen M, Crocq M-A, Propping P, Korner J, Rietschel M, van Os J, Wright P, Murray R M, Gill M (1995). An association study of a neurotrophin-3 (NT-3) gene polymorphism with schizophrenia. Acta Psychiatrica Scandinavica, 92, 425-428.

316. Wright I, McGuire P, Poline J-B, Travere J, Murray RM, Frith C, Frackowiak R, Friston K. (1995). A voxel-based method for the statistical analysis of grey and white matter density applied to schizophrenia. Neuroimage, 2, 244-252.

317. Takei N, Van os J, Murray RM (1995). Maternal exposure to influenza and risk of schizophrenia: a 22 year study from the Netherlands. Journal of Psychiatric Research, 29 (6), 435-445.

318. Duggan C, Sham P, Minne C, Lee A, Murray RM (1995). Neuroticism - a trait vulnerability marker for depression/evidence from a family study. Journal of Affective Disorders, 35, 139-143.

319. Murray RM, Woodruff PWR (1995). Developmental Insanity or Dementia Praecox: A new perspective on an old debate. Neurology, Psychiatry and Brain Research, 3, 167-176.

320. Dawson E, Gill M, Curtis D, Castle D, Hunt N, Murray R, Powell JF (1995). Genetic association between alleles of pancreatic phospholipase A2 gene and bipolar affective disorder. Psychiatric Genetics, 5, 177-180

321. Vallada H, Curtis D, Sham PC, Murray RM, McGuffin P, Nanko S, Gill M, Owen M, Collier DA (1995). Chromosome 22 markers demonstrate transmission disequilibrium with schizophrenia. Psychiatric Genetics, 5, 127-130.

322. van den Akker OBA, Eves FF, Stein GS, Murray RM (1995). Genetic and environmental factors in premenstrual symptom reporting and its relationship to depression and a general neuroticism trait. Journal of Psychosomatic Research, 39 (4), 477-487.

1996

323. Van Os J, Fahy T, Jones P, Harvey I, Sham P, Lewis S, Bebbington P, Toone B, Williams M, Murray RM (1996). Psychopathological syndromes in the functional psychoses: associations with course and outcome. Psychological Medicine, 26, 161-176.

324. Yakeley J, Murray RM (1996). Schizophrenia. Medicine (Psychiatry), 24 (2), 6-10.

325. Murray RM, Wright I (1996). Seeing Voices. King's College London Report, 4, 36-41.

326. Murray RM (1996). Images in Psychiatry: The Maudsley. American Journal of Psychiatry, 153 (2), 264.

327. McGuire PK, Silbersweig DA, Murray RM, David AS, Frackowiak RSJ, Frith CD (1996). Functional anatomy of inner speech and auditory verbal imagery. Psychological Medicine, 26, 29-38.

328. Gilvarry CM, Sham PC, Jones PB, Cannon M, Wright P, Lewis SW, Bebbington P, Toone BK, Murray RM (1996). Family history of autoimmune diseases in psychosis. Schizophrenia Research, 19, 33-40.

329. Dawson E, Murray R (1996). Schizophrenia: a gene at 6p? Current Biology, 6 (3), 268-271.

330. Verdoux H, van Os J, Sham P, Jones P, Gilvarry K, Murray RM (1996). Does familiality predispose to both emergence and persistence of psychosis? A follow-up study. British Journal of Psychiatry, 168, 620-626.

331. Lim LCC, Craddock N, Owen M, Sham P, Nöthen MN, Körner, Rietschel M, Fimmer R, Propping P, McGuffin P, Murray R, Gill M (1996). Assessing the statistical power to detect linkage in a sample of 51 bipolar affective disorder pedigrees. Behavior Genetics, 26 (2), 113-122.

332. Malesu RR, Cannon M, McKenzie K, Jones PB, Lewis SW, Toone BK, Murray RM (1996). Mixed handedness in patients

25

with functional psychoses. British Journal of Psychiatry, 168, 234-236.

333. Kirov G, Jones P, Harvey I, Lewis SW, Toone B, Sham P, Murray RM (1996). Do obstetric complications cause the earlier age at onset of male compared to female schizophrenics? Schizophrenia Research, 20, 117-124.

334. Kunugi H, Takei N, Murray RM, Saito K, Nanko S (1996). Small head circumference at birth in schizophrenia. Schizophrenia Research, 20, 165-170.

335. Sham PC, Castle DJ, Wessely S, Farmer AE, Murray RM (1996). Further exploration of a latent class typology of schizophrenia. Schizophrenia Research, 20, 105-115.

336. Cannon M, Cotter D, Sham PC, Takei N, Larkin C, Murray RM, O'Callaghan E (1996). Prenatal exposure to the 1957 influenza epidemic and adult schizophrenia: a follow-up study. British Journal of Psychiatry, 168, 368-371.

337. Wright P, Sham P, Gilvarry C, Jones P, Cannon M, Sharma T, Murray RM (1996). Autoimmune diseases in the pedigrees of schizophrenic and control subjects. Schizophrenia Research, 20, 261-267.

338. Fananas L, Van Os J, Hoyos C, McGrath J, Mellor CS and Murray RM (1996). Dermatoglyphic a-b ridge count as a possible marker for developmental disturbance in schizophrenia: replication in two samples. Schizophrenia Research, 20, 307-314.

339. Chua SE & Murray RM (1996). The neurodevelopmental theory of schizophrenia: evidence concerning structure and neuropsychology. Acta Neuropsychiatrica, 8 (2), 25-34.

340. Van Os J, Takei N, Castle DJ, Wessely S, Der G, Macdonald AM, Murray RM (1996). The incidence of mania: time trends in relation to gender and ethnicity. Social Psychiatry and Psychiatric Epidemiology, 31, 129-136.

341. Bebbington P, Wilkins S, Sham P, Jones P, van Os J, Murray R, Toone B, Lewis S (1996). Life events before psychotic episodes: do clinical and social variables affect the relationship? Social Psychiatry and Psychiatric Epidemiology, 31, 122-128.

342. McGuire P, Silbersweig D, Wright I, Murray RM, Frackowiak R and Frith C (1996). The neural correlates of inner speech and auditory verbal imagery in schizophrenia: relationship to auditory verbal hallucinations. British Journal of Psychiatry, 169, 148-159.

343. Van Os J, Castle J, Takei N, Der G, Murray RM (1996). Psychotic illness in ethnic minorities: clarification from the 1991 census. Psychological Medicine, 26, 203-208.

344. Davies NJ, Murray RM (1996). Schizophrenia - A Neurodevelopmental or Neurodegenerative Disorder? In “Strategies for Studying Brain Disorders 3: Dopamine Disease States”. Pp 537-553. Edited by Beninger R, Palomo T, Archer T. Editoria CYM: Madrid.

345. Takei N, Lewis G, Sham PC and Murray RM (1996). Age-period-cohort analysis of the incidence of schizophrenia in Scotland. Psychological Medicine, 26, 963-973.

346. Takei N, Lewis S, Jones PB, Harvey I and Murray RM (1996). Prenatal exposure to influenza and increased cerebrospinal fluid spaces in schizophrenia. Schizophrenia Bulletin, 22 (3), 521-534.

347. Frangou S and Murray RM (1996). Imaging as a tool in exploring the neurodevelopment and genetics of schizophrenia. British Medical Bulletin (Biological Psychiatry), 52 (3), 587-596.

348. Dassa D, Sham PC, van Os J, Abel K, Jones P, Murray RM (1996). Relationship of birth season to clinical features, family history, and obstetric complications in schizophrenia. Psychiatry Research, 64, 11-17.

349. Murray RM & Jones P (1996). Sporadic schizophrenia: another male preserve? European Psychiatry, 11, 286-288.

350. Kuperberg GR and Murray R (1996). Advances in the treatment of schizophrenia. British Journal of Clinical Pharmacology, 50 (6), 315-323.

351. Kunugi H, Curtis D, Vallada HP, Nanko S, Powell JF, Murray RM, McGuffin P, Owen MJ, Gill M and Collier DA (1996). A linkage study of schizophrenia with DNA markers from chromosome 8p21-p22 in 25 multiplex families.

26

Schizophrenia Research, 22, 61-68.

352. Abel K M, O'Keane V, Sherwood R, Murray RM (1996). Plasma homovanillic acid profiles at different phases of the ovulating cycle in healthy women. Biological Psychiatry, 39, 1039-1043.

353. Abel KM, O'Keane V, Murray RM (1996). Enhancement of the prolactin response to D-Fenfluramine in drug naive schizophrenic patients. British Journal of Psychiatry, 168, 57-60.

354. Hutchinson G, Takei N, Fahy T, Bhugra D, Gilvarry K, Moran P, Mallett R, Sham P, Leff J, Murray RM (1996). Morbid risk of psychotic illness in first degree relatives of white and African-Caribbean patients with psychosis. British Journal of Psychiatry, 169, 776-780.

355. Collier DA, Arranz MJ, Sham P, Battersby S, Vallada H, Gill P, Aitchison KJ, Sodhi M, Li T, Roberts WG, Smith B, Morton J, Murray RM, Smith D and Kirov G (1996). The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. Genetics of Nervous System Disease, Neuroreport, 7, 1675-1679.

356. Wright P, Murray RM (1996). Prenatal Influenza, Immunogenes and Schizophrenia: A Hypothesis and Some Recent Findings. In “The Neurodevelopmental Basis of Schizophrenia”. Pp 43-59. Edited by Waddington JL, Buckley PF. RG Landes Co.: Austin, Texas.

357. Wright P, Donaldson P, Underhill J, Choudhuri K, Doherty D and Murray RM (1996). Genetic association of the HLA DRB1 gene locus on chromosome 6p21.3 with schizophrenia. American Journal of Psychiatry, 153 (12), 1530-1533.

358. Mellers, JDC, Sham P, Jones P, Toone BK and Murray RM (1996). A factor analytic study of symptoms in acute schizophrenia. Acta Psychiatrica Scandinavica, 93, 92-98.

359. Takei N, Mortensen PB, Klaening U, Murray RM, Sham P, O'Callaghan E, Munk-Jorgensen P (1996). Relationship between in utero exposure to influenza epidemics and risk of schizophrenia in Denmark. Biological Psychiatry, 40, 817-824.

360. Kunugi H, Nanko S, Takei N, Saito K, Murray RM and Hirose T (1996). Perinatal complications and schizophrenia: data from the Maternal and Child Health Handbook in Japan. Journal of Nervous and Mental Disease, 184 (9), 542-546.

361. Walsh C, Asherson P, Sham P, Castle, D, Williams J, Taylor C, Clement A, Watt D, Sargeant M, Owen M, Gill M, McGuffin P, Murray RM (1996). Age of onset of schizophrenia in multiply affected families is early and shows no sex difference. In “Schizophrenia: Breaking Down the Barriers”. Pp 81-97. Edited by Holliday SG, Ancill RJ, MacEwan GW. John Wiley & Sons Ltd.

362. Kunugi H, Takei N, Saito K, Akizuki S, Murray RM and Nanko S (1996). Relationship between impairment of prenatal brain growth and family history of psychosis in schizophrenia. Journal of Psychiatric Research, 30 (6), 475-481.

363. Neeleman J, Jones P, van Os J & Murray RM (1996). Parasuicide in Camberwell - ethnic differences. Social Psychiatry and Psychiatric Epidemiology, 31, 284-287.

364. Chua SE and Murray RM (1996). The neurodevelopmental theory of schizophrenia: evidence concerning structure and neuropsychology. Annals of Medicine, 28, 547-555.

365. Vallada H, Craddock N, Vasques L, Curtis D, Kirov G, Lauriano V, Gentil V, Passos-Bueno R, Murray RM, Zatz M, McGuffin P, Powell J F, Gill M, Owen M, Collier DA (1996). Linkage studies in bipolar affective disorder with markers on chromosome 21. Journal of Affective Disorders, 41, 217-221.

366. Ashworth A, Abusaad I, Walsh C, Nanko S, Murray RM, Asherson P, McGuffin P, Gill M, Owen MJ and Collier DA (1996). Linkage analysis of the fragile X gene FMR-1 and schizophrenia: no evidence for linkage but report of a family with schizophrenia and an unstable triplet repeat. Psychiatric Genetics, 6, 81-86.

367. Murray RM, Cervilla JA (1996). Esquizofrenia por neurodesarrollo anormal: voces del pasado (Neurodevelopmental schizophrenia: voices from the past). Archivos de Neurobiologia, 59 (4), 225-235.

368. Cleare AJ, Murray RM, O'Keane V (1996). Reduced prolactin and cortisol responses to d-fenfluramine in depressed

27

compared to healthy matched control subjects. Neuropsychopharmacology, 14 (5), 349-354.

369. Levinson DF Collaborative Group (1996). Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. American Journal of Medical Genetics (Neuropsychiatric Genetics), 67, 580-594.

370. Navarro F, van Os J, Jones P, Murray RM (1996). Explaining sex differences in course and outcome in the functional psychoses. Schizophrenia Research, 21, 161-170.

371. Levinson DF Collaborative Group (1996). A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. American Journal of Medical Genetics (Neuropsychiatric Genetics), 67, 40-45.

372. Collier DA, Stober G, Li T, Heils A, Catalano M, Di Bella D, Arranz MJ, Murray RM, Vallada HP, Bengel D, Müller CR, Roberts GW, Smeraldi E, Kirov G, Sham P and Lesch KP (1996). A novel functional polymorphism within thepromoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Molecular Psychiatry, 1, 453-460.

373. Li T, Sham PC, Vallada H, Xie T, Tang X, Murray RM, Liu X, Collier DA. (1996). Preferential transmission of thehigh activity allele of COMT in schizophrenia. Psychiatric Genetics, 6 (3), 131-133.

1997

97.1 Frangou S, Sharma T, Alarcon G, Sigmundsson T, Takei N, Binnie C, Murray RM (1997). The Maudsley Family Study, II: endogenous event-related potentials in familial schizophrenia. Schizophrenia Research, 23, 45-53.

97.2 O'Connell P, Woodruff PWR, Wright I, Jones P, Murray RM (1997). Developmental insanity or dementia praecox: was the wrong concept adopted? Schizophrenia Research, 23, 97-106.

97.3 Verdoux H, Takei N, Cassou de Saint-Mathurin R, Murray RM, Bourgeois ML (1997). Seasonality of birth in schizophrenia: the effect of regional population density. Schizophrenia Research, 23, 175-180.

97.4 Davies NJ, Sham PC, Gilvarry C, Jones PB, Murray RM (1997). Comparison of the family history with the family study method: Report from the Camberwell Collaborative Psychosis Study. American Journal of Medical Genetics (Neuropsychiatric Genetics), 74, 12-17.

97.5 Lin M-W, Sham P, Hwu H-G, Collier D, Murray R, Powell JF (1997). Suggestive evidence for linkage of schizophrenia to markers on chromosome 13 in Caucasian but not Oriental populations. Rapid Communication. Human Genetics, 99, 417-420.

97.6 Sodhi MS, Murray RM (1997). Review. Central & Peripheral Nervous Systems. Future therapies for schizophrenia. Expert Opinion on Therapeutic Patents, 7 (2), 151-165.

97.7 Woodruff PWR, Phillips ML, Rushe T, Wright IC, Murray RM, David AS (1997). Corpus callosum size and inter-hemispheric function in schizophrenia. Schizophrenia Research, 23, 189-196.

97.8 van Os J, Marcelis M, Sham P, Jones P, Gilvarry K, Murray RM (1997). Psychopathological syndromes and familial morbid risk of psychosis. British Journal of Psychiatry, 170, 241-246.

97.9 Kirov G, Murray RM (1997). The molecular genetics of schizophrenia: progress so far. Molecular Medicine Today, March 1997, 124-130.

97.10 Frangou S, Sharma T, Sigmundsson T, Barta P, Pearlson G, Murray RM (1997). The Maudsley Family Study 4. Normal planum temporale asymmetry in familial schizophrenia. British Journal of Psychiatry, 170, 328-333.

97.11 Pilowsky LS, O'Connell P, Davies N, Busatto GF, Costa DC, Murray RM, Ell PJ, Kerwin RW (1997). In vivo effects on striatal dopamine D2 receptor binding by the novel atypical antipsychotic drug sertindole - a 123I IBZM single photon emission tomography (SPET) study. Psychopharmacology, 130, 152-158.

97.12 Russell AJ, Munro JC, Jones PB, Hemsley DA, Murray RM (1997). Schizophrenia and the myth of intellectual decline. American Journal of Psychiatry, 154 (5), 635-639. Letters and reply (Nov 98): American Journal of Psychiatry

28

155 (11), 1633-1637.

97.13 Howard RJ, Graham C, Sham P, Dennehey J, Castle DJ, Levy R, Murray R (1997). A controlled family study of late-onset non-affective psychosis (late paraphrenia). British Journal of Psychiatry, 170, 511-514.

97.14 Walsh E and Murray R M (1997). Does case management influence the rate of violence and self-destructive behaviours in the severely mentally ill? International Journal of Psychiatry in Clinical Practice, 1 (2), 95-100.

97.15 Hutchinson G, Takei N, Bhugra D, Fahy TA, Gilvarry C, Mallett R, Moran P, Leff J, Murray RM (1997). The increased rate of psychosis among African-Caribbeans in Britain is not due to an excess of pregnancy and birth complications. British Journal of Psychiatry, 171, 145-147.

97.16 Castle DJ, Wessely S, Howard R, Murray RM (1997). Schizophrenia with onset at the extremes of adult life. International Journal of Geriatric Psychiatry, 12, 712-717.

97.17 Stefan MD, Murray RM (1997). Schizophrenia: developmental disturbance of brain and mind? Acta Paediatrica Scandinavica Suppl., 422, 112-116.

97.18 van Os J, Wright P, Murray R (1997). Risk factors for emergence and persistence of psychosis. In “Progress in Clinical Psychiatry 1”. Pp 152-206. Edited by van Kammen DP, Weller MPI. WB Saunders: London.

97.19 Verdoux H, Geddes JR, Takei N, Lawrie SM, Bovet P, Eagles JM, Heun R, McCreadie RG, McNeil TF, O'Callaghan E,Stöber G, Willinger U, Wright P, Murray RM (1997). Obstetric complications and age at onset in schizophrenia:

an international collaborative meta-analysis of individual patient data. American Journal of Psychiatry, 154, 1220-1227.

97.20 van Os J, Fahy T, Jones P, Harvey I, Toone B, Murray R (1997). Tardive dyskinesia: who is at risk? Acta Psychiatrica Scandinavica, 96, 206-216.

97.21 Li T, Xu K, Deng H, Cai G, Liu J, Liu X, Wang R, Xiang X, Zhao J, Murray RM, Sham PC and Collier DA (1997).Association analysis of the dopamine D4 gene exon III VNTR and heroin abuse in Chinese subjects. Molecular Psychiatry, 2, 413-416.

97.22 Grech A, Takei N, Murray RM (1997). Maternal exposure to influenza and paranoid schizophrenia. Schizophrenia Research, 26, 121-125.

97.23 Cannon M, Jones P, Murray RM, Wadsworth MEJ (1997). Childhood laterality and later risk of schizophrenia in the 1946 British birth cohort. Schizophrenia Research, 26, 117-120.

97.24 van Os J, Jones P, Lewis G, Wadsworth M, Murray RM (1997). Developmental precursors of affective illness in a general population birth cohort. Archives of General Psychiatry, 54, 625-631.

97.25 Kirov GK, Murray RM, Seth RV, Feeney S (1997). Observations on switching patients with schizophrenia to risperidone treatment. Acta Psychiatrica Scandinavica, 95, 439-443.

97.26 Persaud R, Russouw H, Harvey I, Lewis S, Ron M, Murray RM and du Boulay G (1997). Focal signal hyperintensities in schizophrenia. Schizophrenia Research, 27, 55-64.

97.27 Abel KM, O'Keane V, Murray RM and Cleare AJ (1997). Serotonergic function and negative and depressive symptomatology in schizophrenia and major depression. Psychoneuroendocrinology, 22 (7), 539-548.

97.28 Cannon M, Jones P, Gilvarry C, Rifkin L, McKenzie K, Foerster A, Murray RM (1997). Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences. The American Journal of Psychiatry, 154 (11), 1544-1550.

97.29 Wickham H, Murray RM (1997). Can biological markers identify endophenotypes predisposing to schizophrenia? International Review of Psychiatry, 9, 355-364.

97.30 van Os J, Fananas L, Cannon M, Marshall J, Macdonald A, Murray R (1997). Dermatoglyphic abnormalities in psychosis: a twin study. Biological Psychiatry, 41, 624-626.

29

97.31 van Os J, Wright P, Murray RM (1997). Follow-up studies of schizophrenia I: natural history and non-psychopathological predictors of outcome. European Psychiatry, 12 (Suppl.5), 327s-41s.

97.32 Woodruff PWR, Wright IC, Shuriquie N, Russouw H, Rushe T, Howard RJ, Graves M, Bullmore ET, Murray RM (1997). Structural brain abnormalities in male schizophrenics reflect fronto-temporal dissociation. Psychological Medicine, 27, 1257-1266.

97.33 Sharma T, du Boulay G, Lewis S, Sigmundsson T, Gurling H, Murray RM (1997). The Maudsley Family Study I: Structural brain changes on magnetic resonance imaging in familial schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 21, 1297-1315.

97.34 Bullmore ET, O'Connell P, Frangou S, Murray RM (1997). Schizophrenia as a developmental disorder of neural network integrity: the dysplastic net hypothesis. In “Neurodevelopment and Adult Psychopathology”. Pp 253-266. Edited by Keshavan MS, Murray RM. Cambridge University Press.

97.35 Woodruff PWR, Wright IC, Bullmore ET, Brammer M, Howard RJ, Williams SCR , Shapleske J, Rossell S, David AS, McGuire PK, Murray RM (1997). Auditory hallucinations and the temporal cortical response to speech in schizophrenia: a functional magnetic resonance imaging study. American Journal of Psychiatry, 154 (12), 1676-1682.

97.36 Bullmore ET, Frangou S, Murray RM (1997). The dysplastic net hypothesis: an integration of developmental and dysconnectivity theories of schizophrenia. Schizophrenia Research, 28 (2-3), 143-156.

97.37 Chua SE, Wright IC, Poline J-B, Liddle PF, Murray RM, Frackowiak RSJ, Friston KJ, McGuire PK (1997). Grey matter correlates of syndromes in schizophrenia: a semi-automated analysis of structural magnetic resonance images. British Journal of Psychiatry, 170, 406-410.

97.38 Arranz M J, Erdmann J, Kirov G, Rietschel M, Sodhi M, Albus M, Ball D, Maier W, Davies N, Franzek E, Abusaad I, Weigelt B, Murray RM, Shimron-Abarnell D, Kerwin RW, Propping P, Sham PC, Nöthen MM, Collier DA (1997). 5-HT2a receptor and bipolar affective disorder: association studies in affected patients. Neuroscience Letters, 224, 95-98.

97.39 Li T, Vallada H, Curtis D, Arranz M, Xu K, Cai G, Deng H, Liu J, Murray R, Liu X, Collier D (1997). Catechol-O-methyltransferase Val158Met polymorphism: frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. Pharmacogenetics, 7, 349-353.

97.40 Kunugi H, Vallada H, Curtis D, Sham PC, Hoda F, Arranz MJ, Li T, Nanko S, Murray RM, McGuffin P, Owen M, Gill M, Collier DA (1997). Catechol-o-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families. Psychiatric Genetics, 7, 97-101.

97.41 Dann J, DeLisi LE et al (Levinson Collaborative Group) (1997). A linkage study of schizophrenia to markers within Xp11 near the MAOB gene. Psychiatry Research, 70 (3), 131-43.

97.42 Cleare AJ, Murray RM, O'Keane V (1997). Do noradrenergic reuptake inhibitors affect serotonergic function in depression? Psychopharmacology (Berl), 134 (4), 406-10.

97.43 Kunugi H, Vallada HP, Hoda F, Kirov G, Gill M, Aitchison KJ, Ball D, Arranz MJ, Murray RM, Collier DA (1997). No evidence for an association of affective disorders with high- or low-activity allele of catechol-o-methyltransferase gene. Biological Psychiatry, 42 (4), 282-5.

1998

98.1 Cannon M, Murray RM (1998). Neonatal origins of schizophrenia. Archive of Diseases in Childhood, 78, 1-3.

98.2 Duggan C, Sham P, Minne C, Lee A, Murray R (1998). Quality of parenting and vulnerability to depression: results from a family study. Psychological Medicine, 28, 185-191.

98.3 Griffiths TD, Sigmundsson T, Takei N, Rowe D, Frangou S, Birkett PB, Sharma T, Reveley AM, Murray RM (1998). Minor physical anomalies in familial and sporadic schizophrenia: the Maudsley Family Study. Journal of Neurology, Neurosurgery and Psychiatry, 64 (1), 56-60.

30

98.4 Takei N, Persaud R, Woodruff P, Brockington I, Murray RM (1998). First episodes of psychosis in Afro-Caribbean and white people: an 18-year follow-up population-based study. British Journal of Psychiatry, 172, 147-153.

98.5 Duggan C, Sham P, Minne C, Lee A and Murray R (1998). Does the method of data collection affect the reporting of depression in the relatives of depressed probands? Journal of Affective Disorders, 47, 151-158.

98.6 Taylor D, Ellison Z, Ementon Shaw L, Wickham H, Murray R (1998). Co-administration of citalopram and clozapine: effect on plasma clozapine levels. International Clinical Psychopharmacology, 13, 19-21.

98.7 Griffiths TD, Sigmundsson T, Takei N, Rowe D, Murray RM (1998). Neurological abnormalities in familial and sporadic schizophrenia. Brain, 121, 191-203.

98.8 Marcelis M, van Os J, Sham P, Jones P, Gilvarry C, Cannon M, McKenzie K, Murray RM (1998). Obstetric complications and familial morbid risk of psychiatric disorders. American Journal of Medical Genetics (Neuropsychiatric Genetics), 81, 29-36.

98.9 Bullmore ET, Woodruff PWR, Wright IC, Rabe-Hesketh S, Howard RJ, Shuriquie N and Murray RM (1998). Does dysplasia cause anatomical dysconnectivity in schizophrenia? Schizophrenia Research, 30, 127-135.

98.10 Cleare AJ, Murray RM, Sherwood RA, O'Keane V (1998). Abnormal 5-HT1D receptor function in major depression: a neuropharmacological challenge study using sumatriptan. Psychological Medicine, 28, 295-300.

98.11 Ismail K, Murray RM, Wheeler MJ, O'Keane V (1998). The dexamethasone suppression test in schizophrenia. Psychological Medicine, 28, 311-317.

98.12 Takei N, Murray RM (1998). The current status of the neurodevelopmental hypothesis of schizophrenia. International Medical Journal, 5 (1), 13-20.

98.13 Murray RM, van Os J (1998). Predictors of outcome in schizophrenia. Journal of Clinical Psychopharmacology, 18 (2), S2-S4.

98.14 Gutiérrez B, Arranz MJ, Collier D A, Vallès V, Guillamat R, Bertranpetit J, Murray RM, Fañanás L (1998). Serotonin transporter gene and risk for bipolar affective disorder: an association study in a Spanish population. Biological Psychiatry, 43, 843-847.

98.15 Verdoux H, Murray RM (1998). Prenatal and perinatal risk factors for schizophrenia: data and doubts. NeuroScience News 1 (4), 18-21.

98.16 Arranz M J, Munro J, Sham P, Kirov G, Murray RM, Collier D A, Kerwin RW (1998). Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response. Schizophrenia Research, 32, 93-99.

98.17 Vallada HP, Collier D (coordinators), and participants (Schizophrenia Collaborative Linkage Group for chromosome 22) (1998). A transmission disequilibrium and linkage analysis of D22S278 marker alleles in 574 families: further support for a susceptibility locus for schizophrenia at 22q12. Schizophrenia Research, 32, 115-121.

98.18 Li T, Arranz M, Aitchison KJ, Bryant C, Liu X, Kerwin RW, Murray R, Sham P and Collier DA (1998). Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophrenia. Schizophrenia Research, 32, 87-92.

98.19 Sharma T, Lancaster E, Lee D, Lewis S, Sigmundsson T, Takei N, Gurling H, Barta P, Pearlson G and Murray RM (1998). Brain changes in schizophrenia: Volumetric MRI study of families multiply affected with schizophrenia - The Maudsley Family Study 5. British Journal of Psychiatry, 173, 132-138.

98.20 Curtis VA, Bullmore ET, Brammer MJ, Wright IC, Williams SCR, Morris RG, Sharma TS, Murray RM, McGuire PK, (1998). Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. American Journal of Psychiatry, 155 (8), 1056-1063.

98.21 McGuire P K, Quested D, Spence S A, Murray R M, Frith C D, Liddle P F (1998). Pathophysiology of 'positive' thought disorder in schizophrenia. British Journal of Psychiatry 173, 231-235.

31

98.22 Davies N, Russell A, Jones P and Murray R (1998). Which characteristics of schizophrenia predate psychosis? Journal of Psychiatric Research, 32, 121-131.

98.23 Kirov G, Murphy K C, Arranz M J, Jones I, McCandles F, Kunugi H, Murray RM, McGuffin P, Collier DA, Owen MJ and Craddock N (1998). Low activity allele of catechol-O-methyltransferase gene associated with rapid cycling bipolar disorder. Molecular Psychiatry, 3, 342-345.

98.24 Marcelis M, Navarro-Mateu F, Murray R, Selten J-P, van Os J (1998). Urbanization and psychosis: a study of 1942-1978 birth cohorts in The Netherlands. Psychological Medicine, 28, 871-879.

98.25 Wright P, Dawson E, Donaldson P T, Underhill J A, Sham P C, Zhao J, Gill M, Nanko S, Owen M J, McGuffin P, Murray R (1998). A transmission/disequilibrium study of the DRB1*04 gene locus on chromosome 6p21.3 with schizophrenia. Schizophrenia Research, 32, 75-80.

98.26 Castle D, Sham P and Murray R (1998). Differences in distribution of ages of onset in males and females with schizophrenia. Schizophrenia Research, 33, 179-183.

98.27 Ellison Z, van Os J, Murray RM (1998). Childhood personality characteristics of schizophrenia: manifestations of, or risk factors for, the disorder? Journal of Personality Disorders, 12 (3), 247-261.

98.28 Duggan C, Sham P, Minne C, Lee A, Murray R (1998). Family history as a predictor of poor long-term outcome in depression. British Journal of Psychiatry, 173, 527-530.

98.29 Shergill SS, Murray RM, McGuire PK (1998). Auditory hallucinations: a review of psychological treatments. Schizophrenia Research, 32, 137-150.

98.30 Crawford TJ, Sharma T, Puri BK, Murray RM, Berridge DM, Lewis SW (1998). Saccadic eye movements in families multiply affected with schizophrenia: the Maudsley Family Study. American Journal of Psychiatry, 155, 1703-1710.

98.31 Verdoux H, Murray RM (1998). What is the role of obstetric complications in schizophrenia? The Harvard Mental Health Newsletter, 15 (1), 8.

98.32 McDonald C, Murray RM (1998). Guide to withdrawing and switching antipsychotics. Prescriber, Nov 5 1998, 117-120.

98.33 Murray RM (1998). Biological and social predictions of outcome in psychosis. In “Important Considerations Regarding Outcomes in the Treatment of Schizophrenia”. Satellite Symposium held at the AEP Conference: London, 1996. Journal of Clinical Psychiatry Monograph 16 (1), 19-22.

98.34 Cleare AJ, Murray RM, O'Keane V (1998). Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response. Biological Psychiatry, 44, 555-561.

98.35 Li T, Hu X, Chandy G, Fantino E, Kalman K, Gutman G, Gargus JJ, Freeman B, Murray RM, Dawson E, Liu X, Bruinvels A T, Sham PC, Collier DA (1998). Transmission disequilibrium analysis of a triplet repeat within the hKCa3 gene using family trios with schizophrenia. Biochemical and Biophysical Research Communications, 251, 662-665.

98.36 Li T, Vallada H, Liu X, Xie T, Tang X, Zhao J, O'Donovan M, Murray R, Sham P and Collier D (1998). Analysis of CAG/CTG repeat size in Chinese subjects with schizophrenia and bipolar affective disorder using the repeat expansion detection method. Biological Psychiatry, 44 (11), 1160-1165.

98.37 Van Os J, Jones P, Sham P, Bebbington P, Murray RM (1998). Risk factors for onset and persistence of psychosis. Social Psychiatry and Psychiatric Epidemiology, 33, 596-605.

98.38 Vallada H, Vasques L, Curtis D, Zatz M, Kirov G, Lauriano V, Gentil V, Murray RM, McGuffin P, Owen M, Gill M, Craddock N and Collier DA (1998). Linkage analysis between bipolar affective disorder and markers on chromosome X. Psychiatric Genetics, 8, 183-6.

1999

99.1 UK 700 Group: Creed F, Burns T, Butler T, Byford S, Murray R, Thompson S, Tyrer P (1999). Comparison of intensive

32

and standard case management for patients with psychosis: rationale of the trial. British Journal of Psychiatry, 174, 74-78.

99.2 Wright IC, Ellison ZR, Sharma T, Friston KJ, Murray RM, McGuire PK (1999). Mapping of grey matter changes in schizophrenia. Schizophrenia Research, 35, 1-14.

99.3 Rushe TM, Woodruff PWR, Murray RM, Morris RG (1999). Episodic memory and learning in patients with chronic schizophrenia. Schizophrenia Research, 35, 85-96.

99.4 Arranz MJ, Li T, Munro J, Liu X, Murray RM, Collier DA, Kerwin RW (1999). Lack of association between a polymorphism in the promoter region of the dopamine-2 receptor gene and clozapine response. Pharmacogenetics, 8, 481-484.

99.5 Hultman CM, Sparen P, Takei N, Murray RM, Cnattingius S (1999). Prenatal and perinatal risk factors for schizophrenia, affective psychosis and reactive psychosis of early onset: case-control study. British Medical Journal, 318, 421-425.

99.6 Cardno A, Marshall J, Coid B, Macdonald A, Ribchester T, Davies N, Venturi P, Jones L, Lewis S, Sham P, Gottesman I, Farmer A, McGuffin P, Reveley A, Murray R (1999). Heritability estimates for psychotic disorders: The Maudsley Twin Psychosis Series. Archives of General Psychiatry, 56, 162-168.

99.7 Curtis VA, Bullmore ET, Morris RG, Brammer MJ, Williams SCR, Simmons A, Sharma TS, Murray RM, McGuire PK (1999). Attenuated frontal activation in schizophrenia may be task dependent. Schizophrenia Research, 37, 35-44.

99.8 Rushe TM, Morris RG, Miotto EC, Feigenbaum JD, Woodruff PWR, Murray RM (1999). Problem-solving and spatial working memory in patients with schizophrenia and with focal frontal and temporal lobe lesions. Schizophrenia Research, 37, 21-33.

99.9 Stewart AL, Rifkin L, Amess PN, Kirkbride V, Townsend JP, Miller DH, Lewis SW, Kingsley DPE, Moseley IF, Foster O, Murray RM (1999). Brain structure and neurocognitive and behavioural function in adolescents who were born very preterm. Lancet, 353, 1653-57.

99.10 Cannon M, Jones P, Huttunen M O, Tanskanen A, Huttunen T, Rabe-Hesketh S, Murray RM (1999). School performance in Finnish children and later development of schizophrenia: a population-based longitudinal study. Archives of General Psychiatry, 56, 457-463.

99.11 Taylor D, Bodani M, Hubbeling A, Murray R (1999). The effect of nefazodone on clozapine plasma concentrations. International Clinical Psychopharmacology, 14 (3), 185-187.

99.12 UK 700 Group: Van Os J, Gilvarry C, van Horn E, Tattan T, Bale R, White I, Murray RM (1999). A comparison of the utility of dimensional and categorical representations of psychosis. Psychological Medicine, 29, 595-606.

99.13 Hutchinson G, Takei N, Sham P, Harvey I, Murray RM (1999). Factor analysis of symptoms in schizophrenia: differences between White and Caribbean patients in Camberwell. Psychological Medicine, 29, 607-612.

99.14 Wright P, Laing P, Donaldson PT, Murray RM (1999). Schizophrenia: the teratogenic antibody hypothesis. In “Psychiatry, Psychoimmunology, and Viruses. Key Topics in Brain Research”. Pp 89-99. Edited by N Müller N. Springer Verlag: Wien.

99.15 Wright P, Takei N, Murray RM, Sham PC (1999). Seasonality, Prenatal Influenza Exposure, and Schizophrenia. In: Prenatal Factors in Schizophrenia. In “Prenatal Exposures in Schizophrenia”. Pp 89-112. Edited by Susser ES, Brown AS,Gorman JM). American Psychiatric Press Inc: Washington DC.

99.16 UK 700 Group: Burns T, Creed F, Fahy T, Thompson S, Tyrer P, White I (1999). Intensive versus standard case management for severe psychotic illness: a randomised trial. Lancet, 353 (9171), 2185-9.

99.17 Kirov G, Murray RM (1999). Ethnic differences in the presentation of bipolar affective disorder. European Psychiatry, 14, 199-204.

99.18 Hickling FW, McKenzie K, Mullen R, Murray R (1999). A Jamaican psychiatrist evaluates diagnoses at a London

33

psychiatric hospital. British Journal of Psychiatry, 175, 283-5.

99.19 Li T, Liu X, Sham P, Aitchison KJ, Cai G, Arranz MJ, Deng H, Liu J, Kirov G, Murray RM, Collier DA (1999). Association analysis between dopamine receptor genes and bipolar affective disorder. Psychiatry Research 86 (3), 193-201.

99.20 Geddes JR, Verdoux H, Takei N, Lawrie SM, Bovet P, Eagles JM, Heun R, McCreadie, RG, McNeil TF, O'Callaghan E, Stöber G, Willinger U, Murray RM (1999). Schizophrenia and complications of pregnancy and labor: an individual patient data meta-analysis. Schizophrenia Bulletin, 25 (3), 413-23.

99.21 Shergill SS, van Os J, Murray RM. Schizophrenia and depression: what is their relationship? In “Managing the Depressive Symptoms of Schizophrenia”. Pp 12-29. Edited by Keck Jr PE. Science Press Ltd.

99.22 UK 700 Group: van Os J, Gilvarry C, Bale R, van Horn E, Tattan T, White I, Murray R (1999). To what extent does symptomatic improvement result in better outcome in psychotic illness? Psychological Medicine, 29, 1183-95.

99.23 Stefanis N, Frangou S, Yakeley J, Sharma T, O'Connell P, Morgan K, Sigmundsson T, Taylor M, Murray RM (1999). Hippocampal volume reduction in schizophrenia: effects of genetic risk and pregnancy and birth complications. Biological Psychiatry, 46, 697-702.

99.24 Sharma T, Lancaster E, Sigmundsson T, Lewis S, Takei N, Gurling H, Barta P, Pearlson G, Murray R (1999). Lack of normal pattern of cerebral asymmetry in familial schizophrenic patients and their relatives - The Maudsley Family Study. Schizophrenia Research, 40, 111-20.

99.25 Orr KGD, Cannon M, Gilvarry CM, Jones PB, Murray RM (1999). Schizophrenic patients and their first-degree relatives show an excess of mixed-handedness. Schizophrenia Research, 39, 167-76.

99.26 Aitchison KJ, Munro J, Wright P, Smith S, Makoff AJ, Sachse C, Sham PC, Murray RM, Collier DA, Kerwin RW (1999). Failure to respond to treatment with typical antipsychotics is not associated with CYP2D6 ultrarapid hydroxylation. British Journal of Clinical Pharmacology, 48, 388-94.

99.27 McKenzie K, Murray RM (1999). Risk factors for psychosis in the UK African-Caribbean population. In “Ethnicity: An Agenda for Mental Health”. Pp 48-59. Edited by Bhugra D, Bahl V. Gaskell: London.

99.28 Cannon M, Jones P, Huttunen MO, Tanskanen A, Murray RM (1999). Motor co-ordination deficits as predictors of schizophrenia among Finnish school children. Human Psychopharmacology: Clinical and Experimental, 14, 491-7.

99.29 Li T, Breen G, Brown J, Liu X, Murray RM, Shaw DJ, Sham PC, St Clair D, Collier DA (1999). No evidence of linkage disequilibrium between a CAG repeat in the SCA 1 gene and schizophrenia in Caucasian and Chinese schizophrenic subjects. Psychiatric Genetics, 9, 123-7.

99.30 Bullmore E, Brammer M, Williams S, Curtis V, McGuire P, Morris R, Murray R, Sharma T (1999). Functional MR imaging of confounded hypofrontality. Human Brain Mapping, 8, 86-91.

99.31 Bullmore ET, Woodruff PWR, Wright C, Rabe-Hesketh S, Howard RJ, Shuriquie N, Murray RM. Does dysplasia cause anatomical dysconnectivity in schizophrenia? In “One World, One Language: Proceedings X World Congress of Psychiatry”. Pp 217-24. Edited by Lopez-Ibor JJ, Mak FL, Visotsky HM, Maj M. Hogrefe & Huber: Gottingen.

99.32 Murray RM, Hutchinson G (1999). Psychosis in migrants: the striking example of African-Caribbeans resident in England. In “Search for the Causes of Schizophrenia”. Pp 129-40. Edited by Gattaz W, Hafner H). Springer: Berlin.

99.33 Takei N, Murray RM (1999). The current status of the neurodevelopmental hypothesis of schizophrenia. In “One World, One Language: Proceedings X World Congress of Psychiatry”. Pp153-63. Edited by Lopez-Ibor JJ, Mak FL, Visotsky HM, Maj M). Hogrefe & Huber: Gottingen.

99.34 McDonald C, Fearon P, Murray R (1999). Neurodevelopmental hypothesis of schizophrenia 12 years on: data and doubts. In “Childhood Onset of "Adult" Psychopathology”. Pp 193-220. Edited by Rapoport, JL. American Psychiatric Press: Washington.

99.35 Gilvarry CM, Walsh E, Samele C, Hutchinson G, Mallett R, Rabe-Hesketh S, Fahy T, van Os J, Murray RM (1999). Life

34

events, ethnicity and perceptions of discrimination in patients with severe mental illness. Social Psychiatry & Psychiatric Epidemiology 34 (11), 600-8.

99.36 Murray RM, Fearon P (1999). The developmental 'risk factor' model of schizophrenia. Journal of Psychiatric Research, 33, 497-9.

99.37 Dazzan P, Murray RM (1999). Schizophrenia is (not simply) a neurodevelopmental disorder. Epidemiologia e Psichiatria Sociale, 8 (4), 235-41.

99.38 Foerster A, Jones PB, Sham PC, Murray RM (1999). The effect of increasingly stringent diagnostic criteria on sex differences in schizophrenia. South African Medical Journal, 89 (12), 1299-302.

99.39 UK 700 Group: Walsh E, Harvey K, White I, Manley C, Fraser J, Stanbridge S, Murray RM (1999). Prevalence and predictors of parasuicide in chronic psychosis. Acta Psychiatrica Scandinavica, 100, 375-82.

99.40 Sander T, Ball D, Murray R, Patel J, Samochowiec J, Winterer G, Rommelspacher H, Schmidt L, Loh E-W (1999). Association analysis of sequence variants of the GABAA α6, ß2 and γ2 gene cluster and alcohol dependence. Alcoholism: Clinical and Experimental Research 23 (3), 427-31.

99.41 Wright IC, Sharma T, Ellison ZR, McGuire PK, Friston KJ, Brammer MJ, Murray RM, Bullmore ET (1999). Supra-regional brain systems and the neuropathology of schizophrenia. Cerebral Cortex 9 (4), 366-78.

99.42 Bowen T, Kirov G, Gill M, Spurlock G, Vallada HP, Murray RM, McGuffin P, Collier D, Owen MJ, Craddock N (1999). Linkage studies of bipolar disorder with chromosome 18 markers. American Journal of Medical Genetics 88 (5), 503-9.

99.43 Loh E-W, Smith I, Murray R, McLaughlin M, NcNulty S, Ball D (1999). Association between variants at the GABAAß2, GABAAα6 and GABAAγ2 gene cluster and alcohol dependence in a Scottish population. Molecular Psychiatry, 4,

539-44.

99.44 Murray RM, O’Callaghan E, Castle DJ, Lewis SW (1999). A Neurodevelopmental approach to the classification of

schizophrenia. Schizophrenia Bulletin, 18 (2), 319-331.

2000

00.01 Spence SA, Liddle PF, Stefan M, Hellewell JSE, Sharma T, Friston KJ, Hirsch SR, Frith CD, Murray RM, Deakin JFW, Grasby PM (2000). Functional anatomy of verbal fluency in people with schizophrenia and those at genetic risk. British Journal of Psychiatry, 176, 52-60.

00.02 Chua SE, Sharma T, Takei N, Murray RM, Woodruff PWR (2000). A magnetic resonance imaging study of corpus callosum size in familial schizophrenic subjects, their relatives and normal controls. Schizophrenia Research, 41, 397-403.

00.03 Gilvarry C, Takei N, Russell A, Rushe T, Hemsley D, Murray RM (2000). Premorbid IQ in patients with functional psychosis and their first degree relatives. Schizophrenia Research, 41, 417-29.

00.04 Hemsley D, Murray RM (2000). Commentary: Psychological and social treatments for schizophrenia: not just old remedies in new bottles. Schizophrenia Bulletin, 26 (1), 145-51.

00.05 McDonald C, Murray RM (2000). Early and late environmental risk factors for schizophrenia. Brain Research Reviews, 31, 130-7.

00.06 Ichiki M, Kunugi H, Takei N, Murray RM, Baba H, Arai H, Oshima I, Okagami K, Sato T, Hirose T, Nanko S (2000). Intra-uterine physical growth in schizophrenia: evidence confirming excess of premature birth. Psychological Medicine, 30, 597-604.

00.07 Wright P, Nimgaonkar V, Ganguli R, Murray RM (2000). HLA and Psychiatric Disease. In “HLA in Health and Disease” . Pp 419-26. Edited by Lechler R, Warrens A. Academic Press: London.

35

00.08 Murray RM, Yakeley JW (2000). Schizophrenia. Medicine (Psychiatry), 28 (4), 19-22.

00.09 Blackwood NJ, Howard RJ, ffytche DH, Simmons A, Bentall RP, Murray RM (2000). Imaging attentional and attributional bias: an fMRI approach to the paranoid delusion. Psychological Medicine, 30, 873-83.

00.10 Allardyce J, Morrison G, van Os J, Kelly J, Murray RM and McCreadie RG (2000). Schizophrenia is not disappearing in South West Scotland. British Journal of Psychiatry, 177, 38-41.

00.11 Arranz MJ, Munro J, Birkett J, Bolonna A, Mancama D, Sodhi M, Lesch KP, Meyer JFW, Sham P, Collier DA, Murray RM, Kerwin RW (2000). Pharmacogenetic prediction of clozapine response. The Lancet, 355, 1615-6.

00.12 Kirkpatrick B, Castle D, Murray RM, Carpenter WT (2000). Risk factors for the deficit syndrome of schizophrenia. Schizophrenia Bulletin, 26 (1), 233-42.

00.13 Fearon P, Cotter P, Murray RM (2000). Is the association between obstetric complications and schizophrenia mediated by glutamatergic excitotoxic damage in the foetal/neonatal brain? In “Psychopharmacology of Schizophrenia”. Pp 21-40. Edited by Reveley M, Deakin B. Chapman & Hall: London.

00.14 Kelly J, Murray RM (2000). A Century of Schizophrenia is Enough. In “Schizophrenia: Volume 2”. Pp 65-8. Edited by Maj M, Sartorius N). WPA Series: Evidence and Experience in Psychiatry. John Wiley & Sons: Chichester.

00.15 Russell AJ, Munro J, Jones PB, Hayward P, Hemsley D, Murray RM (2000). The National Adult Reading Test as a measure of premorbid IQ in schizophrenia. British Journal of Clinical Psychology, 39, 297-305.

00.16 Wright I C, Rabe-Hesketh S, Woodruff PWR, David AS, Murray RM, Bullmore ET (2000). Meta-analysis of regional brain volumes in schizophrenia. American Journal of Psychiatry 157 (1), 16-25.

00.17 Mata I, Sham PC, Gilvarry CM, Jones PB, Lewis SW, Murray RM (2000). Childhood schizotypy and positive symptoms in schizophrenic patients predicts schizotypy in relatives. Schizophrenia Research, 44, 129-36.

00.18 Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H (2000). Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Archives of General Psychiatry, 57, 1053-8.

00.19 Shergill SS Bullmore E, Simmons A, Murray RM, McGuire P (2000). Functional anatomy of auditory verbal imagery in schizophrenic patients with auditory hallucinations. American Journal of Psychiatry, 157 (10), 1691-3.

00.20 van Os J, Woodruff PWR, Fananas L, Ahmad F Shuriquie N, Howard R, Murray RM (2000). Association between cerebral structural abnormalities and dermatoglyphic ridge counts in schizophrenia. Comprehensive Psychiatry, 41 (5), 380-4.

00.21 Murray RM, Castle DJ (2000). Genetic and environmental risk factors for schizophrenia. In “New Oxford Textbook of Psychiatry: Volume 1”. Pp 599-605. Edited by Gelder MC, Lopez-Ibor Jr JJ, Andreasen N. Oxford University Press.

00.22 Shergill S, Brammer M, Williams S, Murray RM, McGuire PK (2000). Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Archives of General Psychiatry, 57, 1033-8.

00.23 Curtis VA, van Os J, Murray RM (2000). The Kraepelinian dichotomy: evidence from developmental and neuroimaging studies. Journal of Neuropsychiatry & Clinical Neuroscience, 12 (3), 398-405.

00.24 Gilvarry CM, Russell A, Hemsley D, Murray RM (2000). Trail Making Test performance in the first-degree relatives of schizophrenic and affective psychotic patients. Cognitive Neuropsychiatry, 5 (3), 219-34.

00.25 Kelly J, Murray RM (2000). What risk factors tell us about the causes of schizophrenia and related psychoses. Current Psychiatry Reports, 2, 378-85.

00.26 UK 700 Group: van Os, Gilvarry C, Bale R, van Horn E, Tattan T, White I, Murray R (2000). Diagnostic value of the DSM and ICD categories of psychosis: an evidence-based approach. Social Psychiatry and Psychiatric Epidemiology, 35, 305-11.

36

00.27 Li T, Ball D, Zhao J, Murray RM, Liu X, Sham PC, Collier DA (2000). Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11 [published erratum appears in Molecular Psychiatry 5 (4), 452]. Molecular Psychiatry 5 (1), 77-84.

00.28 Riley BP, Makoff A, Mogudi-Carter M, Jenkins T, Williamson R, Collier D and Murray R (2000). Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families. American Journal of Medical Genetics, 96, 196-201.

0.29 Loh E-W, Higuchi S, Matsushita S, Murray R, Chen C-K and Ball D (2000). Association analysis of the GABA A receptor subunit genes cluster on 5q33-34 and alcohol dependence in a Japanese population. Molecular Psychiatry, 5, 301-7.

2001

01.01 Allin M, Matsumoto H, Santhouse AM, Nosarti C, AlAsady MHS, Stewart AL, Rifkin L, Murray RM (2001). Cognitive and motor function and the size of the cerebellum in adolescents born very pre-term. Brain, 124, 60-6.

01.02 Wright P, Nimgaonkar VL, Donaldson PT and Murray RM (2001). Schizophrenia and HLA: a review. Schizophrenia Research, 47, 1-12.

01.03 UK 700 Group: McKenzie K, Samele C, van Horn E, Tattan T, van Os J, Murray R (2001). Comparison of the outcome and treatment of psychosis in people of Caribbean origin living in the UK and British Whites. British Journal of Psychiatry 178, 160-5.

01.04 UK 700 Group: Walsh E, Harvey K, White I, Fraser J, Higgitt A Murray R (2001). Suicidal behaviour in psychosis: prevalence and predictors from a randomised controlled trial of case management. British Journal of Psychiatry, 178, 255-60.

01.05 Wickham H, Walsh C, Asherson P, Taylor C, Sigmundsson T, Gill M, Owen M, McGuffin P, Murray R, Sham P (2001). Familiality of symptom dimensions in schizophrenia. Schizophrenia Research, 47, 223-232.

01.06 Gilvarry CM, Russell A, Hemsley D, Murray RM (2001). Neuropsychological performance and spectrum personality traits in the relatives of patients with schizophrenia and affective psychosis. Psychiatry Research, 101(2), 89-100.

01.07 Kunugi H, Nanko S, Murray RM (2001). Obstetric complications and schizophrenia: prenatal underdevelopment and subsequent neurodevelopmental impairment. British Journal of Psychiatry, 178 (suppl.40), s25-9.

01.08 Sharpley M S, Hutchinson G, McKenzie K, Murray RM (2001). Understanding the excess of psychosis among the African-Caribbean population in England: review of current hypotheses. British Journal of Psychiatry 178 (suppl.40), s60-8.

01.09 Shergill SS, Bullmore ET, Brammer MJ, Williams S, Murray RM, McGuire PK (2001). A functional study of auditory verbal imagery. Psychological Medicine, 31, 241-53.

01.10 Cannon M, Walsh E, Hollis C, Kargin M, Taylor E, Murray RM, Jones PB (2001). Predictors of later schizophrenia and affective psychosis among attendees at a child psychiatry department. British Journal of Psychiatry, 178, 420-6.

01.11 Li T, Underhill J, Liu KX, Sham PC, Donaldson P, Murray RM, Wright P, Collier DA (2001). Transmission disequilibrium analysis of HLA Class II DRB1, DQA1, DQB1 and DPB1 polymorphisms in schizophrenia using family trios from a Han Chinese population. Schizophrenia Research, 49, 73-8.

01.12 Bramon E, Kelly J, van Os J and Murray RM (2001). The cascade of increasingly deviant development that culminates in the onset of schizophrenia. NeuroScience News, 4 (1), 5-19.

01.13 Kircher TJ, Bullmore E, Brammer MJ, Williams SCR, Broome MR, Murray RM, McGuire PK (2001). Differential activation of temporal cortex during sentence completion in schizophrenic patients with and without formal thought disorder. Schizophrenia Research, 50, 27-40.

01.14 Kelly J, Murray RM, van Os J (2001). The Outcome of Psychotic Illness. In “Comprehensive Care of Schizophrenia”.

37

Pp.37-58. Edited by Lieberman JA, Murray RM. Martin Dunitz: London.

01.15 Shergill SS, Murray RM (2001). Affective Symptoms in Schizophrenia. In “Comprehensive Care of Schizophrenia”. Pp 205-18. Edited by Lieberman JA, Murray RM. Martin Dunitz: London.

01.16 Cardno AG, Sham PC, Murray RM, McGuffin P (2001). Twin study of symptom dimensions in psychoses. British Journal of Psychiatry, 179, 39-45.

01.17 Matsumoto H, Simmons A, Williams S, Pipe R, Murray R, Frangou S (2001). Structural magnetic imaging of the hippocampus in early onset schizophrenia. Biological Psychiatry, 49, 824-31.

01.18 Blackwood NJ, Howard RJ, Bentall RP, Murray RM (2001). Cognitive neuropsychiatric models of persecutory delusions. American Journal of Psychiatry, 158 (4), 527-39.

01.19 Matsumoto H, Simmons A, Williams S, Hadjulis M, Pipe R, Murray R, Frangou S (2001). Superior temporal gyrus abnormalities in early onset schizophrenia: similarities and differences with adult-onset schizophrenia. American Journal of Psychiatry, 158 (8), 1299-1304.

01.20 Allardyce J, Boydell J, van Os J, Morrison G, Castle D, Murray RM and McCreadie RG (2001). Comparison of the incidence of schizophrenia in rural Dumfries and Galloway and urban Camberwell. British Journal of Psychiatry, 179, 335-9.

01.21 Curtis VA, Dixon TA, Morris RG, Bullmore ET, Brammer MJ, Williams SCR, Sharma T, Murray RM, McGuire PK (2001). Differential frontal activation in schizophrenia and bipolar illness during verbal fluency. Journal of Affective Disorders, 66, 111-121.

01.22 Fearon P, Cannon M, Murray RM (2001). A critique of the idea and science of risk factor research in schizophrenia. International Journal of Mental Health, 30, 82-90.

1.23 Cai G, Li T, Deng H, Zhao J, Hu X, Murray R, Liu X, Sham P and Collier D (2001). Affected sibling pair linkage analysis of qualitative and quantitative traits for schizophrenia on chromosome 22 in a Chinese population. American Journal of Medical Genetics, 105 (4), 321-7.

01.24 Boydell J, van Os J, McKenzie K, Allardyce J, Goel R, McCreadie RG, Murray RM (2001). Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment. British Medical Journal, 323, 1336-8.

01.25 UK 700 Group: Samele C, van Os J, McKenzie K, Wright A, Gilvarry C, Manley C, Tattan T, Murray R (2001). Does socioeconomic status predict course and outcome in patients with psychosis? Social Psychiatry and Psychiatric Epidemiology, 36, 573-81.

1.26 Kircher TJ, Liddle PF, Brammer MJ, Williams SCR, Murray RM, McGuire PK (2001). Neural correlates of formal thought disorder in schizophrenia. Archives of General Psychiatry, 58, 769-74.

1.27 UK 700 Group: Walsh E, Gilvarry C, Samele C, Harvey K, Manley C, Tyrer P, Creed F, Murray R, Fahy T (2001). Reducing violence in severe mental illness: randomised controlled trial of intensive case management compared with standard care. British Medical Journal, 323, 1093-6.

01.28 Rushe TM, Rifkin L, Stewart AL, Townsend JP, Roth SC, Wyatt JS and Murray RM (2001). Neuropsychological outcome at adolescence of very preterm birth and its relation to brain structure. Developmental Medicine and Child Neurology, 43, 226-33.

01.29 Rabe-Hesketh S, Toulopoulou T and Murray RM (2001). Multilevel modeling of cognitive function in schizophrenic patients and their first degree relatives. Multivariate Behavioral Research, 36, 279-98.

01.30 Gilvarry CM, Russell A, Jones P, Sham P, Hemsley D, Murray RM (2001). Verbal fluency in patients with schizophrenia and affective psychoses and their first degree relatives. Psychological Medicine, 31, 695-704

01.31 Bramon E and Murray R M (2001). A plausible model of schizophrenia must incorporate psychological and social, as well as neurodevelopmental, risk factors. Dialogues in Clinical Neuroscience, 3, 7-20.

38

1.32 Rutter M, Pickles A, Murray RM, Eaves L (2001). Testing hypotheses on specific environmental causal effects on behavior. Psychological Bulletin, 127, 291-324.

01.33 Mata I, Madoz V, Arranz MJ, Sham P, Murray RM (2001). Olanzapine: concordant response in monozygotic twins. British Journal of Psychiatry 178, 86 (letter).

01.34 Chen RY, Sham P, Chen EY, Li T, Cheung EF, Hui TC, Kwok CL, Lieh-Mak F, Zhao JH, Collier D, Murray R (2001). No association between T102C polymorphism of serotonin-2A receptor gene and clinical phenotypes of Chinese schizophrenic patients. Psychiatry Research, 105, 175-85.

01.35 UK 700 Group: Gilvarry C, Barber J A, van Os J, Murray RM (2001). Neuropsychological performance of psychotic patients in community care: results from the UK700 study. Acta Psychiatrica Scandinavica. 104 (Suppl.408), 81-91.

01.36 Shergill SS, Cameron LA, Brammer MJ, Williams SC, Murray RM, McGuire PK (2001). Modality specific neural correlates of auditory and somatic hallucinations. Journal of Neurology, Neurosurgery and Psychiatry, 71 (5), 688-90.

2002

02.01 Cardno AG, Sham PC, Farmer AE, Murray RM and McGuffin P (2002). Heritability of Schneider's first rank symptoms. British Journal of Psychiatry, 180, 35-8.

02.02 Smith S, Wheeler MJ, Murray R, O'Keane V (2002). The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary-gonadal axis. Journal of Clinical Psychopharmacology, 22, 109-14.

02.03 Kircher TTJ, Liddle PF, Brammer MJ, Williams SCR, Murray RM, McGuire PK (2002). Reversed lateralization of temporal activation during speech production in thought disordered patients with schizophrenia. Psychological Medicine, 32, 439-49.

02.04 MacCabe JH, Aldouri E, Fahy TA, Sham PC, Murray RM (2002). Do schizophrenic patients who managed to get to university have a non-developmental form of illness? Psychological Medicine, 32, 535-44.

02.05 UK 700 Group: Walsh E, Leese M, Taylor PJ, Johnston I, Burns T, Creed F, Higgitt A, Murray R (2002). Psychosis in high security and general psychiatric services. British Journal of Psychiatry, 180, 351-7.

02.06 Cardno AG, Rijsdijk FV, Sham PC, Murray RM, McGuffin P (2002). A twin study of genetic relationships between psychotic symptoms. American Journal of Psychiatry, 159, 539-45.

02.07 Allin M, Murray R (2002). Schizophrenia: a neurodevelopmental or neurodegenerative disorder? Current Opinion in Psychiatry, 15, 9-15.

02.08 Cannon M, Caspi A, Moffitt TE, Harrington H, Taylor A, Murray RM, Poulton R (2002). Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort. Archives of General Psychiatry, 59, 449-56.

02.09 Cannon M, Huttunen MO, Tanskanen AJ, Arseneault L, Jones PB, Murray RM (2002). Perinatal and childhood risk factors for later criminality and violence in schizophrenia. British Journal of Psychiatry, 180, 496-501.

02.10 Nosarti C, Al-Asady MHS, Frangou S, Stewart AL, Rifkin L, Murray RM (2002). Adolescents who were born very preterm have decreased brain volumes. Brain, 135, 1616-23.

02.11 Munro JC, Russell AJ, Murray RM, Kerwin RW, Jones PB (2002). IQ in childhood psychiatric attendees predicts outcome of later schizophrenia at 21 year follow-up. Acta Psychiatrica Scandinavica, 106, 139-42.

02.12 Cannon M, Jones PB, Murray RM (2002). Obstetric complications and schizophrenia: historical and meta-analytic review. American Journal of Psychiatry, 159, 1080-92.

02.13 Laurent A, Gilvarry C, Russell A, Murray R (2002). Personality dimensions and neuropsychological performance in first-degree relatives of patients with schizophrenia and affective psychosis. Schizophrenia Research, 55, 239-48.

39

02.14 Smith SM, O'Keane V, Murray R (2002). Sexual dysfunction in patients taking conventional antipsychotic medication. British Journal of Psychiatry, 181, 49-55.

02.15 Shergill SS, Brammer MJ, Fukuda R, Bullmore E, Amaro E Jr, Murray RM, McGuire PK (2002). Modulation of activity in temporal cortex during generation of inner speech. Human Brain Mapping, 16 (4), 219-27.

02.16 Santhouse AM, ffytche DH, Howard RJ, Williams SC, Stewart AL, Rooney M, Wyatt JS, Rifkin L, Murray RM (2002). The functional significance of perinatal corpus callosum damage: an fMRI study in young adults. Brain, 125 (8), 1782-92.

02.17 Walker J, Curtis V, Murray RM (2002). Schizophrenia and bipolar disorder: similarities in pathogenic mechanisms but differences in neurodevelopment. International Clinical Psychopharmacology, 17 (Suppl 3), S11-19.

02.18 Kuperberg G, Kerwin R, Murray R (2002). Developments in the pharmacological treatment of schizophrenia. Expert Opinion on Investigational Drugs, 11 (1), 1-7.

02.19 Wright IC, Sham P, Murray RM, Weinberger DR, Bullmore ET (2002). Genetic contributions to regional variability in human brain structure: methods and preliminary results. NeuroImage, 17, 256-271.

02.20 Walker J, Curtis V, Shaw P, Murray RM (2002). Schizophrenia and bipolar disorder are distinguished mainly by differences in neurodevelopment. Neurotoxicity Research, 4, 427-36.

02.21 Murray RM (2002). What do we need to treat in schizophrenia? Progress in Neurology and Psychiatry, 6, 20-23.

02.22 McDonald C, Grech A, Toulopoulou T, Schulze K, Chapple B, Sham P, Walshe M, Sharma T, Sigmundsson T, Chitnis X, Murray RM (2002). Brain volumes in familial and non-familial schizophrenic probands and their unaffected relatives. American Journal of Medical Genetics (Neuropsychiatric Genetics), 114, 616-25.

02.23 Santhouse AM, ffytche DH, Howard RJ, Williams SCR, Rifkin L, Murray RM (2002). Functional imaging of the mechanisms underlying the bilateral field advantage. NeuroImage, 17, 680-87.

02.24 Fearon P, Murray RM (2002). Intellectual function and schizophrenia (Editorial). British Journal of Psychiatry, 181, 276-7.

02.25 McKenzie K, Jones P, Lewis S, Williams M, Toone B, Sham P, Murray RM (2002). Lower prevalence of pre-morbid neurological illness in African-Caribbean than White psychotic patients in England. Psychological Medicine, 32, 1285-91.

2.26 Castle DJ, Murray R M (2002). Gender issues in schizophrenia. In “Biological Psychiatry”. Pp679-84. Edited by D'haenen H, den Boer JA, Willner P. John Wiley & Sons.

02.27 Nilsson E, Lichtenstein P, Cnattingius S, Murray R M, Hultman C M (2002). Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophrenia Research, 58, 221-29.

02.28 Church S M, Cotter D, Bramon E, Murray RM (2002). Does schizophrenia result from developmental or degenerative processes? Journal of Neural Transmission, S63, 129-47.

02.29 Guerra A, Fearon P, Sham P, Jones P, Lewis S, Mata I, Murray R (2002). The relationship between predisposing factors, premorbid function and symptom dimensions in psychosis: an integrated approach. European Psychiatry, 17, 311-20.

02.30 Murray RM, McDonald C and Bramon E (2002). Neurodevelopmental impairment, dopamine sensitisation, and social adversity in schizophrenia. World Psychiatry 1 (3), 137-45.

02.31 UK 700 Group: Samele C, Gilvarry C, Walsh E, Manley C, van Os J, Murray R (2002). Patients' perceptions of intensive case management. Psychiatric Services 53 (11), 1432-37.

02.32 Arseneault L, Cannon M Poulton R, Murray R, Caspi A, Moffitt T (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. British Medical Journal, 325, 1212-3.

40

2.33 Dazzan P, Murray RM (2002). Neurological soft signs in first-episode psychosis: a systematic review. British Journal of Psychiatry, 181 (S43), s50-s57.

2.34 Castle DJ, Murray RM (2002). Schizophrenia: Aetiology, Genetics and Risk Factors. In “Principles and Practice of Geriatric Psychiatry” 2nd Edition. Pp.503-8. Edited by Copeland JRM, Abou-Saleh MT, Blazer DG

Wiley:Chichester.

02.35 MacCabe JH, Marks IM, Murray RM (2002). Behavior therapy attenuates clozapine-induced obsessions and compulsions. Journal of Clinical Psychiatry, 63 (12), 1179-80.

02.36 Wickham H, Walsh C, Asherson P, Gill M, Owen MJ, McGuffin P, Murray R, Sham P (2002). Familiality of clinical characteristics in schizophrenia. Journal of Psychiatric Research, 36 (5), 325-30.

2.37 Cannon M, Huttunen M, Murray R (2002). The developmental epidemiology of psychiatric disorders. In “Textbook in

Psychiatric Epidemiology” 2nd Edition. Pp 239-255. Edited by Tsuang MT, Tohen M. Wiley-Liss: NewYork.

2.38 Murray RM, Walsh E, Arseneault L (2002). Some possible answers to questions about schizophrenia that haveconcerned John Gunn. Criminal Behaviour and Mental Health, 12, S4-S9.

2.39 Rosa A, Lourdes F, van Os J, Ribchester T, Davies N, Arias B, McDonald A, Murray RM (2002). Further evidence that congenital dermatoglyphic abnormalities are associated with psychosis: A twin study. Schizophrenia Bulletin, 28, 697-701

2003

03.01 Bresnahan M, Boydell J, Murray R, Susser E (2003). Temporal variation in the incidence, course and outcome of schizophrenia. In “The Epidemiology of Schizophrenia”. Pp 34-48. Edited by Murray RM, Jones PB, Susser E, van Os J, Cannon M. Cambridge University Press.

03.02 Boydell J, Murray R (2003). Urbanization, migration and risk of schizophrenia. In “The Epidemiology of Schizophrenia”. Pp 49-67. Edited by Murray RM, Jones PB, Susser E, van Os J, Cannon M. Cambridge University Press.

03.03 Cardno A, Murray R (2003). The 'classical' genetic epidemiology of schizophrenia. In “The Epidemiology of Schizophrenia”. Pp 195-219. Edited by Murray RM, Jones PB, Susser E, van Os J, Cannon M. Pp. 195-219. Cambridge University Press.

03.04 Murray R, Grech A, Phillips P, Johnson S (2003). What is the relationship between substance abuse and schizophrenia? In “The Epidemiology of Schizophrenia”. Pp 317-342. Edited by Murray RM, Jones PB, Susser E, van Os J, Cannon M. Cambridge University Press.

3.5 Boydell J, van Os J, Lambri M, Castle D, Allardyce J, McCreadie RG, Murray RM (2003). Incidence of schizophrenia in south-east London between 1965 and 1997. British Journal of Psychiatry, 182 (1), 45-49.

03.06 Toulopoulou T, Morris RG, Rabe-Hesketh S, Murray RM (2003). Selectivity of verbal memory deficit in schizophrenic patients and their relatives. American Journal of Medical Genetics 116 (Suppl 1), 1-7.

03.07 Tsapakis EM, Guillin O, Murray RM (2003). Does dopamine sensitisation underlie the association between schizophrenia and drug abuse? Current Opinion in Psychiatry, 16 (Suppl 2), S45-S52.

3.8 Dean K, Murray RM (2003). Should Schizophrenia Survive? Introduction to Maudsley Discussion Paper No.12: Does Schizophrenia Exist? Pp.1-6. Institute of Psychiatry: London.

03.09 Schulze K, McDonald C, Frangou S, Sham P, Grech A, Toulopoulou T, Walshe M, Sharma T, Sigmundsson T, Taylor M, Murray RM (2003). Hippocampal volume in familial and non-familial schizophrenic probands and their unaffected relatives. Biological Psychiatry, 53(7), 562-70.

41

03.10 Kravariti E, Morris RG, Rabe-Hesketh S, Murray RM, Frangou S (2003). The Maudsley early onset schizophrenia study: cognitive function in adolescents with recent onset schizophrenia. Schizophrenia Research, 61(2-3), 137-48.

03.11 Kunugi H, Urushibara T, Murray RM, Nanko S, Hirose T (2003). Prenatal underdevelopment and schizophrenia: a case report of monozygotic twins. Psychiatry and Clinical Neurosciences, 57(3), 271-4.

03.12 Shergill S, Brammer M, Fukuda R, Williams S, Murray RM, McGuire PK (2003). Engagement of brain areas implicated in processing inner speech in people with auditory hallucinations. British Journal of Psychiatry, 182, 525-31.

03.13 Arseneault L, Cannon M, Murray R, Poulton R, Caspi A, Moffitt T (2003). Childhood origins of violent behaviour inadults with schizophreniform disorder. British Journal of Psychiatry, 183, 520-525.

3.14 Bhugra D, Hutchinson G, Hilwig M, Takei N, Fahy TA, Neehall J, Murray RM (2003). Pregnancy and birth complications in patients with schizophrenia in Trinidad and London. West Indian Medical Journal 52 (2), 124-126.

3.15 Dean K, Bramon E, Murray RM (2003). The causes of schizophrenia: neurodevelopmental and other risk factors. Journal of Psychiatric Practice, 9, 442-454.

3.16 Blackwood N, Bentall R P, ffytche D, Simmons A, Murray RM, Howard R (2003). Self-responsibility and the self- serving bias: an fMRI investigation of causal attributions. Neuroimage, 20, 1076-1085

3.17 Chen C-K, Lin S-K, Sham P, Ball D, Loh E-W, Hsiao C-C, Chiang Y-L, Ree S-C, Lee C-H, Murray RM. (2003).Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis.Psychological Medicine, 33, 1407-1414.

3.18 Toulopoulou T, Rabe-Hesketh S, King H, Murray RM, Morris RG (2003). Episodic memory in schizophrenicpatients and their relatives. Schizophrenia Research, 63, 261-271.

3.19 Linney YM, Murray RM, Peters ER, Macdonald AM, Rijsdijk F, Sham PC (2003). A quantitative genetic analysis of schizotypal personality traits. Psychological Medicine, 33, 803-816.

3.20 Kington J, Murray RM (2003). Schizophrenia: the new evidence. The Mental Health Review 8(3), 31-34.

3.21 McKenzie K, van Os J, Samele C, van Horn E, Tattan T, Murray R (for UK700 Group) (2003). Suicide and attempted suicide among people of Caribbean origin with psychosis living in the UK. British Journal of Psychiatry, 183, 40-44

3.22 Jeffries AR, Mungall AJ, Dawson E, Halls K, Langford CF, Murray RM, Dunham I, Powell JF (2003). Β-1,3-Glucuronyltransferase-1 gene implicated as a candidate for a schizophrenia-like psychosis through molecular analysis of a balanced translocation. Molecular Psychiatry, 8, 654-663.

3.23 Mata I, Gilvarry CM, Jones PB, Lewis SW, Murray RM, Sham P C (2003). Schizotypal personality traits in nonpsychotic relatives are associated with positive symptoms in psychotic probands. Schizophrenia Bulletin, 29, 273-283.

3.24 Walsh E, Moran P, Scott C, McKenzie K, Burns T, Creed F, Tyrer P, Murray RM, Fahy T, UK700 Group (2003)Prevalence of violent victimisation in severe mental illness. British Journal of Psychiatry, 183, 233-238

3.25 Dazzan P, Kravariti E, Fearon P, Murray RM (2003). The neuromotor, behavioural and cognitive predictors of schizophrenia In “Preventive Strategies for Schizophrenic Disorders”. Pp 188-209. Edited by Grispini A.

Giovanni Fioriti Editore: Roma.

3.26 Kravariti E, Morris RG, Rabe-Hesketh S, Murray RM, Frangou S (2003). The Maudsley early-onset schizophrenia study: ognitive function in adolescent-onset schizophrenia. Schizophrenia Research 65 (2-3), 95-103.

3.27 Murray RM (2003) Schizophrenia: improving the treatment through increased understanding. European Psychiatry 18(2), 25s-26s.

3.28 Rascle C, Kravariti E, Dazzan P, Bramon E, Fearon P, Boydell J, Murray RM (2003). What do we know about the infancy and childhood of individuals who become schizophrenic? In “Schizophrénies débutantes. Diagnostic etmodalités thérapeutiques”. Pp 101-111. Edited by Petitjean F, Marie-Cardine M. John Libbey Eurotext., Paris etFédération FranÇaise de Psychiatrie.

42

3.29 Mata I, Gilvarry CM, Jones PB, Lewis SW, Murray RM, Sham PC (2003). Schizotypal personality traits in nonpsychotic relatives are associated with positive symptoms in psychotic probands. Schizophrenia Bulletin, 29 (2), 273-283.

3.30 McGrath J, Murray RM (2003). Risk factors for schizophrenia; from conception to birth. In “Schizophrenia”. Pp 187-205.Edited by Hirsch S, Weinberger D. Blackwell, Oxford.

2004

04. 01 Howes OD, Bhatnagar A, Gaughran FP, Amiel SA, Murray RM, Pilowsky LS (2004). A prospective study of impairment in glucose control caused by clozapine without change in insulin resistance. American Journal of Psychiatry,

161, 361-363.

04. 02 Simonoff E, Elander J, Holmshow J, Pickles A, Murray R, Rutter M (2004). Predictors of antisocial personality. Continues from childhood to adult life. British Journal of Psychiatry, 184, 118-127.

04. 03 Arseneault L, Cannon M, Witton J, Murray R M (2004). Causal association between cannabis and psychosis:examination of evidence. British Journal of Psychiatry, 184, 110-117.

04. 04 Bramon E, Croft R J, McDonald C, Virdi GK, Gruzelier JG, Baldeweg T, Sham PC, Frangou S, Murray RM (2004). Mismatch negativity in schizophrenia: a family study. Schizophrenia Research 67, 1-10.

04. 05 Toulopoulou T, Murray RM (2004). Verbal memory deficit in patients with schizophrenia: an important future target for treatment. Expert Review of Neurotherapeutics, 4 (1), 43-52.

4.6 Allin M, Henderson M, Suckling J, Nosarti C, Rushe T, Fearon P, Stewart A L, Bullmore ET, Rifkin L, Murray R M(2004). The effects of very low birth weight on brain structure in adulthood. Developmental Medicine and Child Neurology, 46, 46-53.

4.7 Chapple B, Grech A, Sham P, Toulopoulou T, Walshe M, Schulze K, Morgan K, Murray R M, and McDonald C (2004). Normal cerebral asymmetry in familial and non-familial schizophrenic probands and their unaffected relatives. Schizophrenia Research, 67, 33-40.

4.8 Dazzan P, Morgan K, Orr K, Hutchinson G, Chitnis X, Suckling J, Fearon P, Salvo J, McGuire PK, Mallett RM, Jones

PB, Leff J, Murray RM (2004). The structural brain correlates of neurological soft signs in first episode psychoses Brain, 127(1), 143-153.

4.9 Walsh E, Gilvarry C, Samele C, Harvey K, Manley C, Tattan T, Tyrer P, Creed F, Murray R, Fahy T (for UK700 Group) (2004). Predicting violence in schizophrenia: a prospective study. Schizophrenia Research, 67 (2-3), 247-252.

4.10 Dazzan P, Kravariti E, Fearon P, Murray RM (2004). Is the development of schizophrenia predictable? In “Early Clinical Intervention and Prevention of Schizophrenia”. Pp 225-252. Edited by Stone WS, Faraone SV, Tsuang M.Humana Press. Totowa, New Jersey.

4.11 Nosarti C, Rifkin L, Murray RM (2004). The neurodevelopmental consequences of very preterm birth: brain plasticity and its limits. In “Neurodevelopmental Mechanisms in the Genesis and Epigenesis of Psychopathology”. Pp 34-62. Edited by Cicchetti D, Walker E. Cambridge University Press.

4.12 Blackwood N, Bentall R P, ffytche D, Simmons A, Murray R M and Howard R. (2004). Persecutory delusions and thedetermination of self-relevance: an fMRI investigation. Psychological Medicine, 34, 1-6.

4.13 Howes O, Bhatnagar A, Gaughran F, Murray R, Pilowsky L (2004). Clozapine causes impaired glucose control without changes in insulin resistance- a prospective study. American Journal of Psychiatry. 161 (2), 361-363.

4.14 Howes OD, McDonald CM, Cannon M, Arsenault L, Boydell J, Murray RM (2004). Pathways to schizophrenia: the impactof environmental factors. International Journal of Neuropsychopharmacology, 7 (S1), 1-7.

43

4.15 Rushe T M, Temple C M, Rifkin L, Woodruff P W R, Bullmore E T, Stewart A L, Simmons A, Russell T A and Murray RM. (2004) Lateralisation of language function in young adults born very preterm. Archives of Disease in Childhood, Fetal Neonatal Ed., 89, F112-F118.

4.16 Blackwood N, Bentall RP, ffytche D, Simmons A, Murray RM, Howard R (2004). The cerebellum and decisionmaking under uncertainty. Cognitive Brain Research, 20, 46-53.

4.17 Schnack HG, van Haren NEM, Hulshoff Pol HE, Picchioni M, Weisbrod M, Sauer H, Cannon T, Huttunen M, MurrayR, Khan RS (2004). Reliability of brain volumes from multicenter MRI acquisition: a calibration study. Human Brain Mapping, 22, 321-320.

4.18 Li T, Chen C, Hu X, Ball D, Lin S, Chen W, Sham PC, Loh E, Murray RM, Collier DA (2004). Association analysis of the DRD4 and COMT genes in methamphetamine abuse. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics) 9999, 1-5.

4.19 Meaney AM, Smith S, Howes OD, O’Brien M, Murray RM and O’Keane V (2004). Effects of long-term prolactin-raising antipsychotic medication on bone mineral density in patients with schizophrenia. British Journal of Psychiatry, 184, 503-508.

4.20 Dixon, TA, Kravariti E., Frith CD, Murray RM, McGuire PK (2004). Effect of symptoms on executive function in bipolar illness. Psychological Medicine, 34, 811-821.

4.21 Murray RM, Chen C, Grech A, Arseneault L, Cannon M, Zanelli J (2004). What is the relationship between methamphetamine and cannabis abuse and schizophrenia? In “Schizophrenia: Challenging the Orthodox”. Pp:

75- 80. Edited by McDonald C, Schulze K, Murray R, Wright P. Martin Dunitz, London.

4.22 Pariante CM, Vassilopoulou K, Velakoulis D, Phillips L, Soulsby B, Wood SJ, Brewer W, Smith DJ, Dazzan P, Yung AR , Zervas IM, Christodoulou GN, Murray R, McGorry PD, Pantelis C (2004). Pituitary volume in psychosis. British Journal of Psychiatry, 185, 5-10.

4.23 Fearon P, O'Connell P, Frangou S, Aquino S, Nosarti C, Allin M, Taylor M, Stewart A, Rifkin L, Murray RM (2004).Brain volumes in adult survivors of very low birth weight: a sibling-controlled study. Paediatrics, 114, 367-371.

4.24 Connor SEJ, Ng V, McDonald C, Schulze K, Morgan K, Dazzan P and Murray RM (2004). A study of hippocampal shape anomaly in schizophrenia and in families multiply affected by schizophrenia or bipolar disorder. Neuroradiology, 46, 523-534.

4.25 Li T, Ma X, Sham C P, Sun X, Hu X, Wang Q, Meng H, Deng W, Liu X, Murray RM and Collier DA (2004). Evidence for association between novel polymorphisms in the PRODH gene and schizophrenia in a Chinese population. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics), 129B, 13-15.

4.26 Nosarti C, Rushe TM, Woodruff PWR, Stewart AL, Rifkin L, Murray RM (2004). Corpus callosum size and very preterm birth: relationship to neuropsychological outcome. Brain, 127, 2080-2089.

4.27 McDonald C, Zanelli J, Rabe-Hesketh S, Ellison-Wright I, Sham P, Kalidindi S, Murray RM and Kennedy N (2004).Meta-analysis of Magnetic Resonance Imaging brain morphometry studies in bipolar disorder Biological Psychiatry, 56, 411-41.

4.28 van Haren NEM, Picchioni M, McDonald C, Marshall N, Davis N, Ribchester T, Hulshoff Poll HE, Sharma T, Sham P,Kahn RS and Murray RM (2004). A controlled study of brain structure in monozygotic twins concordant and discordant for schizophrenia. Biological Psychiatry, 56, 454-461.

4.29 Toulopoulou T, Grech A, Morris RG, Schulze K, McDonald C, Chapple B, Rabe-Hesketh and Murray RM (2004).The relationship between volumetric brain changes and cognitive function: a family study on schizophrenia. Biological Psychiatry, 56, 447-453.

4.30 Murray RM (2004). Mental illness. In “The Oxford companion to the mind.” P 582. Edited by Gregory RL. Oxford University Press.

4.31 Murray RM, Sham P, van Os J, Zanelli J, Cannon M, McDonald C (2004). A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophrenia Research, 71, 405-416.

44

4.32 Howes OD, Gaughran FP, Amiel SA, Murray RM, Pilowsky LS (2004). The effect of clozapine on factors controlling glucose homeostasis. Journal of Clinical Psychiatry 65, 1352-1355.

4.33 Monks PJ, Thompson JM, Bullmore ET, Suckling J, Brammer MJ, Williams SCR, Simmons A, Iles N, Lloyd AJ,Harrison CL, Seal M, Murray RM, Ferrier IN, Young AH, Curtis VA (2004). A Functional MRI study of working memory task in euthymic bipolar disorder: evidence for task-specific dysfunction. Bipolar Disorders,

6, 550-564.

4.34 Shergill SS, Brammer MJ, Amaro E, Williams SCR, Murray RM and McGuire PK (2004). Temporal course of auditory hallucinations. British Journal of Psychiatry, 185, 516-517.

4.35 Li T, Stefansson H, Gudfinnsson E, Cai G, Liu X, Murray RM, Steinthorsdottir, Januel D, Gudnadottir VG, Petursson, Ingason A, Gulcher JR, Stefansson K and Collier DA (2004). Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype. Molecular Psychiatry, 9, 698-704.

04.37 Kennedy N, Boydell J, van Os J and Murray RM (2004). Ethnic differences in first clinical presentation of bipolar disorder: results from an epidemiological study. Journal of Affective Disorders, 83, 161-168.

04.38 McDonald C, Bullmore ET, Sham PC, Chitnis X, Wickham MB, Bramon E and Murray RM (2004). Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Archives of General Psychiatry. 61, 974-984.

4.39 Allin M, Nosarti C, Rifkin L, Murray RM (2004). Brain Plasticity and Long Term Function after Early Cerebral Insult: the

Example of Very Preterm Birth. In “Neurodevelopment and Schizophrenia”. Pp 89-107. Edited by Keshavan

MS, Kennedy JL, Murray RM. Cambridge University Press.

04.40 Bramon, E., Rabe-Hesketh, S., Sham, P., Murray, R., Frangou, S., 2004. Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophrenia Research, 70, 315-329.

4.41 McDonald C, Murray RM (2004). Can Structural MRI Provide an Alternative Phenotype for Genetic Studies of Schizophrenia? In “Neurodevelopment and Schizophrenia”. Pp 138-155. Edited by Keshavan MS, Kennedy JL, Murray RM. Cambridge University Press.

04.42 Kravariti E, Dazzan P, Fearon P, Murray RM (2004). Can one identify preschizophrenia children? In “Neurodevelopment and Schizophrenia”. Pp 415-421. Edited by Keshavan MS, Kennedy JL, Murray RM. Cambridge University Press.

04.43 Boydell J, van Os J, Murray RM (2004). Is there a role for social factors in a comprehensive development model for schizophrenia? In “Neurodevelopment and Schizophrenia”. Pp 224-247. Edited by Keshavan MS, Kennedy JL, Murray RM. Cambridge University Press.

04.44 Chen C, Murray RM (2004). How does drug abuse interact with familial and developmental factors in the etiology of schizophrenia? In “Neurodevelopment and Schizophrenia”. Pp 248-269. Edited by Keshavan MS, Kennedy JL Murray RM. Cambridge University Press.

04.45 Howes OD, Murray RM (2004). Schizophrenia. In “The Oxford companion to the mind”. Pp 820-823. Edited by Gregory RL. Oxford University Press.

04.46 Howes OD, Murray RM (2004). Schizophrenia: evidence for a neurochemical basis. In “The Oxford companion to the mind”. Pp 823-824. Edited by Gregory RL. Oxford University Press.

4.47 Wickham H, McGuffin P, Murray R (2004). Genetics of mental illness. In “The Oxford companion to the mind”. Pp 369- 370. Edited by Gregory RL. Oxford University Press.

4.48 Chen CK, Hu X, Lin S, Sham PC, Loh E, Li T, Murray RM & Ball DM (2004). Association analysis of dopamine D2-like receptor genes and methamphetamine abuse. Psychiatric Genetics 14 (3), 1-4.

4.49 Boydell J, van Os J, McKenzie K, Murray RM (2004). The association of inequality with the incidence of

45

schizophrenia: an ecological study. Social Psychiatry and Psychiatric Epidemiology 399(8), 597-9.

4.50 Johns L, Cannon M, Singleton N, Murray RM, Farrell M, Brugha T, Bebbington P, Jenkins R, Meltzer H (2004). The

prevalence and correlates of self-reported psychotic symptoms in the British populations. British Journal of

Psychiatry, 185, 298-305.

4.51 MacCabe, Murray RM (2004). Intellectual functioning in schizophrenia: a marker of neurodevelopmental damage? Journal of Intellectual Disability Research, 48, 519-523.

2005

5.1 Walshe M, McDonald C, Taylor M, Zhao J, Sham P, Grech A, Schulze K, Bramon E, Murray R (2005) Obstetric complications in patients with schizophrenia and their unaffected siblings. European Psychiatry, 20, 28 - 34.

5.2 Lloyd T, Kennedy N, Fearon P, Kirkbride J, Mallett R, Leff J, Holloway J, Harrison G, Dazzan P, Morgan K, Murray R M & Jones PB (2005). Incidence of bipolar affective disorder in three UK cities. Results from the MRC Aesop

Study. British Journal of Psychiatry, 186, 126-131.

5.3 Kravariti, E, Dixon, T, Frith, C, Murray, R M, & McGuire, P (2005). Association of symptoms on executive function in schizophrenia and bipolar disorder. Schizophrenia Research, 74, 221-231.

5.4 Kennedy N, BoydelL J, Kalidindi S, Fearon P, Jones P B. van Os J, Murray R M (2005) Gender differences in incidence and age at onset of mania and bipolar disorder: results from a 35-year study. American

Journal of Psychiatry, 162, 257- 262.

5.5 Dazzan P, Morgan KD, Orr K, Hutchinson G, Chitnis X, Suckling J, Fearon P, McGuire PK, Mallett RM, Jones PB, Leff

J, Murray RM (2005). Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the ÆSOP study. Neuropsychopharmacology, 4, 765-74.

5.6 Murray R, Bramon E (2005). Schizophrenia: Neurodevelopmental Theory. In “Kaplan & Sadock's Comprehensive Textbook of Psychiatry”, vol 2, 8th ed. Pp.1381- 1396. Edited by Sadock, B, Sadock V. Lippnicott Williams & Wilkins, Philadelphia.

05.07 Howes O.D, Wheeler MJ, Meaney AM, O'Keane V, Fogelman I, Blake G, Murray RM, Smith S. (2005). Bone mineral density and its relationship to prolactin levels in patients taking antipsychotic treatment. Journal of Clinical Psychopharmacology, 25 (1), 1-3.

5.8 Dean K, Murray RM (2005). Environmental risk factors for psychosis. Dialogues in clinical neuroscience, 7 (1), 69-80.

5.9 Nosarti C, Allin MPG, Frangou S, Rifkin L, Murray RM (2005). Decreased caudate volume is associated with hyperactivity in adolescents born very preterm. Biological Psychiatry, 57, 661-6.

5.10 Morgan C, Mallett R, Hutchinson G, Morgan K, Bagalkote H, Fearon P, Dazzan P, Boydell J, Harrison G, Murray R,

Jones P, Craig T and Leff J (2005). Pathways to Care and Ethnicity 1. Sample characteristics and compulsory admission. A report from the AESOP study. British Journal of Psychiatry, 186, 281-289.

5.11 Morgan C, Mallett R, Hutchinson G, Morgan K, Bagalkote H, Fearon P, Dazzan P, Boydell J, Harrison G, Murray R, Jones P, Craig T and Leff J (2005). Pathways to Care and Ethnicity 2. Sources of referral and help-seeking. A report from the AESOP study. British Journal of Psychiatry, 186, 290-296.

5.12 Dempster E L, Toulopoulou T, McDonald C, Bramon E, Walshe M, Filbey F, Wickham H, Sham P C, Murray R M,

Collier D A. (2005). Association between BDNF val66met genotype and episodic memory. American

46

Journal of Medical Genetics Part B (Neuropsychiatric Genetics), 134B, 73-75.

5.13 Pariante CM, Dazzan P, Danese A, Morgan KD, Brudaglio F, Morgan C, Fearon P, Orr K, Hutchinson G, Pantelis C,

Velakoulis D, Jones PB, Leff J, Murray RM (2005). Increased pituitary volume in antipsychotic-free and

antipsychotic-treated patients of the AESOP first-onset psychosis study. Neuropsychopharmacology, 30 (10),

1923- 1931.

5.14 McDonald C, Bullmore E. Sham P, Chitnis X, Sucking J, MacCabe J, Walshe M and Murry R M. (2005). Regional volume

deviations of brain structure in schizophrenia and psychotic bipolar disorder. Computational morphometry study. British Journal of Psychiatry 186, 369-377.

5.15 O’Daly OG, Guillin O, Tsapakis EM, Martinez D, Shergill SS, Murray RM (2005). Schizophrenia and substance abuse co-morbidity: a role for dopamine sensitization? Journal of Dual Diagnosis 1(2), 11-40.

5.16 McDonald C, Zanelli J, Murray RM, Kennedy N (2005). Structural MRI studies in bipolar disorder: a meta-analysis.

In “Bipolar disorder: the upswing in research and treatment”. Pp 27-36. Edited by McDonald C, Schulze K, Murray RM, Tohen M. Martin Dunitz: London.

5.17 Howes OD, Wheeler MJ, Meaney AM, O'Keane V, Fogelman I, Blake G, Murray RM, Smith S (2005). Bone mineral

density and its relationship to prolactin levels in patients taking antipsychotic treatment. Journal of Clinical

Psychopharmacology. 25(3), 259-61.

05.18 Kennedy N, Everitt B, Boydell J, van Os J, Jones P B and Murray R M (2005). Incidence and distribution of first- episode mania by age: results from a 35-year study. Psychological Medicine 35 (6), 855-863.

5.19 Chen C, Lin S, Sham PC, Ball D, Loh E, Murray RM. (2005). Morbid risk for psychiatric disorder among the relatives

of methamphetamine users with and without psychosis. American Journal of Medical Genetics Part B

(Neuropsychiatric Genetics), 136B, 87-91.

5.20 Grech A, van Os J, Jones PB, Lewis SW, Murray RM (2005). Cannabis use and outcome of recent psychosis . European Psychiatry, 20, 349-353.

5.21Toulopoulou, T, Mapua-Filbey, F, Quraishi, S, Kravariti, E, Morris R. G, McDonald, C, Walshe M, Bramon, E,

Murray, R M (2005). Cognitive performance in presumed obligate carriers for psychosis. British Journal of


5.22Zhang, F, St Clair, D, Liu, X, Sun, X, Sham, P.C, Crombie, C, Ma, X, Wang, Q, Meng, H, Deng, W, Yates, P, Hu, X,

Walker, N, Murray R.M, Collier, D.A, Li, T. (2005). Association analysis of the RGS4 gene in Han Chinese and Scottish populations with schizophrenia. Genes, Brain and Behaviour, 4, 444-448.

5.23 Caspi A, Moffitt T E, Cannon M, McClay J, Murray R, Harrington H L, Taylor A, Arsenault L, Williams B, Braithwaite A, Poulton R, Craig I W. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the Catechol-O-Methayltransferase Gene gene: Longitudinal evidence of a gene X

environment interaction. Biological Psychiatry, 57, 1117-1127

05.24 Zanelli J W, Simon H, Rabe-Hesketh S, Walshe M, McDonald C, Murray R M, MacCabe J H. (2005). Eye tracking in schizophrenia: does the antisaccade task measure anything that the smooth pursuit task does not? Psychiatry

47

Research, 136, 181-188

05.25 Rijsdijk, F V, van Haren, N E M, Picchioni, M M, McDonald, C, Toulopoulou, T, Hulshoff Pol, H E, Kahn, R S, Murray, R, Sham, P C (2005). Brain MRI abnormalities in schizophrenia: same genes or same environment? Psychological Medicine, 35, 1399-1409.

5.26 Henquet, C, Murray R, Linszen, D, van Os, J (2005). The environment and schizophrenia: the role of cannabis use

Schizophrenia Bulletin, 31 (3), 608-612.

5.27MacCabe J, Simon H, Zanelli J, Walwyn R, McDonald C, Murray R (2005). Saccadic distractibility is elevated in

schizophrenic patients but not in their well relatives. Psychological Medicine, 35, 1727-1736.

5.28 Bramon E, Walshe M, McDonald C, Martin B, Toulopoulou T, Wickam H, van Os J, Fearon P, Sham P, Fananas L,

Murray R (2005). Dermatoglyphics and schizophrenia: a meta-analysis and investigation of the impact of obstetric complication on a-b ridge count. Schizophrenia Research, 75, 399-404.

05.29 Bramon E, McDonald C, Croft RJ, Landau S, Filbey F, Gruzelier JH, Sham PC, Frangou S and Murray R M (2005). Is the P300 wave endophenotype for schizophrenia? A meta-analysis and a family study. NeuroImage, 27, 960-968.

05.30 Garner B, Pariante CM, Wood SJ, Velakoulis D, Phillips L, Soulsby B, Brewer WJ, Smith DJ, Dazzan P, Berger GE, Yung AR, van den Buuse M, Murray R, McGorry PD, Pantelis C (2005). Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biological Psychiatry. 58 (5), 417-23.

5.31DiForti M, Murray RM (2005). Cannabis consumption and risk of developing schizophrenia: myth or reality? Epidemiologia e Psichiatria Sociale, 14 (4), 184-187.

5.32Morrison PD, Murray RM (2005). Schizophrenia? Current Biology 15 (24), R980-984 .

5.33Schaufelberger M, Senhorini MCT, Barreiros MA, Amaro Jr E, Menezes PR, Scazufca M, Castro CC, Ayres AM, Murray RM, McGuire P, Busatto G (2005). Frontal and anterior cingulated activation during overt verbal fluency in patients with first episode psychosis. Revista Brasileira Psiquiatria. 27 (3), 228-32.

5.34Allin MPG, Salaria S, Nosarti C, Wyatt J, Rifkin L, Murray RM (2005). Vermis and lateral lobes of the cerebellum in adolescents born very premature. Brain Imaging, 18 (16), 1827-24.

5.35Broome MR, Woolley JB, Tabraham P, Johns LC, Bramon E, Murray GK, Pariante C, McGuire PK, Murray RM (2005). What causes the onset of psychosis? Schizophrenia Research, 79, 23-34.

5.36Li T, Zhang F, Liu X, Sun X, Sham PC, Crombie C, Ma X, Wang Q, Meng H, Deng W, Yates P, Hu X, Walker N, Murray RM, St Clair D, Collier DA (2005). Molecular Psychiatry, 10, 1037-1044.

2006

6.1 Gilmore JH, Murray RM (2006). Prenatal and perinatal factors. In “Textbook of Schizophrenia”. Pp 71-85. Edited by Lieberman JA, Perkins DO, Stroup TS. American Psychiatric Press: Washington DC.

6.2 Toulopoulou, T., Quraishi, S., McDonald, C., Murray, R. M. 2006. The Maudsley Family Study: Premorbid and current general intellectual function levels in familiar bipolar I disorder and schizophrenia. J. Clin. Exp.

Neuropsychology, 28, 1-17.

6.3 Morgan C, Fearon P, Hutchinson G, McKenzie K, Lappin JM, Abdul-Al R, Morgan K, Dazzan P, Boydell J, Harrison G, Craig T, Leff J, Jones P, Murray R (2006). Duration of untreated psychosis and ethnicity in the AESOP first- onset psychosis study. Psychological Medicine. 36, 239-248.

48

6.4 Morgan C, Dazzan P, Morgan K, Jones P, Harrison G, Leff J, Murray R, Fearon P, on behalf of the AESOP study group (2006). First episode psychosis and ethnicity: initial findings from the AESOP study. World Psychiatry 5,

40-46.

6.5 Dean K, Walsh E, Moran P, Tyrer P, Creed F, Byford S, Burns T, Murray R and Fahy T. (2006). Violence in women with psychosis in the community: prospective study. British Journal of Psychiatry, 188, 264-270.

6.6 Bramon E, Dempster E, Frangou S, McDonald C, Schoenberg P, MacCabe JH, Walshe M, Sham P, Collier D, Murray RM (2006). Is there an association between the COMT gene and P300 endophenotypes. European Psychiatry 21, 70-73.

6.7 Picchioni MM, Toulopoulou T, Landau S, Davies N, Ribchester T, Murray RM (2006). Neurological abnormalities in schizophrenic twins. Biological Psychiatry, 59, 341-348.

6.8 Ettinger U, Picchioni M, Hall M, Schulze K, Toulopoulou T, Landau S, Crawford TJ, Murray RM. (2006). Antisaccade performance in monozygotic twins discordant for schizophrenia: The Maudsley Twin Study. American Journal of Psychiatry, 163, 543-545.

6.9 Kirkbride JB, Fearon P, Morgan C, Dazzan P, Morgan K, Tarrant J, Lloyd T, Holloway J, Hutchinson G, Leff JP, Mallett RM, Harrison GL, Murray RM, Jones PB (2006). Heterogeneity in incidence rates of schizophrenia and other

psychotic syndromes. Archives of General Psychiatry, 63, 250-258.

6.10 McDonald C, Marshall N, Sham PC, Bullmore ET, Schulze K, Chapple B, Bramon E, Filbey F, Quraishi S, Walshe M, Murray RM (2006). Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. American Journal of Psychiatry, 163, 478-487.

6.11 Guindalini C, Howard M, Haddley K, Laranjeira R, Collier D, Ammar N, Craig I, O’Gara C, Bubb VJ, Greenwood T, Kelsoe J, Asheron P, Murray RM, Castelo A, Quinn JP, Vallada H, Breen G (2006). A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. Proceedings of the National Academy of Sciences USA (PNAS), 103, 4552-4557.

6.12 Nosarti C, Rubia K, Smith AB, Frearson S, Williams SC, Rifkin L, Murray RM (2006). Altered functional neuroanatomy of response inhibition in adolescent boys who were born very preterm. Developmental Medicine and Child Neurology, 48, 265-71.

6.13 Lappin JM, Morgan K, Morgan C, Hutchison G, Chitnis X, Suckling J, Fearon P, McGuire PK, Jones PB, Leff J, Murray RM, Dazzan P. (2006). Gray matter abnormalities associated with duration of untreated psychosis. Schizophrenia Research, 83, 145-153

6.14 Hall M.H, Schulze K, Bramon E, Murray R, Sham P, Rijsdijk F. (2006). Genetic overlap between P300, P50 and duration mismatch negativity. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics) 141, 336-43.

6.15 Hall M, Schulze KK, Rijsdijk FV, Picchioni M, Ettinger U, Bramon E, Freedman R, Murray R, Sham P (2006). Heritability and reliability of P300, P50 and duration mismatch negativity. Behavior Genetics, 36, 845-857.

6.16 Murray MR, Fearon P, Cannon M, McDonald C, Zanelli J, Cardon A (2006). Are the genetic and environmental factors impacting on schizophrenia and bipolar disorder the same or different?. In “Beyond nature and nurture in psychiatry”. Pp185-191. Edited by MacCabe J, Murray R. Martin Dunitz Ltd, London.

6.17 Dikeos DG, Wickham H, McDonald C, Walshe M, Sigmudsson T, Bramon E, Grech A, Toulopoulou T, Murray R, Sham PC. (2006). Distribution of symptom dimensions across Kraepelinian divisions. British Journal of Psychiatry,

189, 346-353.

6.18 Mata I, Arranz M.J, Staddon S, Lopez-Ilundain J.M., Tabares-Seisdedos R, Murray R.M. (2006). The high-activity Val allele of the catechol-O-methyltransferase gene predicts greater cognitive deterioration in patients with psychosis. Psychiatric Genetics, 16 , 213-216

6.19 Schulze K, MacCabe J, Rabe-Hesketh S, Crawford T, Marshall N, Zanelli J, Walshe M, Bramon E, Murray R. M and

49

McDonald C. The relationship between eye movement and brain structural abnormalities in patients with schizophrenia and their unaffected relatives Journal of Psychiatric Research, 40 , 589-598

6.20 Jones PB, Barnes TRE, Davies L, Dunn G, Lloyd H, Hayurst K, Murray RM, Markwick A, Lewis SW. (2006). Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia. Archives of General Psychiatry, 63, 1079-1087

6.21 Morgan C, Kirkbride J, Leff J, Craig t, Hutchinson G, McKenzie K, Morgan K, Dazzan P, Doody GA, Jones P, Murray R, Fearon P (2006). Parental separation, loss and psychosis in different ethnic groups: a case-control studyPsychological Medicine, 37, 495-503.

6.22 Fearon P, Kirkbride J, Morgan C, Dazzan P, Morgan K, Lloyd T, Hutchinson G, Tarrant J, Fung WLA, Holloway J, Mallett R, Harrison G, Leff J, Jones PB, Murray RM (2006). Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychological Medicine, 36, 1541-1550.

06.23 Howes O, Gaughran F, Smith S, Amiel S, Murray R, Pilowsky L. (2006). The relationship between prolactin levels andglucose homeostasis in antipsychotic treated schizophrenic patients. Journal of Clinical Psychopharmacology, 26:629-631

06.24 Allin M, Rooney M, Griffiths T, Cuddy M, Wyatt J, Rifkin L, Murray R. (2006) Neurological abnormalities in young adults born preterm. Journal of Neurology, Neurosurgery and Psychiatry, 77: 295-499.

06.25 Howes OD, Smith S, Gaughran FP, Amiel SA, Murray RM, Pilowsky LS (2006). The relationship between Prolactinlevels and glucose homeostasis in antipsychotic-treated schizophrenia. Journal of Clinical Psychopharmacology, 6, 629-631

06.26 Dazzan P, Morgan KD, Chitnis X, Suckling J, Morgan C, Fearon P, McGuire PK, Jones PB, Leff J, Murray RM (2006). The Structural Brain Correlates of Neurological Soft Signs in Health Individuals. Cerebral Cortex, 16, 1225-1231.

06.27 Dempster EL, Toulopoulou T, McDonald C, Bramon E, Walshe M, Wickham H, Sham PC, Murray RM, Collier DA (2006). Episodic Memory Performance Predicted by the 2bp Deletion in Exon 6 of the “Alpha 7-Like”

Nicotinic Receptor Subunit Gene. .American Journal of Psychiatry, 163, 1832-1834.

06.28 Kravariti E, Toulopoulou T, Mapua-Filby F, Schulze K, Walshe M, Sham P, Murray RM, McDonald C (2006). Intellectual asymmetry and genetic liability in first-degree relatives of probands with schizophrenia. British Journal of Psychiatry, 188, 186-187.

06.29 Lancefield K, Nosarti C, Rifkin L, Allin M, Sham P, Murray R (2006). Cerebral asymmetry in 14 year olds born very preterm. Brain Research, 1093, 33-40.

6.30 Lewis SW, Barnes TRE, Davies L, Murray RM, Dunn G, Hayhurst KP, Markwick A, Lloyd H, Jones PB (2006). Randomised Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia. Schizophrenia Bulletin, 32 , 715-723

6.31 Dean K, Fearon P, Morgan K, Hutchinson G, Orr K, Chitnis X, Suckling J, Mallett R, Leff J, Jones PB, Murray RM, Dazzan P (2006). Grey matter correlates of minor physical anomalies in the AESOP first-episode psychosis study. British Journal of Psychiatry, 189 , 221-228.

06.32 Scott J, McNeil Y, Cavanagh J, Cannon M, Murray R (2006). Exposure to obstetric complications and subsequent development of bipolar disorder: Systematic review. British Journal of Psychiatry, 189, 3-11.

06.33 Nakanishi S, Kunugi H, Murray RM, Nojima S, Ogawa T, Takahashi T (2006). Effects of switching from conventional antipsychotics to risperidone in Japanese patients with chronic schizophrenia. Psychiatry and Clinical Neuroscience, 60, 751-757.

6.34 Smith GN, Boydell J, Murray RM, Flynn S, McKay K, Sherwood M, Honer WG (2006). The incidence of schizophrenia in European immigrants to Canada. Schizophrenia Research, 87, 205-211

6.35 Allin M, Rooney M, Cuddy M, Wyatt J, Walshe M, Rifkin L, Murray RM. (2006) Personal ity dimensions in young

50

adults born preterm. Pediatrics, 117, 309-316

6.36 Boydell J, van Oz J, Caspi A, Kennedy N, Giouroukou E, Fearon P, Farrell M, Murray RM (2006) Trenda in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999. Psychological Medicine, 36, 1441-1446.

6.37 Morgan C, Rudwan A-Al, Lappin JM, Jones P, Fearon P, Leese M, Croudace T, Morgan K, Dazzan P, Craig T, Leff J, Murray R (2006). Clinical and social determinants of duration of untreated psychosis in the AESOP first episode psychosis study. British Journal of Psychiatry, 189, 446-452.

6.38 Cannon M, Moffitt TE, Caspi A, Murray RM, Harrington H, Poulton R (2006). Neuropsychological performance at the age of 13 years and adult schizophreniform disorder: prospective birth cohort study. British Journal of Psychiatry, 189, 463-464.

2007

07.01 Dean O, Dazzan P, Lloyd T, Morgan C, Morgan K, Doody GA, Hutchinson G, Orr K, Jones PB, Murray RM, Fearon P. (2007). Minor physical anomalies across ethnic groups in a first episode psychosis sample. Schizophrenia Research, 89, 86-90.

07.02 Wang Q, Chan R, Sun J, Yao J, Deng W, Sun X, Liu X, Sham PC, Ma X, Meng H, Murray RM, Collier DA and Li T. (2007) Reaction time of the Continuous Performance Test is an endophenotypic marker for schizophrenia: A study of first-episode neuroleptic-naïve schizophrenia, their non-psychotic first-degree relatives and healthy population controls. Schizophrenia Research, 89, 293-298.

07.03 Laurens KR, Hodgins S, Maughan B, Murray RM, Rutter ML and Taylor EA (2007). Community screening for psychotic-like experiences and other putative antecedents of schizophrenia in children aged 9-12 years. Schizophrenia Research, 90, 130-146.

7.4 Morrison P and Murray RM (2007). Reefer madness: cannabinoid psychoses;. The Biochemist, 29 (2), 8-10.

7.5 Lappin, JM, Diforti M, Murray RM (2007). Improved understanding and treatment of schizophrenia. European Neuropsychopharmacology, 17, v-vi.

7.6 Di Forti M, Lappin JM, Murray RM (2007). Risk factors for schizophrenia – All roads lead to dopamine. European Neuropsychopharmacology, 17, S101-S107.

7.7 Howes OD, Wheeler MJ, Pilowsky LS, Landau S, Murray RM, Smith S (2007). Sexual function and gonadal hormones in patients taking antipsychotic treatments for schizophrenia or schizoaffective disorder. Journal of Clinical

Psychiatry, 68 (3), 361-367.

7.8 Raznahan A, O’Daly O, Tsapakis E M, Murray R M (2007) Environmental Determinants of Psychosis: A Focus on Drug Abuse . In Recognition and Prevention of Major Mental and Substance Use Disorders. Edited by Tsuang MT, Stone WS, and Lyons MJ. American Psychiatric Publishing Inc. Washington, pp 21-53. .

7.9 Di Forti M, Morrison PD, Butt A, Murray RM (2007). Cannabis use and psychiatric and cognitive disorders: the chicken or the egg? Current Opinion in Psychiatry, 20 (3), 228-234.

7.10 Ayres AM, Busatto GF, Menezes PR, Schaufelberger MS, Coutinho L, Murray RM, McGuire PK, Rushe T, Scazufca M. (2007). Cognitive deficits in first-episode psychosis: a population-based study in São Paulo, Brazil. Schizophrenia Research, 90, 338-343.

7.11 Hall M-H, Rijsdijk F, Kalidindi S, Schulze K, Kravariti E, Kane F, Sham P, Bramon E, Murray RM (2007). Genetic overlap between bipolar illness and event-related potentials. Psychological Medicine, 37, 667-678.

7.12 Kirkbride JB, Fearon P, Morgan C, Dazzan P, Morgan K, Murray RM (2007). Neighbourhood variation in the incidence of psychotic disorders in Southeast London. Social Psychiatry and Psychiatric Epidemiology, 42 (6), 438-445.

51

7.13 Samele C, Patel, M, Boydell J, Leese M, Wessely S, Murray R (2007). Physical illness and lifestyle risk factors in people with their first presentation of psychosis. Social Psychiatry and Psychiatric Epidemiology, 42, 117-124.

7.14 Sukhwinder S. Shergill, Richard A. Kanaan, Xavier A. Chitnis, Owen O’Daly, Derek K. Jones, Sophia Frangou, Steven C.R. Williams, Robert J. Howard, Gareth J.Barker, Robin M. Murray, and Philip McGuire (2007). A diffusion tensor imaging study of fasciculi in schizophrenia. American Journal of Psychiatry, 164 (3), 467-473.

7.15 Lovestone S, Killick R, Di Forti M, Murray R (2007). Schizophrenia as a GSK-3 dysregulation disorder. Trends in Neuroscience, 40 (4), 142-149.

7.16 Dean K, Walsh E, Morgan C, Demjaha A, Dazzan P, Morgan K, Lloyd T, Fearon P, Jones PB, Murray R (2007). Aggressive behaviour in first contact with services: findings from the AESOP First Episode Psychosis Study. Psychological Medicine, 37, 547-557.

7.17 MacCabe JH, Martinsson L, Lichtenstein P, Nilsson E, Cnattingius S, Murray RM, Haltman CM (2007). Adverse pregnancy outcomes in mothers with affective psychosis. Bipolar Disorder, 9, 305-309.

7.18 Morgan C, Kirkbride J, Leff J,, Craig T, Hutchinson G, Mckenzie K, Morgan K, Dazzan P, Doody GA, Jones P, Murray R, Fearon P (2007). Parental separation, loss and psychosis in different ethnic groups: a case-control study. Psychological Medicine, 37, 495-503.

7.19 Ettinger U, Picchioni M, Landau S, Matsumoto K, van Haren NE, Marshall N, Hall M-H, Schulze K, Toulopoulou T, Davies N, Ribchester T, McGuire PK, Murray RM (2007). Magnetic resonance imaging of the thalamus and adhesion interthalamicia in twins with schizophrenia. Archives of General Psychiatry, 64, 401-409.

7.20 Rössler W, Riecher-Rössler, Angst J, Murray R, Gamma A, Eich D, van Os J, Ajdacic Goss A (2007). Psychotic experiences in the general population: A twenty-year prospective community study. Schizophrenia Research, 90, 1-14.

7.21 Murray RM, Dutta R (2007). The right answer for the wrong reasons? World Psychiatry, 6 (2), 29-30.

7.22 Schaufelberger MS, Duran FLS, Lappin JM, Schazufca M, Amaro Jr E, Leite CC, De Castro CC, Murray RM, McGuire PK, Menezes PR, Bustatto GF (2007). Grey matter abnormalities in Brazilians with first-episode psychosis. British Journal of Psychaitry, Suppl S1, 117-122.

7.23 Dutta R, Greene T, Addington J, McKenzie K, Phillips M, Murray RM (2007). Biological, life course, and cross-cultural studies all point toward the value of dimensional and developmental ratings in the classification of psychosis. Schizophrenia Bulletin, 33, 868-876.

7.24 Lewis SW, Barnes TRE, Davies L, Murray RM, Dunn G, Hayhurst KP, Markwick A, Lloyd H, Jones PH (2007). Randomized controlled trial of effect of prescription of Clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Schizophrenia Bulletin, 32 (4), 715-723.

7.25 Hall M, Rijsdijk F, Picchioni M, Schulze K, Ettinger U, Toulopoulou T, Bramon E, Murray RM, Sham P (2007). Substantial Shared Genetic Influences on Schizophrenia and Event-Related Potentials. American Journal of Psychiatry, 164, 804-812.

7.26 Curtis V, Thompson JM, Seal ML, Monks PJ, Lloyd AJ, Harrison L, Brammer N, Williams SCR, Murray RM, Young AH, Ferrier IN, (2007). The Nature of Abnormal Language Processing in Euthymic Bipolar I Disorder: Evidence for a Relationship between Task Demand and Prefrontal Function. Bipolar Disorder, 9, 358-369.

7.27 Tosato S, Ruggeri M, Bonetto C, Bertani M, Marrella G, Lasalvia A, Cristofalo D, Aprili G, Tansella M, Dazzan P, DiForti M, Murray RM, Collier DA (2007). Association study of dysbindin gene with clinical outcome measures in a representative cohort of Italian schizophrenic patients. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics), 144B, 647-659.

7.28 Dean, K, Moran P, Fahy T, Tyrer P, Leese M, Creed F, Burns T, Murray R, Walsh E (2007). Predictors of violent victimization amongst those with psychosis. Acta Psychiaticar Scandinavica, 116, 345-353.

7.29 Picchioni, M, Murray RM (2007). Schizophrenia. British Medical Journal, 335, 91-95.

52

7.30 Ajdacic-Gross V, Luber C, Warnke I, Haker H, Murray RM, Rossler W (2007). Changing incidence of psychotic disorders among the young in Zurich. Schizophrenia Research, 95, 9-18.

7.31 Walshe M, Taylor M, Schulze K, Bramon E, Frangou S, Stahl d, Kravariti E, Daly E, Fearon P, Murray RM, McDonald CM (2007). Familial liability to schizophrenia and premorbid adjustment. British Journal of Psychiatry, 191, 260-261.

7.32 Murray RM, Morrison PD, Henquet C, Di Forti D (2007). Cannabis, the mind and society: the hash reality. Nature Reviews: Neuroscience, 8, 885-895.

7.33 Birkett P, Signundsson T, Sharma T, Toulopoulou T, Griffiths TD, Reveley A, Murray R (2007). Reaction time and sustained attention in schizophrenia and its genetic predisposition. Schizophrenia Research, 95, 76-85.

7.34 Catani M, Allin MP, Husain M, Pugliese L, Mesulam MM, Murray RM, Jones DK (2007). Symmetries in human brain language pathways correlate with verbal recall. Proceedings of the National Academy of Sciences, USA, 104 (43), 17163-8.

7.35 Lappin J, Morgan K, Morgan C, Dazzan P, Reichenberg A, Zanelli J, Fearon P, Jones P, Lloyd T, Tarrant J, Farrant A, Leff J, Murray R (2007). Duration of untreated psychosis and neuropsychological function in first episode psychosis. Schizophrenia Research, 95 (1-3), 103-10.

7.36 Kravariti E, Morris R G, Rabe-Hesketh S, Murray R M and Frangou S (2007). Comparative profile analysis of cognitive function in recent-onset and chronic patients with adolescent-onset schizophrenia. Schizophrenia Research, 94, 240-4.

7.37 Nosarti C, Giouroukou E, Micali N, Rifkin L, Morris R, Murray R (2007). Impaired executive functioning in young adults born very preterm. Journal of the International Neuropsychological Society, 13 (4), 571-81.

7.38 Kirkbride JB, Morgan C, Fearon P, Dazzan P, Murray RM, Jones PB (2007). Neighbourhood-level effects on psychoses: re-examining the role of context. Psychological Medicine, 37, 1413-25.

7.39 Boydell J, Dean K, Dutta R, Giouroukou E, Fearon P, Murray R (2007). A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis. Schizophrenia Research, 93, 203-10.

7.40 Howes O, Wheeler MJ, Pilowsky LS, Landau S, Murray RM, Smith S (2007). Sexual Function and Gonadal Hormones in Patients Taking Antipsychotic Treatment for Schizophrenia or Schizoaffective Disorder. Journal of Clinical Psychiatry, 68, 361-7.

7.41 Dutta R, Boydell J, Kennedy N, van Os J, Fearon P, Murray RM (2007). Suicide and other causes of mortality in bipolar disorder: a longitudinal study. Psychological Medicine, 37, 839-47.

7.42 Schulze K, Hall H, McDonald C, Marshall N, Walshe M, Murray RM, Bramon E (2007). P50 auditory evoked potential suppression in bipolar disorder patients with psychotic features and their unaffected relatives. Biological Psychiatry, 62 , 121-8

7.43 Ma X, Sun J, Yao J, Wang Q, Hu X, Deng W, Sun X, Liu X, Murray RM, Collier DA, Li T (2007). A quantitative association study between schizotypal traits and COMT, PRODH and BDNF genes in a healthy Chinese population. Psychiatry Research, 153, 7-15.

7.44 Menezes PR, Scazufca M, Bustatto G, Coutinho LMS, McGuire P, Murray (2007). Incidence of first contact psychosis in Sao Paulo, Brazil “Brazilian first contact psychosis study” 2007. British Journal of Psychiatry, 191, (Suppl 51), S102-S106.

7.45 Howes OD, Montgomery AJ, Asselin M-C, Murray RM, Grasby PM, McGuire PK (2007). Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phas of psychosis. British Journal of Psychiatry, 191 (Suppl 51), S13-S18.

7.46 Morgan KD, Dazzan P, Orr KG, Hutchinson G, Chitnis X, Suckling J, Lythgoe D, Pollock S-J, Rossell S, Shapleske J, Fearon P, Morgan C, David A, McGuire PK, Jones PB, Leff J, Murray RM (2007). Grey matter abnormalities in

53

first-episode schizophrenia and affective psychosis. British Journal of Psychiatry, 191 (Suppl 51), S111-S116.

7.47 Lappin JM, Dazzan, P, Morgan K, Morgan C, Chitnis X, Suckling J, Fearon P, Jones PB, Leff J, Murray RM, McGuire PK (2007). Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosis. British Journal of Psychiatry, 191 (Suppl 51), S123-S127.

7.48 Toulopoulou T, Picchioni M, Rijsdijk F, Hall M-H, Ettinger U, Sham P, Murray R (2008). Substantial genetic overlap between neurocognitive schizophrenia. Archives of General Psychiatry, 64, 1348-1355.

2008

8.1 Harvey SB, Dean K, Morgan C, Walsh E, Demjaha A, Dazzan P, Mogan K, Lloyd T, Fearon P, Jones PB, Murray RM (2008). Self-harm in first-episode psychosis. British Journal of Psychiatry, 192, 178-184.

8.2 Parker J, Mitchel A, Kalpakidou A, Walshe M, Jung H-Y, Nosarti C, Santosh P, Rifkin L, Wyat J, Murray RM, Allin M (2008). Cerebellar growth and behaviour & neuropsychological outcome in preterm adolescents. Brain, 131, 1344-1351.

8.3 Cooper C, Morgan, C Byrne M, Dazzan P, Morgan K, Hutchinson G, Doody GA, Harrison G, Leff J, Jones P, Ismail K, Murray R, Bebbington PE, Fearon P (2008). Perceptions of disadvantage, ethnicity and psychosis. British Journal of Psychiatry, 192, 185-190.

8.4 Michalopoulou PG, Surguladze S, Morley LA, Giampietro VP, Murray RM, Shergill SS (2008). Facial fear processing and psychotic symptoms in schizophrenia: a functional magnetic resonance imaging study. British Journal of Psychiatry, 192, 191-196.

8.5 PreKumar P, Cooke MA, Fannon D, Peters E, Michel TM, Aasen I, Murray RM, Kuipers E, Kumari V (2008). Misattribution bias of threat-related facial expression is related to a longer duration of illness and poor executive function in schizophrenia and schizoaffective disorder. European Psychiatry, 23, 14-19.

8.6 Toulopoulou T, Chau SE, Lam I, Cheung V, Murray RM (2008). Evidence of normal hearing laterality in familial schizophrenic patients and their relatives. American Journal of Medical Genetics, Part B (Neuropsychiatric Genetics), 147B, 73-76.

8.7 Proitsi P, Li T, Hamilton G, Di Forti M, Collier D, Killick R, Chen R, Sham P, Murray R, Powell J, Lovestone S (2008). Positional pathways of wnt signalling genes in schizophrenia: Association with DKK4. Biological Psychiatry, 63, 13-16.

8.8 Schulze KK, Hall M-H, McDonald C, Marshall N, Walshe M, Murray RM, Bramon E (2008). Auditory P300 in patients with bipolar disorder and their unaffected relatives. Bipolar Disorder, 10, 377-386.

8.9 Nosarti C, Giouroukou, Healy E, Rifkin L, Walshe M, Reichenberg A, Chitnis X, Williams SCR, Murray RM (2008). Grey and white matter distribution in very preterm adolescents mediates neurodevelopmental outcome. Brain, 131, 205-217.

8.10 Lloyd T, Dazzan P, Kean K, Park SBG, Fearon P, Doody GA, Tarrant J, Morgan KD, Morgan C, Hutchinson G, Leff J, Harrison G, Murray RM, Jones PB (2008). Minor physical anomalies in patients with first-episode psychosis: their frequency and diagnostic specificity. Psychological Medicine, 38, 71-77.

8.11 Allin M, Walshe M, Fern A, Nosarti C, Cuddy M, Rifkin L, Murray R, Rushe T, Wyatt J (2008). Cognitive maturation in preterm and term born adolescents. J Neurol Neurosurg & Psychiatry, 79, 381-386.

8.12 Birkett P, Sigmundsson T, Sharma T, Toulopoulou T, Griffiths T, Reveley A, Murray RM (2008). Executive function and genetic predisposition to schizophrenia - The Maudsley Family Study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 147B, 285-293.

54

8.13 Mondelli V, Dazzan P, Gabilondo A, Tournikioti K, Walshe M, Marshall N, Schulze KK, Murray RM, McDonald C, Pariente CM (2008). Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar

disorder. Psychoneuroendocriniology, 33, 1004-1012.

8.14 Rosa, A, Picchioni MM, Kalidindi S, Loat C, Knight J, Toulopoulou T, Vonk R, van der Schot AC, Nolen W, Kahn RS, McGuffin P, Murray RM, Craig, IW (2008) Differential methylation of the x-chromosome is a possible source of discordance for bipolar disorder female monozygotic twins. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 147B, 459-462.

8.15 Flomen RH, Davies AF, Di Forti M, La Cascia C, Mckie-Oglivie C, Murray R, Makoff AJ (2008). The copy number variant involving part of the Alpha-7 nicotinic receptor gene contains a polymorphic inversion. European Journal of

Human Genetics, 16, 1364-1371.

8.16 Murray, RM, Lappin, J, Di Forti M (2008). Schizophrenia: from developmental deviance to dopamine dysregulation. European Neuropsychopharmacology, 18, S129-S134.

8.17 Surguladze SA, Elkin A, ecker C, Kalidindi S, Corsico A, Giampietro V, Lawrence N, Deeley Q, Murphy DG, Kucharska- Pietura K, Russell TA, McGriffin P, Murray R, Phillips ML (2008). Genetic variation in the serotonin

transporter modulates neural system-wide response to fearful faces. Genes Brain Behavior, 7, 543-551.

8.18 Stefansson H, Rujescu D, Cichon S, Pietiläinen OP, Ingason A, Steinberg S, Fossdal R, Sigurdsson E, Sigmundsson T, Buizer-Voskamp JE, Hansen T, Jakobsen KD, Muglia P, Francks C, Matthews PM, Gylfason A, Halldorsson

BV, Gudbjartsson D, Thorgeirsson TE, Sigurdsson A, Jonasdottir A, Jonasdottir A, Bjornsson A, Mattiasdottir S, Blondal T, Haraldsson M, Magnusdottir BB, Giegling I, Möller HJ, Hartmann A, Shianna KV, Ge D, Need AC, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Paunio T, Toulopoulou T, Bramon E, Di Forti M, Murray R, Ruggeri M, Vassos E, Tosato S, Walshe M, Li T, Vasilescu C, Mühleisen

TW, Wang AG, Ullum H, Djurovic S, Melle I, Olesen J, Kiemeney LA, Franke B; GROUP, Sabatti C, Freimer NB, Gulcher JR, Thorsteinsdottir U, Kong A, Andreassen OA, Ophoff RA, Georgi A, Rietschel M, Werge T, Petursson H, Goldstein DB, Nöthen MM, Peltonen L, Collier DA, St Clair D, Stefansson K (2008). Large recurrent microdeletions associated with schizophrenia. Nature, 455, 232-237.

8.19 Argyropoulos SV, Landau S, Kalidindi S, Toulopoulou T, Castle DJ, Murray RM, Picchioni MM (2008). Twins discordant for schizophrenia: psychopathology of the non-schizophrenic co-twins. Acta Psychiaticar Scandinavica, 118, 214-219.

8.20 Prata DP, Mechelli A, Fu CHY, Picchioni M, Kane F, Kalidindi S, McDonald C, Demjaha A, Miorelli A, Murray R, Collier DA, McGuire P (2008). DISC1 effects prefrontal cortical function in healthy subjects. Molecular Psychiatry, 10, 915-917.

8.21 Mapua-Filbey F Russell T, Morris RG, Murray RM, McDonald C (2008). Functional magnetic resonance imaging fMRI) of attention processes in presumed obligate carriers of schizophrenia: preliminary findings. Annals of General Psychiatry, 7:18, 1-13.

8.22 Hall M-H, Schulze K, Sham P, Kalidindi S, McDonald C, Bramon E, Levy DL, Murray RM, Rijsdijk F (2008). Further evidence for shared genetic effects between psychotic bipolar disorder and P50 suppression: A combined twin and family study. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics), 147B, 619-627

8.23 Kirkbride JB, Boydell J, Ploubidis GB, Morgan C, Dazzan P, McKenzie K, Murray RM, Jones PB (2008). Testing the association between the incidence of schizophrenia and social capital in an urban area. Psychological Medicine, 38, 1083-1094.

8.24 Laurens KR, West SA, Murray RM, Hodgins S (2008). Psychotic-like experiences and other antecedents of schizophrenia in children aged 9-12 years: a comparison of ethnic and migrant groups in the United Kingdom. Psychological Medicine, 38, 1103-1111.

8.25 MacCabe JH, Lambe MP, Cnattingius S, Torrang A, Bjork C, Sham PC, David AS, Murray RM, Hultman CM (2008). Scholastic achievement at age 16 and risk of schizophrenia and other psychoses: a national cohort study. Psychological Medicine, 38, 1133-1140.

8.26 Luzi S, Morrison PD, Powell J, Di Forti M, Murray RM (2008). What is the mechanism whereby cannabis use increases risk of psychosis? Neurotoxicity Research, 14, 105-112.

55

8.27 Henquet C, Di Forti M, Morrison P, Kuepper R, Murray RM (2008). Gene-environment interplay between cannabis and psychosis. Schizophrenia Bulletin, 34, 1111-1121.

8.28 Vassos E, Sham PC, Cai G, Deng H, Liu X, Sun X, Zhao J, Murray RM, Collier DA, Li T (2008). Correlation and familial aggregation of dimensions of psychosis in affected sibling pair from China. British Journal of Psychiatry, 193, 305-310.

8.29 Dazzan P, Lloyd T, Morgan KD, Zanelli J, Morgan C, Orr K, Hutchinson G, Fearon P, Allin M, Rifkin L, McGuire PK, Doody GA, Holloway J, Leff J, Harrison G, Jones PB, Murray RM (2008). Neurological abnormalities and cognitive ability in first-episode psychosis. British Journal of Psychiatry, 193, 197-202.

8.30 Filby FM, Toulopoulou T, Morris RG, McDonald C, Bramon E, Walshe M, Murray RM (2008). Selective attention deficits reflect increased genetic vulnerability to schizophrenia. Schizophrenia Research, 101, 169-175.

8.31 Walshe M, Rifkin L, Rooney M, Healy E, Nosariti C, Wyatt J, Stahl D, Murray RM, Allin M (2008). Psychiatric disorder in young adults born very preterm: role of family history. European Psychiatry, 23, 527-531.

8.32 Zanetti MV, Schaufelberger MS, de Castro CC, Menezes PR, Scazufca M, McGuire PK, Murray RM, Busatto GF (2008). White-matter hyperintensities in first-episode psychosis. British Journal of Psychiatry, 193, 25-30.

8.33 Bramon E, Shaikh M, Broome M, Lappin J, Bergé, Day F, Woolley J, Tabraham P, Madré M, Johns L, Howes O, Valmaggia L, Pérez V, Sham P, Murray RM, McGuire P (2008). Abnormal P300 in people with high risk of developing psychosis. NeuroImage, 41, 553-560.

8.34 Cardno AG, Rijsdijk FV, Murray RM, McGuffin P (2008). Twin study refining psychotic symptom dimensions as phenotypes for genetic research. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics) 147B, 1213-1221.

8.35 Hori H, Noguchi H, Hashimoto R, Nakabayashi T, Saitoh O, Murray RM, Okabe S, Kunugi H (2008). Personality in schizophrenia assessed with the temperament and character inventory (TCI). Psychiatry Research, 160, 175-

183.

8.36 Fu, CHY, Williams SCR, Cleare AJ, Scott J, Mitterschiffthaler MT, Walsh ND, Donaldson C, Suckling J, Andrew C, Steiner H, Murray RM (2008). Neural responses to sad facial expressions in major depression following cognitive behavioural therapy. Biological Psychiatry, 64, 505-512.

8.37 Drapier D, Surguladze S, Marshall N, Schulze K, Fern A, Hall M-H, Walshe M, Murray RM, McDonald C (2008). Genetic liability for bipolar disorder is characterized by excess frontal activation in response to a working memory task. Biological Psychiatry, 64, 513-520.

8.38 Morgan C, Kirkbridge J, Hutchinson G, Craig T, Morgan K, Dazzan P, Boydell J, Doody GA, Jones PB, Murray RM, Leff J, Fearon P (2008). Cumulative social disadvantage, ethnicity and first-episode psychosis: a case-control study. Psychological Medicine, 38 1701-1715.

8.39 Mechelli A, Prata DP, Fu CH, Picchioni M, Kane F, Kalidindi S, McDonald C, Demjaha A, Kravariti E, Toulopoulou T, Murray R, Collier DA, McGuire PK (2008). The effects of neuregulin1 on brain function in controls and patients with schizophrenia and bipolar disorder. Neuroimage, 42, 817-26.

8.40 Gibbs AA, Dazzan P, Morgan KD, Naudts K, Morgan C, Hutchinson g, Fearon P, Leff J, Murray RM, David AS (2008). Sexual dimorphic changes in the amygdale in relation to delusional beliefs in first episode psychosos. Journal of Psychiatric Research, 42, 913-919.

8.41 LiT, Ma Xiaohong, Hu X, Wang Y, Yan C, Meng H, Liu X, Toulopoulou T, Murray RM, Collier DA (2008). PRODH gene is associated with executive function in schizophrenic families. American Journal of Medical Genetics Part B (Neuropsychiatric Genetics) 147B, 654-657.

56

2009

9.1 Morgan C, Fisher H, Hutchinson G, Kirkbride J, Craig TK, Morgan K, Dazzan P, Boydell J, Doody GA, Jones PB, Murray RM, Leff J, Fearon P (2009). Ethnicity, social disadvantage and psychotic-like experiences in a healthy population based sample. Acta Psychiatrica Scandinavica, 119, 226-23

9.2 Ihara, K, Morgan C, Fearon P, Dazzan P, Demjaha A, Lloyd T, Kirdbride JB, Hayhurst H, Murray RM, Jones PB (2009). The prevalence, diagnostic significance and demographic characteristics of Schneiderian first-rank symptoms in an epidemiological sample of first-episode psychoses. Psychotherapy, 42, 81-91.

9.3 Lawrence EJ, Rubia K, Murray RM, McGuire PK, Walshe M, Allin M, Giampietro V, Rifkin L, Williams SCR, Nosarti C (2009). The neural basis of response inhibition allocation as medicated by gestational age. Human Brain Mapping, 30, 1038-1050.

9.4 Smith MJ, Thirthalli J, Ben Abdallah A, Murray RM, Cottler LB (2009). Prevalence of psychotic symptoms in substance users: a comparison across substances. Comprehensive Psychiatry, 50, 245-250.

9.5 Prata D, Mechelli A, Fu CHY, Picchioni M, Kane F, Kalidindi S, McDonald C, Howes O, Kravariti E, Demjaha A, Toulopoulou T, DiForti M, Muray RM, Collier DA, McGuire PK (2008). Opposite effects of

catechol-o- methyltransferase val158met on cortical function in healthy subjects and patients with schizophrenia. Biological Psychiatry, 65, 473-380.

9.6 Kravariti E, Schulze K, Kane F, Kalidindi S, Bramon E, Walshe M, Marshall N, Hall M-H, Georgiades A, McDonald C, Murray RM (2009). Stroop-test interference in bipolar disorder. British Journal of Psychiatry, 194, 285-286.

9.7 Fisher H, Morgan C, Dazzan P, Craig TK, Morgan K, Hutchinson G, Jones PB, Doody GA, Pariante C, McGuffin P, Murray RM, Leff J, Fearon P (2009). Gender differences in the association between childhood abuse and psychosis. British Journal of Psychiatry, 194, 319-325.

9.8 Dutt A, McDonald C, Dempster E, Prata D, Shaikh M, Williams I, Schulze K, Marshall N, Walshe M, Allin M, Collier D, Murray R, Bramon E (2009). The effect of COMPT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on

hippocampal and lateral ventricular volume in psychosis. Psychological Medicine, 39, 1783-1797.

9.9 Hall M-H, Schulze K, Rijsdijk F, Kalidindi S, McDonald C, Bramon E, Murray RM, Sham P (2009). Are auditory P300 and duration MMN heritable and putative endophenotypes of psychotic bipolar disorder? A Maudsley bipolar twin and family study. Psychological Medicine, 39, 1277-1287.

9.10 Harland R, Antonova E, Owen GS, Broome M, Landau S, Deeley Q, Murray R (2009). A study of psychiatrists’ concepts of mental health. Psychological Medicine, 39, 1-10.

9.11 Zanelli J, MacCabe J, Toulopoulou T, Walshe M, McDonald C, Murray RM. (2009). Neuropsychological correlates of eye movement abnormalities in schizophrenic patients and their unaffected relatives. Psychiatric Research, 168, 193-197.

9.12 Hall M-H, Taylor G, Sham P, Schulze K, Rijsdijk F, Picchioni M, Toulopoulou T, Ettinger U, Bramon E, Murray RM, Salisbury DF (2009). The early auditory gamma-band response is heritable and a putative endophenotype of schizophrenia. Schizophrenia Bulletin, (on-line pub).NEED TO UPDATE THIS

9.13 Demjaha A, Morgan K, Morgan C, Landau S, Dean K, Reichenberg A, Sham P, Fearon P, Hutchinson G, Jones PB, Murray RM, Dazzan P (2009). Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11? Psychological Medicine 39, 1943-1955.

9.14 Howes OD, Montgomery AJ, Asslin M-C, Murray RM, Valli I, Tabraham P, Bramon-Bosch E, Valmaggia L, Johns L, Broome M, McGuire PK, Grasby PM (2009). Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Archives of General Psychiatry, 66, 13-20.

9.15 Di Forti M, Morgan C, Dazzan P, Pariante C, Mondelli V, Marques TR, Handley R, Luzi S, Russo M, Paparelli A, Butt A,

57

Stilo SA, Wiffen B, Powell J, Murray RM (2009). High-potency cannabis and the risk of psychosis. British

Journal of Psychiatry. 195:488-91.

9.16 Kravariti E, Morgan K, Fearon P, Zanelli JW, Lappin JM, Dazzan P, Morgan C, Doody GA, Harrison G, Jones PB,

Murray RM, Reichenberg A (2009). Neuropsychological functioning in first-episode schizophrenia. British

Journal of Psychiatry. 195:336-45.

9.17 Prata DP, Mechelli A, Fu CH, Picchioni M, Toulopoulou T, Bramon E, Walshe M, Murray RM, Collier DA, McGuire P (2009). Epistasis between the DAT 3' UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia. Proc Natl Acad Sci U S A. 106:13600-5.

9.18 Allan CL, Cardno AG, Rijsdijk FV, Kalidindi S, Farmer A, Murray RM, McGuffin P (2009). Twin study of illness history variables in psychosis. Schizophrenia Research, 115:237-44.

9.19 Chaddock CA, Barker GJ, Marshall N, Schulze K, Hall MH, Fern A, Walshe M, Bramon, E, Chitnis XA, Murray R,

McDonald C, (2009). White matter microstructural impairments and genetic liability to familial bipolar I

disorder. British Journal of Psychiatry 194, 527-534.

9.20 Costafreda SG, Fu CH, Picchioni M, Kane F, McDonald C, Prata DP, Kalidindi S, Walshe M, Curtis V, Bramon E,

Kravariti E, Marshall N, Toulopoulou T, Barker GJ, David AS, Brammer MJ, Murray RM, McGuire PK,

(2009). Increased inferior frontal activation during word generation: a marker of genetic risk for schizophrenia

but not bipolar disorder? Human Brain Mapping 30, 3287-3298.

9.21 Ingason A, Rujescu D, Cichon S, Sigurdsson E, Sigmundsson T, Pietilainen OP, Buizer-Voskamp JE, Strengman E,

Francks C, Muglia P, Gylfason A, Gustafsson O, Olason PI, Steinberg S, Hansen T, Jakobsen KD, Rasmussen

HB, Giegling I, Moller HJ, Hartmann A, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-

Henriksson A, Bramon E, Kiemeney LA, Franke B, Murray R, Vassos E, Toulopoulou T, Muhleisen TW, Tosato

S, Ruggeri M, Djurovic S, Andreassen OA, Zhang Z, Werge T, Ophoff RA, Rietschel M, Nothen MM, Petursson

H, Stefansson H, Peltonen L, Collier D, Stefansson K, Clair DM, (2009). Copy number variations of chromosome 16p131 region associated with schizophrenia. Molecular Psychiatry (on-line pub).NEED

TO UPDATE

9.22 Morrison, PM, Zois V, McKeown DA, Lee TD, Holt DW, Powell JF, Kapur S, Murray RM (2009). The acute affects of

synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychological Medicine, 29, 1607-1616.

9.23 Prata DP, Mechelli A, Picchioni MM, Fu CH, Toulopoulou T, Bramon E, Walshe M, Murray RM, Collier DA, McGuire P (2009). Altered effect of dopamine transporter 3'UTR VNTR genotype on prefrontal and striatal function in schizophrenia. Arch Gen Psychiatry, 66, 1162-1172.

9.24 Quraishi S, Walshe M, McDonald C, Schulze K, Kravariti E, Bramon E, Morris RG, Murray RM, Toulopoulou T (2009) Memory functioning in familial bipolar I disorder patients and their relatives. Bipolar Discorder 11, 209-214.

9.25 Rujescu D, Ingason A, Cichon S, Pietilainen OP, Barnes MR, Toulopoulou T, Picchioni M, Vassos,E, Ettinger U, Bramon E, Murray R, Ruggeri M, Tosato S, Bonetto C, Steinberg S, Sigurdsson E, Sigmundsson T, Petursson H, Gylfason A, Olason PI, Hardarsson G, Jonsdottir GA, Gustafsson O, Fossdal R, Giegling I, Moller HJ, Hartmann AM,

58

http://www.ncbi.nlm.nih.gov/pubmed/19949195






Hoffmann P, Crombie C, Fraser G, Walker N, Lonnqvist J, Suvisaari J, Tuulio-Henriksson A, Djurovic S, Melle I, Andreassen OA, Hansen T, Werge T, Kiemeney LA, Franke B, Veltman J, Buizer-Voskamp JE, Sabatti C, Ophoff RA, Rietschel M, Nothen MM, Stefansson K, Peltonen L, St Clair D, Stefansson H, Collier DA (2009). Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet, 18, 988-996.

9.26 Stefansson H, Ophoff RA, Steinberg S, Andreassen OA, Cichon S, Rujescu D, Werge T, Pietilainen OP, Mors O, Mortensen PB, Sigurdsson E, Gustafsson O, Nyegaard M, Tuulio-Henriksson A, Ingason A, Hansen T, Suvisaari J, Lonnqvist J, Paunio T, Borglum AD, Hartmann A, Fink-Jensen A, Nordentoft M, Hougaard D, Norgaard-Pedersen B, Bottcher Y, Olesen J, Breuer R, Moller HJ, Giegling I, Rasmussen HB, Timm S, Mattheisen M, Bitter I, Rethelyi JM, Magnusdottir BB, Sigmundsson T, Olason P, Masson G, Gulcher JR, Haraldsson M, Fossdal R, Thorgeirsson TE, Thorsteinsdottir U, Ruggeri M, Tosato S, Franke B, Strengman E, Kiemeney LA, Melle I, Djurovic S, Abramova L, Kaleda V, Sanjuan J, de Frutos R, Bramon E, Vassos E, Fraser G, Ettinger U, Picchioni M, Walker N, Toulopoulou T, Need AC, Ge D, Yoon JL, Shianna KV, Freimer NB, Cantor RM, Murray R, Kong A, Golimbet V, Carracedo A, Arango C, Costas J, Jonsson EG, Terenius L, Agartz I, Petursson H, Nothen MM, Rietschel M, Matthews PM, Muglia P, Peltonen L, St Clair D, Goldstein DB, Stefansson K, Collier DA (2009). Common variants conferring risk of schizophrenia. Nature, 460, 744-747.

9.27 Picchioni MM, Walshe M, Toulopoulou T, McDonald C, Taylor M, Waters-Metenier S, Bramon E, Regojo A, Murray, RM, Rijsdijk F (2009). Genetic modelling of childhood social development and personality in twins and siblings with schizophrenia. Psychological Medicine, 40, 8, 1305-1316.

9.28 Narberhaus A, Lawrence E, Allin MP, Walshe M, McGuire P, Rifkin L, Murray R, Nosarti C (2009). Neural substrates of visual paired associates in young adults with a history of very preterm birth: Alterations in fronto-parieto-occipital networks and caudate neucleus. NeuroImag, 47, 1884-1893.

9.29 Minatogawa-Chang TM, Schaufelberger MS, Ayres AM, Duran FLS, Gutt EK, Murray RM, Rushe TM, McGurei PK, Menezes PR, Scazufca M, Busatto GF (2009). Cognitive performance is related to cortical grey matter volumes in early stages of schizophrenia: A population-based study of first-episode psychosis. Schizophrenia Research, 200-209.

9.30 Nosarti C, Shergill SS, Allin MP, Walshe M, Rifkin L, Murray RM, McGuire PK (2009). Neural substrates of letter fruency processing I young adults who were born very preterm: Alterations in frontal and striatal regions. NeuroImage, 47, 1904-1933.

9.31 Morrison PD, Murray RM (3009). From real-world events to psychosis: The emerging neuropharmacology of delusions. Schizophrenia Bulletin, 45, 668-674.

9.32 Krabbendam L, O’Daly O, Morley LA, van Os J, Murray RM, Shergill SS (2009). Using the Stroop task to investigate the neural correlates of symptom change in schizophrenia. British Journal of Psychiatry, 194, 373-374.

9.33 Kravariti E, Reichenberg A, Morgan K, Dazzan P, Morgan C, Zanelli JW, Lappin JM, Doody GA, Harrison G, Jones PB, Murray RM, Fearon P (2009). Selective deficits in semantic verbay fluency in patients with a first affective episode with psychotic symptoms and a positive history of mania. Bipolar Disorder, 11, 323 329.

2010

10.1 Zanelli J, Reichenberg A, Morgan K, Fearon P, Kravariti E, Dazzan P, Morgan C, Zanelli C, Demjaha A, Jones PB, Doody GA (2010). Specific and generalized neuropsychological deficits: A comparison of patients with various first-episode psychosis presentations. American Journal of Psychiatry, 167, 78-85.

10.2 Shaikh M, Hall MH, Schulze, K, Dutt A, Walshe M, Williams I, Constante M, Picchioni M, Toulopoulou T , Collier D, Rijsdijk F, Powell J, Arranz M, Murray RM, Bramon E (2010). Do COMT, BDNF and NRG1 polymorphisms influence P50 sensory gating in psychosis? Psychological Medicine, 1-14.

10.3 Steinberg S, Mors O, Borglum AD, Gustafsson O, Werge T, Mortensen PB, Andreassen OA, Sigurdsson E , Thorgeirsson TE, Bottcher Y, Olason P, Ophoff RA , Cichon S, Gudjonsdottir IH, Pietilainen OP, Nyegaard M, Tuulio- Henriksson A, Ingason A, Hansen T, Athanasiu L, Suvisaari J, Lonnqvist J, Paunio T, Hartmann A, Jurgens G,

Nordentoft M, Hougaard D, Norgaard-Pedersen B, Breuer R, Moller H J, Giegling I, Glenthoj B, Rasmussen HB, Mattheisen M, Bitter I, Rethelyi J M, Sigmundsson T, Fossdal R, Thorsteinsdottir U, Ruggeri M, Tosato S,

59

Strengman E, Kiemeney LA, Melle I, Djurovic S, Abramova L, Kaleda V, Walshe M, Bramon E, Vassos E , Li T, Fraser G, Walker N, Toulopoulou T, Yoon J, Freimer N B , Cantor, R M , Murray, R , Kong, A , Golimbet,

V, Jonsson, E G , Terenius, L , Agartz, I , Petursson, H , Nothen, M M, Rietschel M, Peltonen L, Rujescu D, Collier DA, Stefansson H, St Clair D, Stefansson K (2010). Expanding the range of ZNF804A variants conferring risk of psychosis. Molecular Psychiatry, (on-line pub) 1-8.

10.4 Ingason A, Giegling I, Cichon S, Hansen T, Rasmussen HB, Nielsen J, Jurgen G, Muglia P, Hartmann AM, Strengman E, Vasilescu C, Muhleisen TW, Djurovic S, Melle I, Lerer B, Moller H-J, Francks C, Pietilainen O PH, Lonnqvist

J, Suvisaari J, Tuulio-Henriksson A, Walsh M, Vassos E, Di Forti M, Murray R, BOnetto C, Tosato S; Group Investigators: Cantor RM, Rietschel M, Craddock N, Owen MJ, Peltonen L, Andreassen OA, Nothen MM, St Clair D, Ophoff RA, O’Donovan MC, Collier DA, Werge T, Rujescu D (2010). A large replication study and meta-analysis in European samples provides further support for association of AHI1 markers with

schizophrenia. Human Molecular Genetics, 19, 7, 1379-1386.

10.5 Lawrence EJ, Allen GM, Walshe M, Allin M Murray R, Rifkin L, McGuire PK, Nosarti (20100. The corpus callosum and empathy in adults with a history of preterm birth. Journal of the International Neuropsychological Society, 16,

716-720.

10.6 Ettinger U, Schmechtig A, Toulopoulou t, Borg C, Orrells C, Owens S, Matsumoto K, van Haren NE, Hall M-H, Kumari V, McGuire PK, Murray RM, Picchioni M (2010). Prefrontal and Striatal volumes in monozygotic twins concordant and discordant for schizophrenia. Schizophrenia Bulletin, MISSING

10.7 Morgan C, Charalambides M, Hutchinson g, Murray RM (2010). Migration, ethnicity, and pshchosis: towards a sociodevelopmental model. Schizophrenia Bulletin, 36, 655-664.

10.8 Borgwardt SJ, Picchioni MM, Ettinger U, Toulopoulou T, Murray R, McGuire PK (2010). Regional gray matter volume in monozygotic twins concordant and discordant for schizophrenia. Biological Psychiatry, 67, 956-964.

10.9 Laurens KR, Hodgins S, Mould GL, West SA, Schoenberg PLA, Murray RM, Taylor EA (2010). Error-related processing dysfunction I children aged 9 to 12 years presenting putative antecdents of schizophrenia. Biological Psychiatry, 67, 238-245.

10.10 Morgan KD, Dazzan P, Morgan C, Lappin J, Hutchinson G, Chitnis X, Suckling J, Fearon P, Jones PB, Leff J, Murray RM (2010). Differing patterns of brain structure abnormalities between black and white patients with their first

episode of psychosis. Psychological Medicine, 40, 1137-1147.

10.11 Kravariti E, Jacobson C, Morris R, Frangou S, Murray RM, Tsakanikos E, Habel A, Sherer J (2010). Memory in intellectually matched groups of yung participants with 22q11.2 deletion syndrome and those with schizophrenia. Research in Developmental Disabilities, 31, 864-868.

10.12 Mazzoncini R, Donoghue K, Hart J, Morgan C, Doody GA, Dazzan P, Jones PB, Morgan K, Murray RM, Fearon P (2010). Illicit substance use and its correlates in frst episode psychosis. Acta Psychiatrica Scandinavica, 121, 351-358.

10.13 MacCabe JH, Lambe MP, Cnattingius S, Sham PC, David AS, Reichenberg A, Murray RM, Hultman CM (2010). Excellent school performance at age 16 and risk of adult bipolar disorder: national cohort study. British Journal

of Psychiatry, 196 109-115.

10.14 Mondelli V, Dazzan P, Hepgul N, Di Forti M, Aas M, D’Albenzio A, Di Nicola M, Fisher H, Hanley R, Reis Marques T, Morgan C, Navari S, Taylor H, Papadopoulos, Aitchison KJ, Murray RM, Pariante CM (2010). Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: The role of stress and of antipsychotic treatment. Schizophrenia Research, 116, 234-242.

10.15 Kirkwood JB, Lunn DJ, Morgan C, Lappin JM, Dazzan P, Morgan K, Fearon P, Murray RM, Jones PB (2010). Examining evidence for neghbourhood variation in the duration of untreated psychosis. Health & Place, 219-225.

10.16 Reichenberg A, Caspi A, Harrington H, Houts R, Keefe RSE, Murray RM, Poulton R, Moffitt TE (2010). Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. American Journalof


60

10.17 Lawrence JM, McGuire PK, Allin M, Walshe M, Giampietro V, Murray RM, Rifkin L, Nosariti C (2010). The very preterm brain in young adulthood: The neural correlates of verbal paired associate learning. The Journal of

Pediatrics, 889-895.

Papers in Press

Lawrence EJ, McGuire PK, Allin M, Walshe M, Giampietro V, Murray RM, Rifkin L & Nosarti C (2010) The Very Preterm Brain in Young Adulthood: The Neural Correlates of Verbal Paired Associate Learning. Journal of Pediatrics. In press.

Vassos E, Bramon E, Picchioni M, Walshe M, Filbey FM, Kravariti E, McDonald C, Murray RM, Collier DA, Toulopoulou T (2010). Evidence of association of KIBRA genotype with episodic memory in families of psychotic patients and controls. Journal of Psychiatr Research,

Surguladze SA, Marshall N, Schulze K, Hall M-H, Walshe M, Bramon E, Phillips ML, Murray RM, McDonald C (2010). Exaggerated neural response to emotional faces in patients with bipolar disorder and their first degree. NeuroImaging. In press.

Prata DP, Brammer M, Barker G, Picchioni M, Fu C, Kane F, Kalidindi S, McDonald C, Kravariti E, Toulopoulou T, Bramon E, Walshe M, Murray R, Collier DA, McGuire PK. Effect of Oligodentrocyte Transcription Factor 2 (OLIG2) on white matter integrity in healthy subjects and in schizophrenia. In Preparation.

Prata DP, Mechelli A, Fu C, Picchioni M, Kane F, Kalidindi S, McDonald C, Kravariti E, Toulopoulou T, Bramon E, Walshe M, Murray R, Collier DA, McGuire PK. Effect of G7 on cortical functional during verbal fluency. Under review.

61

Documents

CURRICULUM VITAE - UCOMcGuffin P and Murray R M (Eds). Butterworth-Heinmann: Oxford 1991. 5a. Schizophrenia (First Edition) Frangou S and Murray R M. Martin Dunitz: London 1996. (Revised